Author: "Gerald Yonga" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Gerald Yonga"' showing total 73 results

Start Over Author "Gerald Yonga"

73 results on '"Gerald Yonga"'

1. Climate change and health risks in Mukuru informal settlement in Nairobi, Kenya – knowledge, attitudes and practices among residents

Author: Johanne Greibe Andersen, Per Kallestrup, Catherine Karekezi, Gerald Yonga, and Christian Kraef
Subjects: Climate change, Health Knowledge, attitudes, practice, Informal settlements, Slums, Non-communicable diseases, Communicable diseases, Public aspects of medicine, RA1-1270
Abstract: Abstract Background Residents of informal settlements in Sub-Sahara Africa (SSA) are vulnerable to the health impacts of climate change. Little is known about the knowledge, attitudes and practices (KAP) of inhabitants of informal settlements in SSA regarding climate change and its health impacts. The aim of this study was to investigate how inhabitants of an informal settlement in SSA experience climate change and its health impacts and assess related knowledge, attitudes and practices. The study was conducted in Mukuru informal settlement in Nairobi City County, Kenya. Methods A cross-sectional study was conducted in September 2021 using a structured, semi-closed KAP questionnaire. Inclusion criteria were ≥ 18 years of age and living in one of the three main sections in Mukuru: Kwa Njenga, Kwa Reuben or Viwandani. By spinning a pen at the geographic centre of each section, a random direction was selected. Then, in every second household one individual was interviewed, creating a representative mix of ages and genders of the local community. To assess participant characteristics associated with climate change knowledge multivariable logistic regression was used. Thematic content analysis was performed for qualitative responses. Results Out of 402 study participants, 76.4% (n = 307) had heard of climate change before the interview, 90.8% (n = 365) reported that climate change was affecting their community, and 92.6% (n = 372) were concerned with the health-related impact of climate change. Having lived in Mukuru for more than 10 years and living in a dwelling close to the riverside were factors significantly associated with having heard of climate change before (aOR 3.1, 95%CI 1.7 – 5.8 and aOR 2.6, 95%CI 1.1 – 6.1, respectively) and experiencing a climate change related impact on the community (aOR 10.7, 95%CI 4.0 – 28.4 and aOR 7.7; 95%CI 1.7 – 34.0, respectively). Chronic respiratory conditions, vector-borne diseases, including infectious diarrhoea, malnutrition and cardiovascular diseases were identified by respondents as climate related health risks. Conclusions Most respondents were knowledgeable about climate change and were experiencing its (health-related) impact on their community. This study provides insights which may prove useful for policy makers, intervention planners and researchers to work on locally adapted mitigation and adaption strategies.
Published: 2023
Full Text: View/download PDF

2. Improved blood pressure control via a novel chronic disease management model of care in sub‐Saharan Africa: Real‐world program implementation results

Author: Harun A. Otieno, Charles Miezah, Gerald Yonga, Fred Kueffer, Molly Guy, Chemuttaai Lang'At, Douglas A. Hettrick, and Roland Schmieder
Subjects: blood pressure control, digital health, Ghana, hypertension, innovation, Kenya, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract: Abstract A chronic disease management model of care (Empower Health) was launched in rural and urban areas of Ghana and Kenya in 2018. The goal was to improve disease awareness, reduce the burden of disease, and improve the clinical effectiveness and efficiency of managing hypertension. Leveraging the model, clinicians provide patients with tailored management plans. Patients accessed regular blood pressure checks at home, at the clinic, or at community‐partner locations where they received real‐time feedback. On the mobile application, clinicians viewed patient data, provided direct patient feedback, and wrote electronic prescriptions accessible through participating pharmacies. To date, 1266 patients had been enrolled in the “real‐world” implementation cohort and followed for an average of 351 ± 133 days across 5 facilities. Average baseline systolic blood pressure (SBP) was 145 ± 21 mmHg in the overall cohort and 159 ± 16 mmHg in the subgroup with uncontrolled hypertension (n = 743) as defined by baseline SBP ≥ 140 mmHg. SBP decreased significantly through 12 months in both the overall cohort (−9.4 mmHg, p
Published: 2021
Full Text: View/download PDF

3. Burden of prehypertension among adults in Kenya: a retrospective analysis of findings from the Healthy Heart Africa (HHA) Programme

Author: Jared O. Mecha, Elizabeth N. Kubo, Collins O. Odhiambo, Freda G. Kinoti, Kennedy Njau, Gerald Yonga, and Elijah N. Ogola
Subjects: Prehypertension, Prevalence, Cardiovascular disease, Kenya, Sub-Saharan Africa, Public aspects of medicine, RA1-1270
Abstract: Abstract Background Hypertension is the leading risk factor for mortality globally. African countries, including Kenya, have a high and rising prevalence of hypertension. Prehypertension is associated with an increased risk of progression to overt hypertension and a higher risk of cardiovascular disease and mortality. Despite this, little is documented on the prevalence and distribution of prehypertension in sub-Saharan Africa. This study sought to estimate the overall burden of prehypertension in Kenyan adults enrolled in a large hypertension control programme, Healthy Heart Africa. The distribution and determinants of prehypertension in the sample were explored as secondary objectives. Methods This was a post hoc analysis of cross-sectional data obtained from population-level blood pressure (BP) screening of adults aged ≥18 years in the community and ambulatory care facilities in 17/47 sub-national administrative units in Kenya. All participants with a complete record for systolic and diastolic BP were included. Descriptive analyses were performed for sociodemographic characteristics. Pearson’s chi-square test was used to assess differences in categorical variables. Multivariate logistic regression analysis was performed to identify factors independently associated with prehypertension. Results Of 5,985,185 participant records that were included in the analysis, 34% were men (mean age: 45 [SD 2.9] years). The majority (63%) lived in rural Kenya. The prevalence of prehypertension was 54.5% and that of hypertension was 20.8%. Characteristics that were independently associated with prehypertension (adjusted odds ratio [95% CI]) included male sex (1.23 [±0.0023], p 25 years) and rural residence (1.60 [±0.023], p
Published: 2020
Full Text: View/download PDF

4. Prevalence and factors associated with overweight and obesity in Kenya

Author: Rahma Mkuu, Adam Barry, Gerald Yonga, Fredrick Nafukho, Cort Wernz, Tamika Gilreath, Muhammad A.B. Chowdhury, and Idethia Shevon Harvey
Subjects: Overweight and Obesity, Prevalence, Risk Factors, Medicine
Abstract: Overweight and obesity rates continue to rise globally and are associated with increased chronic disease morbidity and mortality. There is evidence of high overweight and obesity prevalence in Kenya, however; a gap exists in the knowledge of national prevalence and predictors of overweight and obesity.This cross-sectional study examined data from the 2015 World Health Organization (WHO) Kenya STEPwise Survey—the first nationally representative survey to objectively measure body mass index (BMI) among Kenyan men and women. Descriptive and logistic regression analysis of 4,340 adults aged 18–69 years examined the prevalence, sociodemographic, and behavioral risk factors associated with having overweight or obesity (overweight/obesity) defined by WHOThe mean BMI was 23.51 with 31.13% having overweight/obese. The likelihood of having overweight/obesity was significantly higher among married individuals [odds ratio (OR) = 1.78, 95% confidence interval (CI) 1.19, 2.66], women (OR = 4.08, 95% CI 3.02, 5.51), urban dwellers (OR = 1.70, 95% CI 1.28, 2.25) and middle wealth or higher (OR = 2.45, 95% CI 1.91, 3.14). The likelihood of having overweight/obesity increased by age, compared to 18–29-year olds; (30–44 years (OR = 2.05 95% CI 1.50, 2.80), 45–59-year olds (OR = 2.67, 95% CI 1.97, 3.63), 60–69-year olds (OR = 3.00, 95% CI 1.99, 4.51). Adults with completed primary education or more had higher odd of having overweight/obesity (OR = 2.15, 95% CI 1.72, 2.70). compared to adults with less than primary education.Likelihood of having Overweight/obesity was highest among women, urban residents, and individuals with high education and wealth. Future studies should ascertain drivers of overweight/obesity to inform Targeted and tailored interventions and policies amongst high-risk groups.
Published: 2021
Full Text: View/download PDF

5. Climate change and health in urban informal settlements in low- and middle-income countries – a scoping review of health impacts and adaptation strategies

Author: Frederikke Højgaard Borg, Johanne Greibe Andersen, Catherine Karekezi, Gerald Yonga, Peter Furu, Per Kallestrup, and Christian Kraef
Subjects: climate change, informal settlements, non-communicable diseases, communicable diseases, low- and middle-income countries, Public aspects of medicine, RA1-1270
Abstract: Background: Climate change affects human health with those with the least resources being most vulnerable. However, little is known about the impact of climate change on human health and effective adaptation methods in informal settlements in low- and middle-income countries. Objective: The objective of this scoping review was to identify, characterize, and summarize research evidence on the impact of climate change on human health in informal settlements and the available adaptation methods and interventions. Method: A scoping review was conducted using the Arksey and O’Malley framework. The four bibliographic databases PubMed, Web of Science, Embase, and the Cochrane library were searched. Eligibility criteria were all types of peer-reviewed publications reporting on climate change or related extreme weather events (as defined by the United Nations Framework Convention on Climate Change), informal settlements (as defined by UN-Habitat), low- and middle-income countries (as defined by the World Bank) and immediate human health impacts. Review selection and characterization were performed by two independent reviewers using a predefined form. Results: Out of 1197 studies initially identified, 15 articles were retained. We found nine original research articles, and six reviews, commentaries, and editorials. The articles were reporting on the exposures flooding, temperature changes and perceptions of climate change with health outcomes broadly categorized as mental health, communicable diseases, and non-communicable diseases. Six studies had a geographical focus on Asia, four on Africa, and one on South America, the remaining four articles had no geographical focus. One article investigated an adaptation method for heat exposure. Serval other adaptation methods were proposed, though they were not investigated by the articles in this review. Conclusion: There is a paucity of original research and solid study designs. Further studies are needed to improve the understanding of the impact, the most effective adaptation methods and to inform policy making.
Published: 2021
Full Text: View/download PDF

6. Fighting non-communicable diseases in East Africa: assessing progress and identifying the next steps

Author: Per Kallestrup, Joseph Mucumbitsi, Christian Kraef, Kaushik Ramaiya, Pamela A Juma, Francois Ndikumwenayo, and Gerald Yonga
Subjects: Medicine (General), R5-920, Infectious and parasitic diseases, RC109-216
Abstract: Sub-Saharan Africa has seen a rapid increase in non-communicable disease (NCD) burden over the last decades. The East African Community (EAC) comprises Burundi, Rwanda, Kenya, Tanzania, South Sudan and Uganda, with a population of 177 million. In those countries, 40% of deaths in 2015 were attributable to NCDs. We review the status of the NCD response in the countries of the EAC based on the available monitoring tools, the WHO NCD progress monitors in 2017 and 2020 and the East African NCD Alliance benchmark survey in 2017. In the EAC, modest progress in governance, prevention of risk factors, monitoring, surveillance and evaluation of health systems can be observed. Many policies exist on paper, implementation and healthcare are weak and there are large regional and subnational differences. Enhanced efforts by regional and national policy-makers, non-governmental organisations and other stakeholders are needed to ensure future NCD policies and implementation improvements.
Published: 2020
Full Text: View/download PDF

7. The COVID-19 Pandemic and Non-communicable Diseases—A Wake-up Call for Primary Health Care System Strengthening in Sub-Saharan Africa

Author: Christian Kraef, Pamela Juma, Per Kallestrup, Joseph Mucumbitsi, Kaushik Ramaiya, and Gerald Yonga
Subjects: Computer applications to medicine. Medical informatics, R858-859.7, Public aspects of medicine, RA1-1270
Abstract: Strengthening Primary Health Care Systems is the most effective policy response in low-and middle-income countries to protect against health emergencies, achieve universal health coverage, and promote health and wellbeing. Despite the Astana declaration on primary health care, respective investment is still insufficient in Sub-Sahara Africa. The SARS-CoV-2019 pandemic is a reminder that non-communicable diseases (NCDs), which are increasingly prevalent in Sub-Sahara Africa, are closely interlinked to the burden of communicable diseases, exacerbating morbidity and mortality. Governments and donors should use the momentum created by the pandemic in a sustainable and effective way by pivoting health spending towards primary health care.
Published: 2020
Full Text: View/download PDF

8. Response to: Cavagna et al The importance of considering cultural and environmental elements in an interventional model of care to fight hypertension in Africa

Author: Harun A. Otieno, Charles Miezah, Gerald Yonga, Fred Kueffer, Molly Guy, Chemuttaai Lang’at, Douglas A. Hettrick, and Roland Schmieder
Subjects: Diseases of the circulatory (Cardiovascular) system, RC666-701
Published: 2021
Full Text: View/download PDF

9. Health disparities across the counties of Kenya and implications for policy makers, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Author: Tom Achoki, PhD, Molly K Miller-Petrie, MSc, Scott D Glenn, MSc, Nikhila Kalra, DPhil, Abaleng Lesego, MIHMEP, Gladwell K Gathecha, MS, Uzma Alam, PhD, Helen W Kiarie, MS, Isabella Wanjiku Maina, MPH, Ifedayo M O Adetifa, PhD, Hellen C Barsosio, MSc, Tizta Tilahun Degfie, PhD, Peter Njenga Keiyoro, ProfPhD, Daniel N Kiirithio, MSc, Yohannes Kinfu, PhD, Damaris K Kinyoki, PhD, James M Kisia, MD, Varsha Sarah Krish, BA, Abraham K Lagat, BS, Meghan D Mooney, BS, Wilkister Nyaora Moturi, PhD, Charles Richard James Newton, ProfMD, Josephine W Ngunjiri, Dr PHD, Molly R Nixon, PhD, David O Soti, MD, Steven Van De Vijver, PhD, Gerald Yonga, ProfMD, Simon I Hay, ProfFMedSci, Christopher J L Murray, ProfDPhil, and Mohsen Naghavi, ProfMD
Subjects: Public aspects of medicine, RA1-1270
Abstract: Summary: Background: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 provided comprehensive estimates of health loss globally. Decision makers in Kenya can use GBD subnational data to target health interventions and address county-level variation in the burden of disease. Methods: We used GBD 2016 estimates of life expectancy at birth, healthy life expectancy, all-cause and cause-specific mortality, years of life lost, years lived with disability, disability-adjusted life-years, and risk factors to analyse health by age and sex at the national and county levels in Kenya from 1990 to 2016. Findings: The national all-cause mortality rate decreased from 850·3 (95% uncertainty interval [UI] 829·8–871·1) deaths per 100 000 in 1990 to 579·0 (562·1–596·0) deaths per 100 000 in 2016. Under-5 mortality declined from 95·4 (95% UI 90·1–101·3) deaths per 1000 livebirths in 1990 to 43·4 (36·9–51·2) deaths per 1000 livebirths in 2016, and maternal mortality fell from 315·7 (242·9–399·4) deaths per 100 000 in 1990 to 257·6 (195·1–335·3) deaths per 100 000 in 2016, with steeper declines after 2006 and heterogeneously across counties. Life expectancy at birth increased by 5·4 (95% UI 3·7–7·2) years, with higher gains in females than males in all but ten counties. Unsafe water, sanitation, and handwashing, unsafe sex, and malnutrition were the leading national risk factors in 2016. Interpretation: Health outcomes have improved in Kenya since 2006. The burden of communicable diseases decreased but continues to predominate the total disease burden in 2016, whereas the non-communicable disease burden increased. Health gains varied strikingly across counties, indicating targeted approaches for health policy are necessary. Funding: Bill & Melinda Gates Foundation.
Published: 2019
Full Text: View/download PDF

10. The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus

Author: Violet Awori, Peter Mativo, Gerald Yonga, and Reena C. Shah
Subjects: Neurocognition, HIV, Public aspects of medicine, RA1-1270, Infectious and parasitic diseases, RC109-216
Abstract: Background: Asymptomatic cognitive impairment in human immunodeficiency virus (HIV)-infected patients has recently been recognised as part of HIV-associated neurocognitive disorders. This has been implicated as one of the causes of poor adherence to antiretroviral therapy (ART). Objective: To assess the association between neurocognitive impairment (asymptomatic and mild forms) and adherence to ART. Methods: This was a cross-sectional survey involving 218 participants consecutively sampled from those attending the HIV treatment clinic at Aga Khan University Hospital in Nairobi. Data collected included quantitative primary data on pre-defined baseline characteristics, neurocognitive assessment by Montreal Cognitive Assessment (MoCA) tool (Appendix 1), instrumental activities of daily living by Lawton score and objective and subjective adherence measures by medication possession ratio (MPR) and simplified medication adherence questionnaire (SMAQ) (see Appendix 2). Univariate and bivariate analyses were conducted to determine the strengths of association between predictor and the outcome variables. Results: Among the 218 participants in the study, a total of 69% had asymptomatic to mild neurocognitive impairment as assessed by the MoCA tool, while a total of 66% were determined as being adherent to ART by objective measures (by MPR) compared to subjective rates of 77% as assessed by SMAQ. However, no statistically significant association was observed between the presence of asymptomatic or mild neurocognitive impairment and likelihood of adherence to ART (p > 0.05). Conclusion: Even though asymptomatic and mild forms of cognitive impairment are prevalent in the population studied, there was no significant association between cognitive impairment and adherence to treatment.
Published: 2018
Full Text: View/download PDF

11. Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors.

Author: Sujha Subramanian, Robai Gakunga, Joseph Kibachio, Gladwell Gathecha, Patrick Edwards, Elijah Ogola, Gerald Yonga, Naftali Busakhala, Esther Munyoro, Jeremiah Chakaya, Nancy Ngugi, Nyawira Mwangi, Daniel Von Rege, Lili-Marie Wangari, David Wata, Robert Makori, Julius Mwangi, Walter Mwanda, and East African Economics and Implementation Group (EAEIG)
Subjects: Medicine, Science
Abstract: The prevalence of non-communicable diseases (NCDs) is rising in low- and middle-income countries, including Kenya, disproportionately to the rest of the world. Our objective was to quantify patient payments to obtain NCD screening, diagnosis, and treatment services in the public and private sector in Kenya and evaluate patients' ability to pay for the services.We collected payment data on cardiovascular diseases, diabetes, breast and cervical cancer, and respiratory diseases from Kenyatta National Hospital, the main tertiary public hospital, and the Kibera South Health Center-a public outpatient facility, and private sector practitioners and hospitals. We developed detailed treatment frameworks for each NCD and used an itemization cost approach to estimate payments. Patient affordability metrics were derived from Kenyan government surveys and national datasets. Results compare public and private costs in U.S. dollars. NCD screening costs ranged from $4 to $36, while diagnostic procedures, particularly for breast and cervical cancer, were substantially more expensive. Annual hypertension medication costs ranged from $26 to $234 and $418 to $987 in public and private facilities, respectively. Stroke admissions ($1,874 versus $16,711) and dialysis for chronic kidney disease ($5,338 versus $11,024) were among the most expensive treatments. Cervical and breast cancer treatment cost for stage III (curative approach) was about $1,500 in public facilities and more than $7,500 in the private facilities. A large proportion of Kenyans aged 15 to 49 years do not have health insurance, which makes NCD services unaffordable for most people given the overall high cost of services relative to income (average household expenditure per adult is $413 per annum).There is substantial variation in patient costs between the public and private sectors. Most NCD diagnosis and treatment costs, even in the public sector, represent a substantial economic burden that can result in catastrophic expenditures.
Published: 2018
Full Text: View/download PDF

12. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial

Author: Mark, Loeb, Ambuj, Roy, Hisham, Dokainish, Antonio, Dans, Lia M, Palileo-Villanueva, Kamilu, Karaye, Jun, Zhu, Yan, Liang, Fastone, Goma, Albertino, Damasceno, Khalid F, Alhabib, Gerald, Yonga, Charles, Mondo, Wael, Almahameed, Arif, Al Mulla, Vitheya, Thanabalan, Purnima, Rao-Melacini, Alex, Grinvalds, Tara, McCready, Shrikant I, Bangdiwala, and Salim, Yusuf
Subjects: Adult, Male, Heart Failure, Canada, Adolescent, Myocardial Infarction, Pneumonia, General Medicine, Kenya, Stroke, Influenza Vaccines, Influenza, Human, Humans, Female
Abstract: Influenza increases the risk of cardiovascular events and deaths. We aimed to see whether influenza vaccination reduces death and vascular events in patients with heart failure.We did a pragmatic, randomised, double-blind, placebo-controlled trial in 30 centres (mostly hospitals affliated with universities or a research institute) in ten countries in Asia, the Middle East, and Africa (7 in India, 4 in Philippines, 4 in Nigeria, 6 in China, 1 in Zambia, 2 in Mozambique, 3 in Saudi Arabia, 1 in Kenya, 1 in Uganda, and 1 in Zambia). Participants (aged ≥18 years; 52·1% female; not disaggregated by race or ethnicity) with heart failure (New York Heart Association class II, III, or IV) were randomly assigned (1:1) by a centralised web-based system with block randomisation stratified by site, to receive 0·5 ml intramuscularly once a year for up to 3 years of either inactivated standard dose influenza vaccine or placebo (saline). We excluded people who had received influenza vaccine in 2 of the previous 3 years, and those likely to require valve repair or replacement. Those who administered assigned treatments were not masked and had no further role in the study. Investigators, study coordinators, outcome adjudicators, and participants were masked to group assignment. The first of two co-primary outcomes was a first-event composite for cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, and the second was a recurrent-events composite for cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalisation for heart failure. Outcomes were assessed every 6 months in the intention-to-treat population. Secondary outcomes were all-cause death, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, all-cause hospitalisation, hospitalisation for heart failure, and pneumonia, both overall and during periods of peak influenza exposure. This study is registered with ClinicalTrials.gov, NCT02762851.Between June 2, 2015, and Nov 21, 2021, we enrolled 5129 participants and randomly assigned (1:1) 2560 (50·0%) to influenza vaccine and 2569 (50·0%) to placebo. The first co-primary outcome occurred in 380 (14·8%) of 2560 participants in the vaccine group and 410 (16·0%) of 2569 participants in the placebo group (hazard ratio [HR] 0·93 [95% CI 0·81-1·07]; p=0·30). The second co-primary outcome occurred in 754 (29·5%) of 2560 participants in the vaccine group and 819 (31·9%) of 2569 participants in the placebo group; HR 0·92 [95% CI 0·84-1·02]; p=0·12). The secondary outcomes of all-cause hospitalisations (HR 0·84 [95% CI 0·74-0·97]; p=0·013) and pneumonia (HR 0·58 [0·42-0·80]; p=0·0006) were significantly reduced in the vaccine group compared with in the placebo group but there was no significant difference between groups for all-cause death, cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, and hospitalisation for heart failure. In a prespecified analysis, in which events were limited to periods of peak influenza circulation, the first co-primary outcome, and the secondary outcomes of all-cause death, cardiovasular death, and pneumonia were significantly lower in the vaccinated group than in the placebo group, whereas the second co-primary outcome and the secondary outcomes of non-fatal myocardial infarction, non-fatal stroke, all-cause hospitalisation, and hospitalisation for heart failure were not significantly lower.Although the prespecified co-primary outcomes during the entire period of observation were not statistically significant, the reduction during the peak influenza circulating period suggests that there is likely to be a clinical benefit of giving influenza vaccine, given the clear reduction in pneumonia, a moderate reduction in hospitalisations, and a reduction in cardiovascular events and deaths during periods of peak circulation of influenza. Taken in conjunction with previous trials and the observational studies, the collective data suggest benefit.UK Joint Global Health Trials Scheme and Canadian Institutes for Health Research Foundation.
Published: 2022
Full Text: View/download PDF

13. Late diagnosis of CHD and its associated factors in Kenya: an analytic cross-sectional study

Author: Mercy Ng’eno, Del-rossi S. Quadros, Naomi Gachara, Isaac Kihurani, and Gerald Yonga
Subjects: Pediatrics, Perinatology and Child Health, General Medicine, Cardiology and Cardiovascular Medicine
Abstract: Introduction: Burden of CHD in Africa is generally underestimated mainly due to significant under-reporting and early-related fetal and neonatal mortality. Objectives: Determine the prevalence and factors associated with late diagnosis of CHD seen at three tertiary care hospitals in Kenya. Design: A cross-sectional study on paediatric patients with CHDs, aged 0–18 years, seen over a 5-year period, between January, 2011 and December, 2016. Setting: Aga Khan University Hospital Nairobi, Mater Hospital, and Kenyatta National Hospital. Methods: Patients were stratified into those diagnosed late (>1 year of age) and those diagnosed early ( Results: The study enrolled 411 patients, with equal gender distribution. Prevalence of late diagnosis (>1 year of age) of CHD was 60.6% (95% CI 55.7–65.3). Median age at diagnosis was 15 (IQR 5–48) months. Presence of a cardiac murmur (OR = 0.87; 95% CI 0.72–0.92, p-value = 0.016) and level of parental education (OR = 4.99; 95% CI 2.25–11.40, p-value Conclusion: Late diagnosis of CHD remains alarmingly high in our setting. Initiatives to enhance early detection and screening of CHD should be adopted to reduce related mortality and morbidity.
Published: 2022
Full Text: View/download PDF

14. Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme

Author: Isabelle, Johansson, Kumar, Balasubramanian, Shrikant, Bangdiwala, Lisa, Mielniczuk, Camilla, Hage, Sanjib Kumar, Sharma, Kelley, Branch, Jun, Zhu, Kristian, Kragholm, Karen, Sliwa, Francois, Alla, Gerald, Yonga, Ambuj, Roy, Andres, Orlandini, Alex, Grinvalds, Tara, McCready, Nana, Pogosova, Stefan, Störk, John J V, McMurray, David, Conen, Salim, Yusuf, Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Bayer
Subjects: Quality of life, Heart Failure, Male, Health Status, Global, Heart failure, Comorbidity, Middle Aged, Health status, Cross-Sectional Studies, Surveys and Questionnaires, Quality of Life, Correlates, Humans, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Cardiology and Cardiovascular Medicine
Abstract: Aims: To examine clinical and social correlates of health-related quality of life (HRQL) in patients with heart failure (HF) from high- (HIC), upper middle- (UMIC), lower middle- (LMIC) and low-income (LIC) countries. Methods and results: Between 2017 and 2020, 23 292 patients with HF (32% inpatients, 61% men) from 40 countries were enrolled in the Global Congestive Heart Failure study. HRQL was recorded at baseline using the Kansas City Cardiomyopathy Questionnaire (KCCQ)-12. In a cross-sectional analysis, we compared age- and sex-adjusted mean KCCQ-12 summary scores (SS: 0–100, higher = better) between patients from different country income levels. We used multivariable linear regression examining correlations (estimated coefficients) of KCCQ-12-SS with sociodemographic, comorbidity, treatment and symptom covariates. The adjusted model (37 covariates) was informed by univariable findings, clinical importance and backward selection. Mean age was 63 years and 40% of patients were in New York Heart Association (NYHA) class III–IV. Average HRQL was 55 SD 27. It was 62.5 (95% confidence interval [CI] 62.0–63.1) in HIC, 56.8 (56.1–57.4) in UMIC, 48.6 (48.0–49.3) in LMIC, and 38.5 (37.3–39.7) in LICs (p < 0.0001). Strong correlates (estimated coefficient [95% CI]) of KCCQ-12-SS were NYHA class III versus class I/II (−12.1 [−12.8 to −11.4] and class IV versus class I/II (−16.5 [−17.7 to −15.3]), effort dyspnoea (−9.5 [−10.2 to −8.8]) and living in LIC versus HIC (−5.8 [−7.1 to −4.4]). Symptoms explained most of the KCCQ-12-SS variability (partial R 2 = 0.32 of total adjusted R 2 = 0.51), followed by sociodemographic factors (R 2 = 0.12). Results were consistent in populations across income levels. Conclusion: The most important correlates of HRQL in HF patients relate to HF symptom severity, irrespective of country income level.
Published: 2022
Full Text: View/download PDF

15. Improved blood pressure control via a novel chronic disease management model of care in sub‐Saharan Africa: Real‐world program implementation results

Author: Fred Kueffer, Charles Miezah, Chemuttaai Lang’at, Douglas A. Hettrick, Gerald Yonga, Harun Otieno, Roland E. Schmieder, and Molly Guy
Subjects: Blood pressure control, medicine.medical_specialty, hypertension, Sub saharan, Endocrinology, Diabetes and Metabolism, digital health, Pharmacy, Disease, 030204 cardiovascular system & hematology, Ghana, 03 medical and health sciences, 0302 clinical medicine, Internal Medicine, medicine, 030212 general & internal medicine, Hypertension in Africa, Original Paper, business.industry, Management model, blood pressure control, model of care, Kenya, innovation, Chronic disease, Blood pressure, Emergency medicine, Cohort, Cardiology and Cardiovascular Medicine, business
Abstract: A chronic disease management model of care (Empower Health) was launched in rural and urban areas of Ghana and Kenya in 2018. The goal was to improve disease awareness, reduce the burden of disease, and improve the clinical effectiveness and efficiency of managing hypertension. Leveraging the model, clinicians provide patients with tailored management plans. Patients accessed regular blood pressure checks at home, at the clinic, or at community‐partner locations where they received real‐time feedback. On the mobile application, clinicians viewed patient data, provided direct patient feedback, and wrote electronic prescriptions accessible through participating pharmacies. To date, 1266 patients had been enrolled in the “real‐world” implementation cohort and followed for an average of 351 ± 133 days across 5 facilities. Average baseline systolic blood pressure (SBP) was 145 ± 21 mmHg in the overall cohort and 159 ± 16 mmHg in the subgroup with uncontrolled hypertension (n = 743) as defined by baseline SBP ≥ 140 mmHg. SBP decreased significantly through 12 months in both the overall cohort (−9.4 mmHg, p
Published: 2021
Full Text: View/download PDF

16. Perspectives of Local Community Leaders, Health Care Workers, Volunteers, Policy Makers and Academia on Climate Change Related Health Risks in Mukuru Informal Settlement in Nairobi, Kenya-A Qualitative Study

Author: Gerald Yonga, Catherine Karekezi, Per Kallestrup, Zipporah Ali, Christian Kraef, and Johanne Greibe Andersen
Subjects: Volunteers, Economic growth, Public infrastructure, Health, Toxicology and Mutagenesis, Climate Change, Health Personnel, Climate change, environmental health, communicable diseases, slums, Grounded theory, Article, Urban planning, Political science, Health care, climate change, informal settlements, non-communicable diseases, low- and middle-income countries, Humans, skin and connective tissue diseases, business.industry, Public Health, Environmental and Occupational Health, Administrative Personnel, Focus group, Kenya, Local community, Medicine, sense organs, business, Qualitative research
Abstract: Sub-Saharan Africa has been identified as one of the most vulnerable regions to climate change. The objective of this study was to explore knowledge and perspectives on climate change and health-related issues, with a particular focus on non-communicable diseases, in the informal settlement (urban slum) of Mukuru in Nairobi, Kenya. Three focus group discussions and five in-depth interviews were conducted with total of 28 participants representing local community leaders, health care workers, volunteers, policy makers and academia. Data were collected using semi-structured interview guides and analyzed using grounded theory. Seven main themes emerged: climate change related diseases, nutrition and access to clean water, environmental risk factors, urban planning and public infrastructure, economic risk factors, vulnerable groups, and adaptation strategies. All participants were conscious of a link between climate change and health. This is the first qualitative study on climate change and health in an informal settlement in Africa. The study provides important information on perceived health risks, risk factors and adaptation strategies related to climate change. This can inform policy making, urban planning and health care, and guide future research. One important strategy to adapt to climate change-associated health risks is to provide training of local communities, thus ensuring adaptation strategies and climate change advocacy.
Published: 2021
Full Text: View/download PDF

17. Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in Sub-Saharan Africa: results from the THESUS-HF registry

Author: Dike B. Ojji, Ahmed Suliman, Clovis Nkoke, Gad Cotter, Christopher L. Edwards, Albertino Damasceno, Karen Sliwa, Serigne Abdou Ba, Lauren Gaeta, Mahmoud U Sani, Anastase Dzudie, Gerald Yonga, Okechukwu S Ogah, Beth A. Davison, and Charles Mondo
Subjects: medicine.medical_specialty, Ejection fraction, Heart disease, business.industry, Proportional hazards model, Hazard ratio, Diastole, Atrial fibrillation, medicine.disease, Heart failure, Internal medicine, Medicine, Original Article, Risk factor, Cardiology and Cardiovascular Medicine, business
Abstract: BACKGROUND: Rheumatic heart disease (RHD) was found in the THESUS-HF registry to be the third most common cause of acute heart failure (AHF) in Sub-Saharan Africa. METHODS: One thousand six patients with AHF from 9 Sub-Saharan African countries were recruited in THESUS-HF, of which 143 (14.3%) had RHD-AHF. Clinical characteristics and outcomes in patients with RHD-AHF and non-RHD-AHF were compared. Kaplan-Meier plots for time to all-cause death and/or HF readmission according to the presence of RHD-AHF and non-RHD-AHF were performed and survival distributions compared using the log-rank test. Cox regression was used to determine the hazard ratio of death to day 180 and death or readmission to day 60 after adjusting for confounders. RESULTS: Patients with RHD-AHF were younger, more often females, had higher rates of atrial fibrillation, had less hypertension, hyperlipidemia and diabetes, had lower BP, and higher pulse rate and better kidney function and echocardiographic higher ejection fraction larger left atria and more diastolic dysfunction. Patients with RHD-AHF had a numerically longer mean stay in the hospital (10.5 vs. 8.8 days) and significantly higher initial hospitalization mortality (9.1% vs. 3.4%). CONCLUSIONS: In conclusion, patients with HF related to RHD were younger, have higher rate of atrial fibrillation and have a worse short-term outcome compared to HF related to other etiologies in Sub-Saharan Africa.
Published: 2021

18. Cardiovascular risk factors among people living with HIV in rural Kenya: a clinic-based study

Author: Sylvia Mbugua, Gerald Yonga, Kenneth Juma, Roseanne Nyabera, Mzee Ngunga, George Odinya, David Zakus, and JO Jowi
Subjects: Adult, Male, medicine.medical_specialty, Waist, Cardiovascular risk factors, Human immunodeficiency virus (HIV), HIV Infections, Rural Health, 030204 cardiovascular system & hematology, Logistic regression, medicine.disease_cause, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Diabetes mellitus, Diabetes Mellitus, Prevalence, Humans, Medicine, Obesity, Stroke, Dyslipidemias, business.industry, Stavudine, General Medicine, Odds ratio, Middle Aged, medicine.disease, Health Surveys, Kenya, Cross-Sectional Studies, Anti-Retroviral Agents, Cardiovascular Diseases, Hypertension, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract: Objective To determine the prevalence of cardiovascular risk factors and their association with antiretroviral therapy (ART) among HIV-infected adults in a rural sub-county hospital in Kenya. Methods This was a descriptive survey of patient charts characterising cardiovascular risk among adult patients (> 18 years) at Ukwala sub-county hospital between June 2013 and January 2015. Post-stratification survey weights were applied to obtain prevalence levels. Adjusted odds ratios (AOR) for each variable related to cardiovascular risk factors were calculated using logistic regression models. Results Overall, the prevalence of diabetes mellitus was 0.4%, 0.3% of patients had had a previous cardiovascular event (heart attack or stroke), 40.4% had pre-hypertension, while 10.4% had stage 1 and 2.9% stage 2 hypertension. Up to 14% of patients had elevated non-fasting total cholesterol levels. Factors associated with hypertension were male gender (AOR 1.59, p = 0.0001), being over 40 years of age (AOR 1.78, p = 0.0001) and having an increased waist circumference (OR 2.56, p = 0.0014). Raised total cholesterol was more likely in those on tenofovir disoproxil fumarate (TDF) (AOR 2.2, p = 0.0042), azidothymidine (AZT) (AOR 2.5, p = 0.0004) and stavudine (D4T) -containing regimens (AOR 3.13, p = 0.0002). Conclusions An elevated prevalence of undiagnosed cardiovascular risk factors such as hypertension and raised total cholesterol levels was found among people living with HIV. There was an association between raised total cholesterol and nucleoside reverse-transcriptase inhibitor (NRTI) -based ART regimens. Our findings provide further rationale for integrating routine cardiovascular risk-factor screening into HIV-care services.
Published: 2019
Full Text: View/download PDF

19. Controlling diabetes and hypertension in sub-Saharan Africa: lessons from HIV programmes

Author: Shabbar Jaffar, Kaushik Ramaiya, Catherine Karekezi, Nelson Sewankambo, Anne Ruhweza Katahoire, Christian Kraef, Gerald Mutungi, Joshua Musinguzi, Josephine Birungi, Anupam Garrib, Joseph Okebe, James A Prior, Katie Bates, Jeffrey V Lazarus, Marie-Claire Van Hout, Max Bachmann, Mbiydzenyuy Ferdinant, Beatrice Gachambi, George Msengi, Gerald Yonga, Janet Lutale, Jean Claude Mbanya, Sayoki Mfinanga, Moffat J Nyirenda, Geoff Gill, and Peter G Smith
Subjects: Sub saharan, business.industry, MEDLINE, Human immunodeficiency virus (HIV), HIV Infections, General Medicine, medicine.disease, medicine.disease_cause, Health Services Accessibility, Premature death, Blood pressure, Environmental health, Diabetes mellitus, parasitic diseases, Hypertension, medicine, Diabetes Mellitus, Humans, business, Noncommunicable Diseases, Delivery of Health Care, Africa South of the Sahara
Abstract: The prevalences of diabetes and hypertension have risen sharply in sub-Saharan Africa, but only a minority of people living with these conditions receive regular care and among those who do, glycaemia and blood pressure are generally poorly controlled. 1 , 2 Diabetes and hypertension can be effectively controlled, 1 , 3 but complications from these two conditions are estimated to be responsible for up to 2 million premature deaths in sub-Saharan Africa each year. 4 Diabetes and hypertension programmes in Africa could learn lessons from HIV programmes that are also relevant for other non-communicable diseases in low-income and middle-income settings.
Published: 2021

20. Prevalence and factors associated with overweight and obesity in Kenya

Author: Adam E. Barry, Fredrick Muyia Nafukho, Muhammad Abdul Baker Chowdhury, Rahma Mkuu, Tamika D. Gilreath, Cort Wernz, Idethia Shevon Harvey, and Gerald Yonga
Subjects: Kenya, Epidemiology, Primary education, 030209 endocrinology & metabolism, Overweight, Logistic regression, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Prevalence, Medicine, 030212 general & internal medicine, business.industry, Public Health, Environmental and Occupational Health, nutritional and metabolic diseases, Regular Article, Odds ratio, medicine.disease, Obesity, Confidence interval, Overweight and Obesity, medicine.symptom, business, Body mass index, Demography
Abstract: Highlights • Almost one third of the sample had overweight/obese. • Women were 4 times more likely to have overweight/obesity. • Middle and high income individuals were 2 times more likely to have overweight/obesity. • The odds of having overweight/obesity increased with increasing age., Overweight and obesity rates continue to rise globally and are associated with increased chronic disease morbidity and mortality. There is evidence of high overweight and obesity prevalence in Kenya, however; a gap exists in the knowledge of national prevalence and predictors of overweight and obesity. This cross-sectional study examined data from the 2015 World Health Organization (WHO) Kenya STEPwise Survey—the first nationally representative survey to objectively measure body mass index (BMI) among Kenyan men and women. Descriptive and logistic regression analysis of 4,340 adults aged 18–69 years examined the prevalence, sociodemographic, and behavioral risk factors associated with having overweight or obesity (overweight/obesity) defined by WHO The mean BMI was 23.51 with 31.13% having overweight/obese. The likelihood of having overweight/obesity was significantly higher among married individuals [odds ratio (OR) = 1.78, 95% confidence interval (CI) 1.19, 2.66], women (OR = 4.08, 95% CI 3.02, 5.51), urban dwellers (OR = 1.70, 95% CI 1.28, 2.25) and middle wealth or higher (OR = 2.45, 95% CI 1.91, 3.14). The likelihood of having overweight/obesity increased by age, compared to 18–29-year olds; (30–44 years (OR = 2.05 95% CI 1.50, 2.80), 45–59-year olds (OR = 2.67, 95% CI 1.97, 3.63), 60–69-year olds (OR = 3.00, 95% CI 1.99, 4.51). Adults with completed primary education or more had higher odd of having overweight/obesity (OR = 2.15, 95% CI 1.72, 2.70). compared to adults with less than primary education. Likelihood of having Overweight/obesity was highest among women, urban residents, and individuals with high education and wealth. Future studies should ascertain drivers of overweight/obesity to inform Targeted and tailored interventions and policies amongst high-risk groups.
Published: 2021

21. Climate change and health in urban informal settlements in low- and middle-income countries – a scoping review of health impacts and adaptation strategies

Author: Peter Furu, Per Kallestrup, Christian Kraef, Gerald Yonga, Johanne Greibe Andersen, Catherine Karekezi, and Frederikke Højgaard Borg
Subjects: Asia, Climate change, communicable diseases, Review Article, Cochrane Library, 03 medical and health sciences, Extreme weather, 0302 clinical medicine, United Nations Framework Convention on Climate Change, Humans, 030212 general & internal medicine, low- and middle-income countries, Adaptation (computer science), Environmental planning, Developing Countries, 030503 health policy & services, Health Policy, Clinical study design, Flooding (psychology), Public Health, Environmental and Occupational Health, Mental health, informal settlements, non-communicable diseases, Geography, climate change, Africa, Public aspects of medicine, RA1-1270, 0305 other medical science
Abstract: Background: Climate change affects human health with those with the least resources being most vulnerable. However, little is known about the impact of climate change on human health and effective adaptation methods in informal settlements in low- and middle-income countries. Objective: The objective of this scoping review was to identify, characterize, and summarize research evidence on the impact of climate change on human health in informal settlements and the available adaptation methods and interventions. Method: A scoping review was conducted using the Arksey and O’Malley framework. The four bibliographic databases PubMed, Web of Science, Embase, and the Cochrane library were searched. Eligibility criteria were all types of peer-reviewed publications reporting on climate change or related extreme weather events (as defined by the United Nations Framework Convention on Climate Change), informal settlements (as defined by UN-Habitat), low- and middle-income countries (as defined by the World Bank) and immediate human health impacts. Review selection and characterization were performed by two independent reviewers using a predefined form. Results: Out of 1197 studies initially identified, 15 articles were retained. We found nine original research articles, and six reviews, commentaries, and editorials. The articles were reporting on the exposures flooding, temperature changes and perceptions of climate change with health outcomes broadly categorized as mental health, communicable diseases, and non-communicable diseases. Six studies had a geographical focus on Asia, four on Africa, and one on South America, the remaining four articles had no geographical focus. One article investigated an adaptation method for heat exposure. Serval other adaptation methods were proposed, though they were not investigated by the articles in this review. Conclusion: There is a paucity of original research and solid study designs. Further studies are needed to improve the understanding of the impact, the most effective adaptation methods and to inform policy making.
Published: 2021
Full Text: View/download PDF

22. Fighting non-communicable diseases in East Africa: assessing progress and identifying the next steps

Author: Gerald Yonga, Per Kallestrup, Kaushik Ramaiya, Pamela A. Juma, Joseph Mucumbitsi, Francois Ndikumwenayo, and Christian Kraef
Subjects: medicine.medical_specialty, Economic growth, 030231 tropical medicine, Population, Disease, control strategies, other study design, lcsh:Infectious and parasitic diseases, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Political science, Health care, medicine, Humans, lcsh:RC109-216, 030212 general & internal medicine, education, Noncommunicable Diseases, Health policy, education.field_of_study, Practice, lcsh:R5-920, biology, business.industry, Corporate governance, Public health, public health, Public Health, Environmental and Occupational Health, health policy, Africa, Eastern, biology.organism_classification, Kenya, Tanzania, Alliance, public Health, business, lcsh:Medicine (General)
Abstract: Sub-Saharan Africa has seen a rapid increase in non-communicable disease (NCD) burden over the last decades. The East African Community (EAC) comprises Burundi, Rwanda, Kenya, Tanzania, South Sudan and Uganda, with a population of 177 million. In those countries, 40% of deaths in 2015 were attributable to NCDs. We review the status of the NCD response in the countries of the EAC based on the available monitoring tools, the WHO NCD progress monitors in 2017 and 2020 and the East African NCD Alliance benchmark survey in 2017. In the EAC, modest progress in governance, prevention of risk factors, monitoring, surveillance and evaluation of health systems can be observed. Many policies exist on paper, implementation and healthcare are weak and there are large regional and subnational differences. Enhanced efforts by regional and national policy-makers, non-governmental organisations and other stakeholders are needed to ensure future NCD policies and implementation improvements.
Published: 2020
Full Text: View/download PDF

23. The COVID-19 Pandemic and Non-communicable Diseases—A Wake-up Call for Primary Health Care System Strengthening in Sub-Saharan Africa

Author: Gerald Yonga, Kaushik Ramaiya, Christian Kraef, Per Kallestrup, Joseph Mucumbitsi, and Pamela A. Juma
Subjects: Economic growth, 2019-20 coronavirus outbreak, Sub saharan, Coronavirus disease 2019 (COVID-19), COVID19, 030231 tropical medicine, Pneumonia, Viral, Declaration, Primary health care, Sub Sahara Africa, lcsh:Computer applications to medicine. Medical informatics, 03 medical and health sciences, primary care, 0302 clinical medicine, Health spending, Commentaries, Pandemic, DRIVERS, Prevalence, Medicine, Humans, health system, 030212 general & internal medicine, NCDs, Noncommunicable Diseases, Pandemics, Africa South of the Sahara, Community and Home Care, Primary Health Care, business.industry, lcsh:Public aspects of medicine, Public Health, Environmental and Occupational Health, COVID-19, lcsh:RA1-1270, Investment (macroeconomics), lcsh:R858-859.7, business, Coronavirus Infections
Abstract: Strengthening Primary Health Care Systems is the most effective policy response in low-and middle-income countries to protect against health emergencies, achieve universal health coverage, and promote health and wellbeing. Despite the Astana declaration on primary health care, respective investment is still insufficient in Sub-Sahara Africa. The SARS-CoV-2019 pandemic is a reminder that non-communicable diseases (NCDs), which are increasingly prevalent in Sub-Sahara Africa, are closely interlinked to the burden of communicable diseases, exacerbating morbidity and mortality. Governments and donors should use the momentum created by the pandemic in a sustainable and effective way by pivoting health spending towards primary health care.
Published: 2020
Full Text: View/download PDF

24. Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design

Author: Wael Almahmeed, Albertino Damasceno, Gerald Yonga, Jun Zhu, Ambuj Roy, Khalid F. AlHabib, Mark Loeb, Antonio L. Dans, Salim Yusuf, Yan Liang, Kamilu M. Karaye, Lia M. Palileo-Villanueva, Arif Al Mulla, Hisham Dokainish, Charles Mondo, and Fastone Goma
Subjects: Research design, medicine.medical_specialty, Intention-to-treat analysis, Influenza vaccine, business.industry, 030204 cardiovascular system & hematology, medicine.disease, Article, 3. Good health, law.invention, Vaccination, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Heart failure, medicine, Observational study, 030212 general & internal medicine, Myocardial infarction, Cardiology and Cardiovascular Medicine, business
Abstract: Background Influenza is associated with an increase in the risk of cardiac and other vascular events. Observational data and small randomized trials suggest that influenza vaccination may reduce such adverse vascular events. Research Design and Methods In a randomized controlled trial patients with heart failure are randomized to receive either inactivated influenza vaccine or placebo annually for 3 years. Patients aged ≥18 years with a clinical diagnosis of heart failure and NYHA functional class II, III and IV are eligible. Five thousand patients from 10 countries where influenza vaccination is not common (Asia, the Middle East, and Africa) have been enrolled. The primary outcome is a composite of the following: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and hospitalizations for heart failure using standardized criteria. Analyses will be based on comparing event rates between influenza vaccine and control groups and will include time to event, rate comparisons using Poisson methods, and logistic regression. The analysis will be conducted by intention to treat i.e. patients will be analyzed in the group in which they were assigned. Multivariable secondary analyses to assess whether variables such as age, sex, seasonality modify the benefits of vaccination are also planned for the primary outcome. Conclusion This is the largest randomized trial to test if influenza vaccine compared to control reduces adverse vascular events in high risk individuals. Trial registration number Clinicaltrials.gov NCT02762851
Published: 2019

25. Initial Rhythm and Resuscitation Outcomes for Patients Developing Cardiac Arrest in Hospital

Author: Gerald Yonga, Benjamin Wachira, Justin A. Ezekowitz, and Leonard M Ngunga
Subjects: Community and Home Care, Resuscitation, medicine.medical_specialty, Epidemiology, business.industry, medicine.medical_treatment, 030208 emergency & critical care medicine, 030204 cardiovascular system & hematology, Return of spontaneous circulation, Ventricular tachycardia, medicine.disease, Mews, 03 medical and health sciences, 0302 clinical medicine, Emergency medicine, Pulseless electrical activity, Ventricular fibrillation, Medicine, Cardiopulmonary resuscitation, Asystole, Cardiology and Cardiovascular Medicine, business
Abstract: Background Health care resource allocation remains challenging in lower middle income countries such as Kenya with meager resources being allocated to resuscitation and critical care. The causes and outcomes for in-hospital cardiac arrest and resuscitation have not been studied. Objectives This study sought to determine the initial rhythm and the survival for patients developing in-hospital cardiac arrest. Methods This was a prospective study for in-hospital cardiac arrest in 6 Kenyan hospitals from July 2014 to April 2016. Resuscitation teams were utilized to collect data during resuscitation using a standardized protocol. Patients with do-not-resuscitate orders, trauma, postsurgical, and pregnancy-related complications were excluded. The Modified Early Warning Score (MEWS)— systolic blood pressure , heart rate, respiration rate, temperature, and responsiveness—was determined based on worst parameters at least 4 hours prior to the arrest. Results A total of 353 patients with cardiac arrest were included over 19 months. The mean age was 61 years, 53.5% were male, and admission diagnoses included cardiovascular disease (15%), pneumonia 18.13%, and cancer 9%. The mean MEWS was 4.48 and low, intermediate, and high MEWS were found in 25.8%, 29.5%, and 44.8%, respectively. The mean time to cardiopulmonary resuscitation was 0.84 min. The initial rhythm was asystole in 47.6%, pulseless electrical activity in 38.2%, ventricular tachycardia/ventricular fibrillation in 5.4%, and unknown in 8.8%. Return of spontaneous circulation (ROSC) occurred in 29.2% of patients with the mean time to ROSC being 5.3 min. ROSC occurred in 17.3% of patients with asystole, 40.7% in pulseless electrical activity, 57.9% in ventricular tachycardia/ventricular fibrillation, and 25.8% in patients with an unknown rhythm. Of all patients, 16 (4.2%) were discharged alive. Conclusions Nonshockable rhythms account for the majority of the cardiac arrests in hospitals in a lower middle income country and are associated with unfavorable outcomes. Future work should be directed to training health care personnel in recognizing early warning signs and implementing appropriate measures in a resource-scarce environment.
Published: 2018
Full Text: View/download PDF

26. From HIV prevention to non-communicable disease health promotion efforts in sub-Saharan Africa

Author: Gerald Yonga, Kenneth Juma, Michael J. A. Reid, Oladimeji Oladepo, Susan Vorkoper, Monika Roy, Tecla M Temu, David Zakus, and Naomi S. Levitt
Subjects: Adult, Male, 0301 basic medicine, Adolescent, Behavior change communication, Immunology, Population, Psychological intervention, MEDLINE, HIV Infections, Health Promotion, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Environmental health, Intervention (counseling), medicine, Humans, Immunology and Allergy, 030212 general & internal medicine, Young adult, Child, Noncommunicable Diseases, skin and connective tissue diseases, education, Africa South of the Sahara, Aged, Aged, 80 and over, education.field_of_study, integumentary system, Delivery of Health Care, Integrated, business.industry, Infant, Newborn, Infant, Middle Aged, Non-communicable disease, medicine.disease, 030112 virology, Infectious Diseases, Health promotion, Child, Preschool, Female, business
Abstract: To synthesize published literature on noncommunicable disease (NCD) behavior change communication (BCC) interventions in sub-Saharan Africa (SSA) among persons living with HIV (PLHIV) and in the general population to inform efforts to adopt similar HIV and NCD BCC intervention activities.We conducted a literature review of NCD BCC interventions and included 20 SSA-based studies. Inclusion criteria entailed describing a BCC intervention targeting any four priority NCDs (cardiovascular disease, type 2 diabetes, cervical cancer, and depression) or both HIV and any of the NCDs. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework was used to assess potential public health impact of these studies. We also solicited expert opinions from 10 key informants on the topic of HIV/NCD health promotion in five SSA countries.The BCC interventions reviewed targeted multiple parts of the HIV and NCD continuum at both individual and community levels. Various strategies (i.e. health education, social marketing, motivational interviewing, mobile health, and peer support) were employed. However, few studies addressed more than one dimension of the RE-AIM framework. Opinions solicited from the key informants supported the feasibility of integrating HIV and NCD BCC interventions in SSA potentially improving access, service provision and service demand, especially for marginalized and vulnerable populations.Although HIV/NCD integration can improve effectiveness of preventive services at individual and community levels, potential public health impact of such approaches remain unknown as reach, adoptability, and sustainability of both integrated and nonintegrated NCD BCC approaches published to date have not been well characterized.
Published: 2018
Full Text: View/download PDF

27. An African cardiology summit

Author: Karen Sliwa, Pilar Millan, George Nel, Saad Subhai, Gerald Yonga, Ahmed Suliman, David A. Wood, and Jean Luc Eiselé
Subjects: geography, medicine.medical_specialty, Civil society, Summit, geography.geographical_feature_category, Heart disease, business.industry, Cardiovascular health, Best practice, 030204 cardiovascular system & hematology, medicine.disease, World health, 03 medical and health sciences, 0302 clinical medicine, Mexico city, Action plan, Internal medicine, Cardiology, Medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, health care economics and organizations
Abstract: The World Heart Federation (WHF) is the umbrella organization of continental and national cardiac societies and heart foundations globally, reporting to the World Health Organization (WHO). The WHF is dedicated to the global fight against CVD, including heart disease, stroke, and rheumatic heart disease (RHD). Building on the first Global Summit on Circulatory Health, held at the 2016 World Congress of Cardiology and Cardiovascular Health in Mexico City, the second Summit held in Singapore July 2017 focused on building a civil society movement for circulatory health.
Published: 2018
Full Text: View/download PDF

28. Response to: Cavagna et al The importance of considering cultural and environmental elements in an interventional model of care to fight hypertension in Africa

Author: Charles Miezah, Gerald Yonga, Douglas A. Hettrick, Harun Otieno, Fred Kueffer, Roland E. Schmieder, Molly Guy, and Chemuttaai Lang’at
Subjects: business.industry, Endocrinology, Diabetes and Metabolism, Internal Medicine, Medicine, Public relations, Cardiology and Cardiovascular Medicine, business
Published: 2021
Full Text: View/download PDF

29. The diagnostic accuracy of Determine™ TB LAM antigen in detection of extra pulmonary tuberculosis (EPTB)

Author: Fatimah O. Juma, Peter Waweru, Gerald Yonga, Mark Nelson, Gunturu Revathi, and Reena Shah
Subjects: Lipopolysaccharides, 0301 basic medicine, Microbiology (medical), medicine.medical_specialty, Tuberculosis, business.industry, 030106 microbiology, MEDLINE, Diagnostic accuracy, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Infectious Diseases, Extra pulmonary tuberculosis, Antigen, Internal medicine, medicine, Humans, 030212 general & internal medicine, business, Tuberculosis, Pulmonary
Published: 2017
Full Text: View/download PDF

30. Burden of prehypertension among adults in Kenya: a retrospective analysis of findings from the Healthy Heart Africa (HHA) Programme

Author: Gerald Yonga, Kennedy Njau, Jared O. Mecha, Elizabeth N. Kubo, Elijah Ogola, Freda Kinoti, and Collins Odhiambo
Subjects: Adult, Male, medicine.medical_specialty, Kenya, Adolescent, Population, 030204 cardiovascular system & hematology, Prehypertension, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Ambulatory care, Environmental health, Epidemiology, medicine, Prevalence, Humans, 030212 general & internal medicine, Risk factor, education, Aged, Retrospective Studies, education.field_of_study, Sub-Saharan Africa, business.industry, lcsh:Public aspects of medicine, Public Health, Environmental and Occupational Health, lcsh:RA1-1270, Odds ratio, Middle Aged, Cardiovascular disease, Cross-Sectional Studies, Female, Biostatistics, business, Research Article
Abstract: Background Hypertension is the leading risk factor for mortality globally. African countries, including Kenya, have a high and rising prevalence of hypertension. Prehypertension is associated with an increased risk of progression to overt hypertension and a higher risk of cardiovascular disease and mortality. Despite this, little is documented on the prevalence and distribution of prehypertension in sub-Saharan Africa. This study sought to estimate the overall burden of prehypertension in Kenyan adults enrolled in a large hypertension control programme, Healthy Heart Africa. The distribution and determinants of prehypertension in the sample were explored as secondary objectives. Methods This was a post hoc analysis of cross-sectional data obtained from population-level blood pressure (BP) screening of adults aged ≥18 years in the community and ambulatory care facilities in 17/47 sub-national administrative units in Kenya. All participants with a complete record for systolic and diastolic BP were included. Descriptive analyses were performed for sociodemographic characteristics. Pearson’s chi-square test was used to assess differences in categorical variables. Multivariate logistic regression analysis was performed to identify factors independently associated with prehypertension. Results Of 5,985,185 participant records that were included in the analysis, 34% were men (mean age: 45 [SD 2.9] years). The majority (63%) lived in rural Kenya. The prevalence of prehypertension was 54.5% and that of hypertension was 20.8%. Characteristics that were independently associated with prehypertension (adjusted odds ratio [95% CI]) included male sex (1.23 [±0.0023], p 25 years) and rural residence (1.60 [±0.023], p Conclusions Approximately one in every two Kenyan adults has prehypertension. This calls for urgent development and roll-out of a national BP screening and control programme. It also provides a strong basis for the formulation of multisectoral national policies that will ensure implementation of evidence-based, low-cost public health interventions geared towards primary prevention of hypertension, especially in population groups that are traditionally considered at low risk, such as young adults and rural residents.
Published: 2019

31. First Africa non-communicable disease research conference 2017: sharing evidence and identifying research priorities

Author: George Odinya, Pamela A. Juma, J.O. Owuor, Shukri F. Mohamed, Kenneth Juma, Gerald Yonga, Maureen Njeru, David Mulabi, and Ann Wanyoike
Subjects: Economic growth, biology, Health Policy, News - Meetings, 030231 tropical medicine, Public Health, Environmental and Occupational Health, Information Dissemination, Psychological intervention, Non-communicable disease, medicine.disease, biology.organism_classification, 03 medical and health sciences, 0302 clinical medicine, Alliance, Tanzania, General partnership, Political science, parasitic diseases, medicine, 030212 general & internal medicine, Research center, Economic consequences
Abstract: Non-communicable diseases (NCDs) prevalence is rising fastest in lower income settings, and with more devastating outcomes compared to High Income Countries (HICs). While evidence is consistent on the growing health and economic consequences of NCDs in sub-Saharan Africa (SSA), specific efforts aimed at addressing NCD prevention and control remain less than optimum and country level progress of implementing evidence backed cost-effective NCD prevention approaches such as tobacco taxation and restrictions on marketing of unhealthy food and drinks is slow. Similarly, increasing interest to employ multi-sectoral approaches (MSA) in NCD prevention and policy is impeded by scarce knowledge on the mechanisms of MSA application in NCD prevention, their coordination, and potential successes in SSA. In recognition of the above gaps in NCD programming and interventions in Africa, the East Africa NCD alliance (EANCDA) in partnership with the African Population and Health Research Center (APHRC) organized a three-day NCDs conference in Nairobi. The conference entitled "First Africa Non-Communicable Disease Research Conference 2017: Sharing Evidence and Identifying Research Priorities" drew more than one hundred fifty participants and researchers from several institutions in Kenya, South Africa, Nigeria, Cameroon, Uganda, Tanzania, Rwanda, Burundi, Malawi, Belgium, USA and Canada. The sections that follow provide detailed overview of the conference, its objectives, a summary of the proceedings and recommendations on the African NCD research agenda to address NCD prevention efforts in Africa.
Published: 2019

32. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

Author: Gregory A Roth, Degu Abate, Kalkidan Hassen Abate, Solomon M Abay, Cristiana Abbafati, Nooshin Abbasi, Hedayat Abbastabar, Foad Abd-Allah, Jemal Abdela, Ahmed Abdelalim, Ibrahim Abdollahpour, Rizwan Suliankatchi Abdulkader, Haftom Temesgen Abebe, Molla Abebe, Zegeye Abebe, Ayenew Negesse Abejie, Semaw F Abera, Olifan Zewdie Abil, Haftom Niguse Abraha, Aklilu Roba Abrham, Laith Jamal Abu-Raddad, Manfred Mario Kokou Accrombessi, Dilaram Acharya, Abdu A Adamu, Oladimeji M Adebayo, Rufus Adesoji Adedoyin, Victor Adekanmbi, Olatunji O Adetokunboh, Beyene Meressa Adhena, Mina G Adib, Amha Admasie, Ashkan Afshin, Gina Agarwal, Kareha M Agesa, Anurag Agrawal, Sutapa Agrawal, Alireza Ahmadi, Mehdi Ahmadi, Muktar Beshir Ahmed, Sayem Ahmed, Amani Nidhal Aichour, Ibtihel Aichour, Miloud Taki Eddine Aichour, Mohammad Esmaeil Akbari, Rufus Olusola Akinyemi, Nadia Akseer, Ziyad Al-Aly, Ayman Al-Eyadhy, Rajaa M Al-Raddadi, Fares Alahdab, Khurshid Alam, Tahiya Alam, Animut Alebel, Kefyalew Addis Alene, Mehran Alijanzadeh, Reza Alizadeh-Navaei, Syed Mohamed Aljunid, Ala'a Alkerwi, François Alla, Peter Allebeck, Jordi Alonso, Khalid Altirkawi, Nelson Alvis-Guzman, Azmeraw T Amare, Leopold N Aminde, Erfan Amini, Walid Ammar, Yaw Ampem Amoako, Nahla Hamed Anber, Catalina Liliana Andrei, Sofia Androudi, Megbaru Debalkie Animut, Mina Anjomshoa, Hossein Ansari, Mustafa Geleto Ansha, Carl Abelardo T Antonio, Palwasha Anwari, Olatunde Aremu, Johan Ärnlöv, Amit Arora, Monika Arora, Al Artaman, Krishna K Aryal, Hamid Asayesh, Ephrem Tsegay Asfaw, Zerihun Ataro, Suleman Atique, Sachin R Atre, Marcel Ausloos, Euripide F G A Avokpaho, Ashish Awasthi, Beatriz Paulina Ayala Quintanilla, Yohanes Ayele, Rakesh Ayer, Peter S Azzopardi, Arefeh Babazadeh, Umar Bacha, Hamid Badali, Alaa Badawi, Ayele Geleto Bali, Katherine E Ballesteros, Maciej Banach, Kajori Banerjee, Marlena S Bannick, Joseph Adel Mattar Banoub, Miguel A Barboza, Suzanne Lyn Barker-Collo, Till Winfried Bärnighausen, Simon Barquera, Lope H Barrero, Quique Bassat, Sanjay Basu, Bernhard T Baune, Habtamu Wondifraw Baynes, Shahrzad Bazargan-Hejazi, Neeraj Bedi, Ettore Beghi, Masoud Behzadifar, Meysam Behzadifar, Yannick Béjot, Bayu Begashaw Bekele, Abate Bekele Belachew, Ezra Belay, Yihalem Abebe Belay, Michelle L Bell, Aminu K Bello, Derrick A Bennett, Isabela M Bensenor, Adam E Berman, Eduardo Bernabe, Robert S Bernstein, Gregory J Bertolacci, Mircea Beuran, Tina Beyranvand, Ashish Bhalla, Suraj Bhattarai, Soumyadeeep Bhaumik, Zulfiqar A Bhutta, Belete Biadgo, Molly H Biehl, Ali Bijani, Boris Bikbov, Ver Bilano, Nigus Bililign, Muhammad Shahdaat Bin Sayeed, Donal Bisanzio, Tuhin Biswas, Brigette F Blacker, Berrak Bora Basara, Rohan Borschmann, Cristina Bosetti, Kayvan Bozorgmehr, Oliver J Brady, Luisa C Brant, Carol Brayne, Alexandra Brazinova, Nicholas J K Breitborde, Hermann Brenner, Paul Svitil Briant, Gabrielle Britton, Traolach Brugha, Reinhard Busse, Zahid A Butt, Charlton S K H Callender, Ismael R Campos-Nonato, Julio Cesar Campuzano Rincon, Jorge Cano, Mate Car, Rosario Cárdenas, Giulia Carreras, Juan J Carrero, Austin Carter, Félix Carvalho, Carlos A Castañeda-Orjuela, Jacqueline Castillo Rivas, Chris D Castle, Clara Castro, Franz Castro, Ferrán Catalá-López, Ester Cerin, Yazan Chaiah, Jung-Chen Chang, Fiona J Charlson, Pankaj Chaturvedi, Peggy Pei-Chia Chiang, Odgerel Chimed-Ochir, Vesper Hichilombwe Chisumpa, Abdulaal Chitheer, Rajiv Chowdhury, Hanne Christensen, Devasahayam J Christopher, Sheng-Chia Chung, Flavia M Cicuttini, Liliana G Ciobanu, Massimo Cirillo, Aaron J Cohen, Leslie Trumbull Cooper, Paolo Angelo Cortesi, Monica Cortinovis, Ewerton Cousin, Benjamin C Cowie, Michael H Criqui, Elizabeth A Cromwell, Christopher Stephen Crowe, John A Crump, Matthew Cunningham, Alemneh Kabeta Daba, Abel Fekadu Dadi, Lalit Dandona, Rakhi Dandona, Anh Kim Dang, Paul I Dargan, Ahmad Daryani, Siddharth K Das, Rajat Das Gupta, José Das Neves, Tamirat Tesfaye Dasa, Aditya Prasad Dash, Adrian C Davis, Nicole Davis Weaver, Dragos Virgil Davitoiu, Kairat Davletov, Fernando Pio De La Hoz, Jan-Walter De Neve, Meaza Girma Degefa, Louisa Degenhardt, Tizta T Degfie, Selina Deiparine, Gebre Teklemariam Demoz, Balem Betsu Demtsu, Edgar Denova-Gutiérrez, Kebede Deribe, Nikolaos Dervenis, Don C Des Jarlais, Getenet Ayalew Dessie, Subhojit Dey, Samath D Dharmaratne, Daniel Dicker, Mesfin Tadese Dinberu, Eric L Ding, M Ashworth Dirac, Shirin Djalalinia, Klara Dokova, David Teye Doku, Christl A Donnelly, E Ray Dorsey, Pratik P Doshi, Dirk Douwes-Schultz, Kerrie E Doyle, Tim R Driscoll, Manisha Dubey, Eleonora Dubljanin, Eyasu Ejeta Duken, Bruce B Duncan, Andre R Duraes, Hedyeh Ebrahimi, Soheil Ebrahimpour, Dumessa Edessa, David Edvardsson, Anne Elise Eggen, Charbel El Bcheraoui, Maysaa El Sayed Zaki, Ziad El-Khatib, Hajer Elkout, Christian Lycke Ellingsen, Matthias Endres, Aman Yesuf Endries, Benjamin Er, Holly E Erskine, Babak Eshrati, Sharareh Eskandarieh, Reza Esmaeili, Alireza Esteghamati, Mahdi Fakhar, Hamed Fakhim, Mahbobeh Faramarzi, Mohammad Fareed, Farzaneh Farhadi, Carla Sofia E sá Farinha, Andre Faro, Maryam S Farvid, Farshad Farzadfar, Mohammad Hosein Farzaei, Valery L Feigin, Andrea B Feigl, Netsanet Fentahun, Seyed-Mohammad Fereshtehnejad, Eduarda Fernandes, Joao C Fernandes, Alize J Ferrari, Garumma Tolu Feyissa, Irina Filip, Samuel Finegold, Florian Fischer, Christina Fitzmaurice, Nataliya A Foigt, Kyle J Foreman, Carla Fornari, Tahvi D Frank, Takeshi Fukumoto, John E Fuller, Nancy Fullman, Thomas Fürst, João M Furtado, Neal D Futran, Silvano Gallus, Alberto L Garcia-Basteiro, Miguel A Garcia-Gordillo, William M Gardner, Abadi Kahsu Gebre, Tsegaye Tewelde Gebrehiwot, Amanuel Tesfay Gebremedhin, Bereket Gebremichael, Teklu Gebrehiwo Gebremichael, Tilayie Feto Gelano, Johanna M Geleijnse, Ricard Genova-Maleras, Yilma Chisha Dea Geramo, Peter W Gething, Kebede Embaye Gezae, Mohammad Rasoul Ghadami, Reza Ghadimi, Khalil Ghasemi Falavarjani, Maryam Ghasemi-Kasman, Mamata Ghimire, Katherine B Gibney, Paramjit Singh Gill, Tiffany K Gill, Richard F Gillum, Ibrahim Abdelmageed Ginawi, Maurice Giroud, Giorgia Giussani, Shifalika Goenka, Ellen M Goldberg, Srinivas Goli, Hector Gómez-Dantés, Philimon N Gona, Sameer Vali Gopalani, Taren M Gorman, Atsushi Goto, Alessandra C Goulart, Elena V Gnedovskaya, Ayman Grada, Giuseppe Grosso, Harish Chander Gugnani, Andre Luiz Sena Guimaraes, Yuming Guo, Prakash C Gupta, Rahul Gupta, Rajeev Gupta, Tanush Gupta, Reyna Alma Gutiérrez, Bishal Gyawali, Juanita A Haagsma, Nima Hafezi-Nejad, Tekleberhan B Hagos, Tewodros Tesfa Hailegiyorgis, Gessessew Bugssa Hailu, Arvin Haj-Mirzaian, Arya Haj-Mirzaian, Randah R Hamadeh, Samer Hamidi, Alexis J Handal, Graeme J Hankey, Hilda L Harb, Sivadasanpillai Harikrishnan, Josep Maria Haro, Mehedi Hasan, Hadi Hassankhani, Hamid Yimam Hassen, Rasmus Havmoeller, Roderick J Hay, Simon I Hay, Yihua He, Akbar Hedayatizadeh-Omran, Mohamed I Hegazy, Behzad Heibati, Mohsen Heidari, Delia Hendrie, Andualem Henok, Nathaniel J Henry, Claudiu Herteliu, Fatemeh Heydarpour, Pouria Heydarpour, Sousan Heydarpour, Desalegn Tsegaw Hibstu, Hans W Hoek, Michael K Hole, Enayatollah Homaie Rad, Praveen Hoogar, H Dean Hosgood, Seyed Mostafa Hosseini, Mehdi Hosseinzadeh, Mihaela Hostiuc, Sorin Hostiuc, Peter J Hotez, Damian G Hoy, Thomas Hsiao, Guoqing Hu, John J Huang, Abdullatif Husseini, Mohammedaman Mama Hussen, Susan Hutfless, Bulat Idrisov, Olayinka Stephen Ilesanmi, Usman Iqbal, Seyed Sina Naghibi Irvani, Caleb Mackay Salpeter Irvine, Nazrul Islam, Sheikh Mohammed Shariful Islam, Farhad Islami, Kathryn H Jacobsen, Leila Jahangiry, Nader Jahanmehr, Sudhir Kumar Jain, Mihajlo Jakovljevic, Moti Tolera Jalu, Spencer L James, Mehdi Javanbakht, Achala Upendra Jayatilleke, Panniyammakal Jeemon, Kathy J Jenkins, Ravi Prakash Jha, Vivekanand Jha, Catherine O Johnson, Sarah C Johnson, Jost B Jonas, Ankur Joshi, Jacek Jerzy Jozwiak, Suresh Banayya Jungari, Mikk Jürisson, Zubair Kabir, Rajendra Kadel, Amaha Kahsay, Rizwan Kalani, Manoochehr Karami, Behzad Karami Matin, André Karch, Corine Karema, Hamidreza Karimi-Sari, Amir Kasaeian, Dessalegn H Kassa, Getachew Mullu Kassa, Tesfaye Dessale Kassa, Nicholas J Kassebaum, Srinivasa Vittal Katikireddi, Anil Kaul, Zhila Kazemi, Ali Kazemi Karyani, Dhruv Satish Kazi, Adane Teshome Kefale, Peter Njenga Keiyoro, Grant Rodgers Kemp, Andre Pascal Kengne, Andre Keren, Chandrasekharan Nair Kesavachandran, Yousef Saleh Khader, Behzad Khafaei, Morteza Abdullatif Khafaie, Alireza Khajavi, Nauman Khalid, Ibrahim A Khalil, Ejaz Ahmad Khan, Muhammad Shahzeb Khan, Muhammad Ali Khan, Young-Ho Khang, Mona M Khater, Abdullah T Khoja, Ardeshir Khosravi, Mohammad Hossein Khosravi, Jagdish Khubchandani, Aliasghar A Kiadaliri, Getiye D Kibret, Zelalem Teklemariam Kidanemariam, Daniel N Kiirithio, Daniel Kim, Young-Eun Kim, Yun Jin Kim, Ruth W Kimokoti, Yohannes Kinfu, Adnan Kisa, Katarzyna Kissimova-Skarbek, Mika Kivimäki, Ann Kristin Skrindo Knudsen, Jonathan M Kocarnik, Sonali Kochhar, Yoshihiro Kokubo, Tufa Kolola, Jacek A Kopec, Parvaiz A Koul, Ai Koyanagi, Michael A Kravchenko, Kewal Krishan, Barthelemy Kuate Defo, Burcu Kucuk Bicer, G Anil Kumar, Manasi Kumar, Pushpendra Kumar, Michael J Kutz, Igor Kuzin, Hmwe Hmwe Kyu, Deepesh P Lad, Sheetal D Lad, Alessandra Lafranconi, Dharmesh Kumar Lal, Ratilal Lalloo, Tea Lallukka, Jennifer O Lam, Faris Hasan Lami, Van C Lansingh, Sonia Lansky, Heidi J Larson, Arman Latifi, Kathryn Mei-Ming Lau, Jeffrey V Lazarus, Georgy Lebedev, Paul H Lee, James Leigh, Mostafa Leili, Cheru Tesema Leshargie, Shanshan Li, Yichong Li, Juan Liang, Lee-Ling Lim, Stephen S Lim, Miteku Andualem Limenih, Shai Linn, Shiwei Liu, Yang Liu, Rakesh Lodha, Chris Lonsdale, Alan D Lopez, Stefan Lorkowski, Paulo A Lotufo, Rafael Lozano, Raimundas Lunevicius, Stefan Ma, Erlyn Rachelle King Macarayan, Mark T Mackay, Jennifer H MacLachlan, Emilie R Maddison, Fabiana Madotto, Hassan Magdy Abd El Razek, Muhammed Magdy Abd El Razek, Dhaval P Maghavani, Marek Majdan, Reza Majdzadeh, Azeem Majeed, Reza Malekzadeh, Deborah Carvalho Malta, Ana-Laura Manda, Luiz Garcia Mandarano-Filho, Helena Manguerra, Mohammad Ali Mansournia, Chabila Christopher Mapoma, Dadi Marami, Joemer C Maravilla, Wagner Marcenes, Laurie Marczak, Ashley Marks, Guy B Marks, Gabriel Martinez, Francisco Rogerlândio Martins-Melo, Ira Martopullo, Winfried März, Melvin B Marzan, Joseph R Masci, Benjamin Ballard Massenburg, Manu Raj Mathur, Prashant Mathur, Richard Matzopoulos, Pallab K Maulik, Mohsen Mazidi, Colm McAlinden, John J McGrath, Martin McKee, Brian J McMahon, Suresh Mehata, Man Mohan Mehndiratta, Ravi Mehrotra, Kala M Mehta, Varshil Mehta, Tefera C Mekonnen, Addisu Melese, Mulugeta Melku, Peter T N Memiah, Ziad A Memish, Walter Mendoza, Desalegn Tadese Mengistu, Getnet Mengistu, George A Mensah, Seid Tiku Mereta, Atte Meretoja, Tuomo J Meretoja, Tomislav Mestrovic, Haftay Berhane Mezgebe, Bartosz Miazgowski, Tomasz Miazgowski, Anoushka I Millear, Ted R Miller, Molly Katherine Miller-Petrie, G K Mini, Parvaneh Mirabi, Mojde Mirarefin, Andreea Mirica, Erkin M Mirrakhimov, Awoke Temesgen Misganaw, Habtamu Mitiku, Babak Moazen, Karzan Abdulmuhsin Mohammad, Moslem Mohammadi, Noushin Mohammadifard, Mohammed A Mohammed, Shafiu Mohammed, Viswanathan Mohan, Ali H Mokdad, Mariam Molokhia, Lorenzo Monasta, Ghobad Moradi, Maziar Moradi-Lakeh, Mehdi Moradinazar, Paula Moraga, Lidia Morawska, Ilais Moreno Velásquez, Joana Morgado-Da-Costa, Shane Douglas Morrison, Marilita M Moschos, Simin Mouodi, Seyyed Meysam Mousavi, Kindie Fentahun Muchie, Ulrich Otto Mueller, Satinath Mukhopadhyay, Kate Muller, John Everett Mumford, Jonah Musa, Kamarul Imran Musa, Ghulam Mustafa, Saravanan Muthupandian, Jean B Nachega, Gabriele Nagel, Aliya Naheed, Azin Nahvijou, Gurudatta Naik, Sanjeev Nair, Farid Najafi, Luigi Naldi, Hae Sung Nam, Vinay Nangia, Jobert Richie Nansseu, Bruno Ramos Nascimento, Gopalakrishnan Natarajan, Nahid Neamati, Ionut Negoi, Ruxandra Irina Negoi, Subas Neupane, Charles R J Newton, Frida N Ngalesoni, Josephine W Ngunjiri, Anh Quynh Nguyen, Grant Nguyen, Ha Thu Nguyen, Huong Thanh Nguyen, Long Hoang Nguyen, Minh Nguyen, Trang Huyen Nguyen, Emma Nichols, Dina Nur Anggraini Ningrum, Yirga Legesse Nirayo, Molly R Nixon, Nomonde Nolutshungu, Shuhei Nomura, Ole F Norheim, Mehdi Noroozi, Bo Norrving, Jean Jacques Noubiap, Hamid Reza Nouri, Malihe Nourollahpour Shiadeh, Mohammad Reza Nowroozi, Peter S Nyasulu, Christopher M Odell, Richard Ofori-Asenso, Felix Akpojene Ogbo, In-Hwan Oh, Olanrewaju Oladimeji, Andrew T Olagunju, Pedro R Olivares, Helen Elizabeth Olsen, Bolajoko Olubukunola Olusanya, Jacob Olusegun Olusanya, Kanyin L Ong, Sok King Sk Ong, Eyal Oren, Heather M Orpana, Alberto Ortiz, Justin R Ortiz, Stanislav S Otstavnov, Simon Øverland, Mayowa Ojo Owolabi, Raziye Özdemir, Mahesh P A, Rosana Pacella, Smita Pakhale, Abhijit P Pakhare, Amir H Pakpour, Adrian Pana, Songhomitra Panda-Jonas, Jeyaraj Durai Pandian, Andrea Parisi, Eun-Kee Park, Charles D H Parry, Hadi Parsian, Shanti Patel, Sanghamitra Pati, George C Patton, Vishnupriya Rao Paturi, Katherine R Paulson, Alexandre Pereira, David M Pereira, Norberto Perico, Konrad Pesudovs, Max Petzold, Michael R Phillips, Frédéric B Piel, David M Pigott, Julian David Pillay, Meghdad Pirsaheb, Farhad Pishgar, Suzanne Polinder, Maarten J Postma, Akram Pourshams, Hossein Poustchi, Ashwini Pujar, Swayam Prakash, Narayan Prasad, Caroline A Purcell, Mostafa Qorbani, Hedley Quintana, D Alex Quistberg, Kirankumar Waman Rade, Amir Radfar, Anwar Rafay, Alireza Rafiei, Fakher Rahim, Kazem Rahimi, Afarin Rahimi-Movaghar, Mahfuzar Rahman, Mohammad Hifz Ur Rahman, Muhammad Aziz Rahman, Rajesh Kumar Rai, Sasa Rajsic, Usha Ram, Chhabi Lal Ranabhat, Prabhat Ranjan, Puja C Rao, David Laith Rawaf, Salman Rawaf, Christian Razo-García, K Srinath Reddy, Robert C Reiner, Marissa B Reitsma, Giuseppe Remuzzi, Andre M N Renzaho, Serge Resnikoff, Satar Rezaei, Shahab Rezaeian, Mohammad Sadegh Rezai, Seyed Mohammad Riahi, Antonio Luiz P Ribeiro, Maria Jesus Rios-Blancas, Kedir Teji Roba, Nicholas L S Roberts, Stephen R Robinson, Leonardo Roever, Luca Ronfani, Gholamreza Roshandel, Ali Rostami, Dietrich Rothenbacher, Ambuj Roy, Enrico Rubagotti, Perminder S Sachdev, Basema Saddik, Ehsan Sadeghi, Hosein Safari, Mahdi Safdarian, Sare Safi, Saeid Safiri, Rajesh Sagar, Amirhossein Sahebkar, Mohammad Ali Sahraian, Nasir Salam, Joseph S Salama, Payman Salamati, Raphael De Freitas Saldanha, Zikria Saleem, Yahya Salimi, Sundeep Santosh Salvi, Inbal Salz, Evanson Zondani Sambala, Abdallah M Samy, Juan Sanabria, Maria Dolores Sanchez-Niño, Damian Francesco Santomauro, Itamar S Santos, João Vasco Santos, Milena M Santric Milicevic, Bruno Piassi Sao Jose, Abdur Razzaque Sarker, Rodrigo Sarmiento-Suárez, Nizal Sarrafzadegan, Benn Sartorius, Shahabeddin Sarvi, Brijesh Sathian, Maheswar Satpathy, Arundhati R Sawant, Monika Sawhney, Sonia Saxena, Mehdi Sayyah, Elke Schaeffner, Maria Inês Schmidt, Ione J C Schneider, Ben Schöttker, Aletta Elisabeth Schutte, David C Schwebel, Falk Schwendicke, James G Scott, Mario Sekerija, Sadaf G Sepanlou, Edson Serván-Mori, Seyedmojtaba Seyedmousavi, Hosein Shabaninejad, Katya Anne Shackelford, Azadeh Shafieesabet, Mehdi Shahbazi, Amira A Shaheen, Masood Ali Shaikh, Mehran Shams-Beyranvand, Mohammadbagher Shamsi, Morteza Shamsizadeh, Kiomars Sharafi, Mehdi Sharif, Mahdi Sharif-Alhoseini, Rajesh Sharma, Jun She, Aziz Sheikh, Peilin Shi, Mekonnen Sisay Shiferaw, Mika Shigematsu, Rahman Shiri, Reza Shirkoohi, Ivy Shiue, Farhad Shokraneh, Mark G Shrime, Si Si, Soraya Siabani, Tariq J Siddiqi, Inga Dora Sigfusdottir, Rannveig Sigurvinsdottir, Donald H Silberberg, Diego Augusto Santos Silva, João Pedro Silva, Natacha Torres Da Silva, Dayane Gabriele Alves Silveira, Jasvinder A Singh, Narinder Pal Singh, Prashant Kumar Singh, Virendra Singh, Dhirendra Narain Sinha, Karen Sliwa, Mari Smith, Badr Hasan Sobaih, Soheila Sobhani, Eugène Sobngwi, Samir S Soneji, Moslem Soofi, Reed J D Sorensen, Joan B Soriano, Ireneous N Soyiri, Luciano A Sposato, Chandrashekhar T Sreeramareddy, Vinay Srinivasan, Jeffrey D Stanaway, Vladimir I Starodubov, Vasiliki Stathopoulou, Dan J Stein, Caitlyn Steiner, Leo G Stewart, Mark A Stokes, Michelle L Subart, Agus Sudaryanto, Mu'awiyyah Babale Sufiyan, Patrick John Sur, Ipsita Sutradhar, Bryan L Sykes, P N Sylaja, Dillon O Sylte, Cassandra E I Szoeke, Rafael Tabarés-Seisdedos, Takahiro Tabuchi, Santosh Kumar Tadakamadla, Ken Takahashi, Nikhil Tandon, Segen Gebremeskel Tassew, Nuno Taveira, Arash Tehrani-Banihashemi, Tigist Gashaw Tekalign, Merhawi Gebremedhin Tekle, Mohamad-Hani Temsah, Omar Temsah, Abdullah Sulieman Terkawi, Manaye Yihune Teshale, Belay Tessema, Gizachew Assefa Tessema, Kavumpurathu Raman Thankappan, Sathish Thirunavukkarasu, Nihal Thomas, Amanda G Thrift, George D Thurston, Binyam Tilahun, Quyen G To, Ruoyan Tobe-Gai, Marcello Tonelli, Roman Topor-Madry, Anna E Torre, Miguel Tortajada-Girbés, Mathilde Touvier, Marcos Roberto Tovani-Palone, Bach Xuan Tran, Khanh Bao Tran, Suryakant Tripathi, Christopher E Troeger, Thomas Clement Truelsen, Nu Thi Truong, Afewerki Gebremeskel Tsadik, Derrick Tsoi, Lorainne Tudor Car, E Murat Tuzcu, Stefanos Tyrovolas, Kingsley N Ukwaja, Irfan Ullah, Eduardo A Undurraga, Rachel L Updike, Muhammad Shariq Usman, Olalekan A Uthman, Selen Begüm Uzun, Muthiah Vaduganathan, Afsane Vaezi, Gaurang Vaidya, Pascual R Valdez, Elena Varavikova, Tommi Juhani Vasankari, Narayanaswamy Venketasubramanian, Santos Villafaina, Francesco S Violante, Sergey Konstantinovitch Vladimirov, Vasily Vlassov, Stein Emil Vollset, Theo Vos, Gregory R Wagner, Fasil Shiferaw Wagnew, Yasir Waheed, Mitchell Taylor Wallin, Judd L Walson, Yanping Wang, Yuan-Pang Wang, Molla Mesele Wassie, Elisabete Weiderpass, Robert G Weintraub, Fitsum Weldegebreal, Kidu Gidey Weldegwergs, Andrea Werdecker, Adhena Ayaliew Werkneh, T Eoin West, Ronny Westerman, Harvey A Whiteford, Justyna Widecka, Lauren B Wilner, Shadrach Wilson, Andrea Sylvia Winkler, Charles Shey Wiysonge, Charles D A Wolfe, Shouling Wu, Yun-Chun Wu, Grant M A Wyper, Denis Xavier, Gelin Xu, Simon Yadgir, Ali Yadollahpour, Seyed Hossein Yahyazadeh Jabbari, Bereket Yakob, Lijing L Yan, Yuichiro Yano, Mehdi Yaseri, Yasin Jemal Yasin, Gökalp Kadri Yentür, Alex Yeshaneh, Ebrahim M Yimer, Paul Yip, Biruck Desalegn Yirsaw, Engida Yisma, Naohiro Yonemoto, Gerald Yonga, Seok-Jun Yoon, Marcel Yotebieng, Mustafa Z Younis, Mahmoud Yousefifard, Chuanhua Yu, Vesna Zadnik, Zoubida Zaidi, Sojib Bin Zaman, Mohammad Zamani, Zohreh Zare, Ayalew Jejaw Zeleke, Zerihun Menlkalew Zenebe, Anthony Lin Zhang, Kai Zhang, Maigeng Zhou, Sanjay Zodpey, Liesl Joanna Zuhlke, Mohsen Naghavi, and Christopher J L Murray., Rubagotti, Enrico, Abay, Solomon M., Roth, Gregory, Abd Allah, Foad, Abdela, Jemal, Abbastabar, Hedayat, and Abbasi, Nooshin
Subjects: Overview, Disease, Territory, Causes of death, humanities
Abstract: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017. The Lancet Publishing Group
Published: 2019

33. Healthy Heart Africa: a prospective evaluation of programme outcomes on individuals' hypertension awareness, screening, diagnosis and treatment in rural Kenya at 12 months

Author: Francis Okello, Ashling Mulvaney, Jane L. Herr, Elijah Ogola, and Gerald Yonga
Subjects: Adult, Male, Pediatrics, medicine.medical_specialty, Health Knowledge, Attitudes, Practice, Time Factors, Adolescent, Black People, Blood Pressure, Intervention group, Health Promotion, Rural Health, Prospective evaluation, Hypertension risk, Young Adult, Patient Education as Topic, Predictive Value of Tests, Risk Factors, Intervention (counseling), Health care, medicine, Humans, Prospective Studies, Antihypertensive Agents, End point, business.industry, Matched control, Cardiovascular Topics, General Medicine, Middle Aged, Kenya, Treatment Outcome, Health Communication, Case-Control Studies, Hypertension, Female, Cardiology and Cardiovascular Medicine, business, Healthcare providers, Risk Reduction Behavior, Program Evaluation
Abstract: OBJECTIVE: To evaluate the impact of Healthy Heart Africa (HHA), a comprehensive hypertension intervention programme, on hypertension awareness, knowledge, screening and diagnosis among rural communities in Kenya. METHODS: Individuals from rural households near intervention and matched control healthcare facilities were randomly surveyed at baseline and the end point (after 12 months). A difference-in-differences analysis estimated the impact of HHA. RESULTS: This analysis included 838 individuals (intervention, n = 432; control, n = 406) at baseline and 698 (n = 364 and n = 334, respectively) at the end point. At baseline, both groups had high hypertension awareness (> 80%) but poor knowledge. After 12 months, healthcare providers were the primary information source for the intervention group only (p < 0.05). At the end point, respondents’ knowledge of hypertension risk factors, consequences and management trended higher among the intervention versus the control group. Hypertension screening/diagnosis and patient recall of provider recommendations remained unchanged in both groups. CONCLUSION: HHA improved hypertension knowledge but screening and diagnosis remained unchanged after 12 months.
Published: 2018

34. Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice

Author: Rachel Nugent, Lauren Courtney, David A Watkins, D. Allen Roberts, Gerald Yonga, Cristina Bisson, Ilya Golovaty, Ruanne V. Barnabas, Brianna Osetinsky, and Pragna Patel
Subjects: 0301 basic medicine, Male, Total cost, Service delivery framework, Cost effectiveness, Immunology, Psychological intervention, HIV Infections, Article, 03 medical and health sciences, 0302 clinical medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Disease management (health), Noncommunicable Diseases, health care economics and organizations, Public economics, Delivery of Health Care, Integrated, Disease Management, Health Care Costs, 030112 virology, Integrated care, Infectious Diseases, Scale (social sciences), Africa, Female, Business, Fiscal sustainability
Abstract: The current article reviews economic aspects of selected HIV/noncommunicable disease (NCD) service delivery integration programs to assess the efficiency of integration in limited capacity settings. We define economies of scope and scale and their relevance to HIV/NCD integration. We summarize the results of a systematic review of cost and cost-effectiveness studies of integrated care, which identified 12 datasets (nine studies) with a wide range of findings driven by differences in research questions, study methods, and health conditions measured. All studies were done in Africa and examined screening interventions only. No studies assessed the cost of integrated, long-term disease management. Few studies estimated the cost-effectiveness of integrated screening programs. The additional cost of integrating NCD screening with HIV care platforms represented a 6-30% increase in the total costs of the programs for noncancer NCDs, with cervical cancer screening costs dependent on screening strategy. We conducted 11 key informant interviews to uncover perceptions of the economics of HIV/NCD integration. None of the informants had hard information about the economic efficiency of integration. Most expected integrated care to be more cost-effective than current practice, though a minority thought that greater specialization could be more cost-effective. In the final section of this article, we summarize research needs and propose a 'minimum economic dataset' for future studies. We conclude that, although integrated HIV/NCD care has many benefits, the economic justification is unproven. Better information on the cost, cost-effectiveness, and fiscal sustainability of integrated programs is needed to justify this approach in limited-resource countries.
Published: 2018

35. Initial Rhythm and Resuscitation Outcomes for Patients Developing Cardiac Arrest in Hospital: Data From Low-Middle Income Country

Author: Leonard Mzee, Ngunga, Gerald, Yonga, Benjamin, Wachira, and Justin A, Ezekowitz
Subjects: Male, Incidence, Middle Aged, Kenya, Cardiopulmonary Resuscitation, Heart Arrest, Survival Rate, Population Surveillance, Outcome Assessment, Health Care, Humans, Female, Prospective Studies, Developing Countries, Poverty
Abstract: Health care resource allocation remains challenging in lower middle income countries such as Kenya with meager resources being allocated to resuscitation and critical care. The causes and outcomes for in-hospital cardiac arrest and resuscitation have not been studied.This study sought to determine the initial rhythm and the survival for patients developing in-hospital cardiac arrest.This was a prospective study for in-hospital cardiac arrest in 6 Kenyan hospitals from July 2014 to April 2016. Resuscitation teams were utilized to collect data during resuscitation using a standardized protocol. Patients with do-not-resuscitate orders, trauma, postsurgical, and pregnancy-related complications were excluded. The Modified Early Warning Score (MEWS)- systolic blood pressure, heart rate, respiration rate, temperature, and responsiveness-was determined based on worst parameters at least 4 hours prior to the arrest.A total of 353 patients with cardiac arrest were included over 19 months. The mean age was 61 years, 53.5% were male, and admission diagnoses included cardiovascular disease (15%), pneumonia 18.13%, and cancer 9%. The mean MEWS was 4.48 and low, intermediate, and high MEWS were found in 25.8%, 29.5%, and 44.8%, respectively. The mean time to cardiopulmonary resuscitation was 0.84 min. The initial rhythm was asystole in 47.6%, pulseless electrical activity in 38.2%, ventricular tachycardia/ventricular fibrillation in 5.4%, and unknown in 8.8%. Return of spontaneous circulation (ROSC) occurred in 29.2% of patients with the mean time to ROSC being 5.3 min. ROSC occurred in 17.3% of patients with asystole, 40.7% in pulseless electrical activity, 57.9% in ventricular tachycardia/ventricular fibrillation, and 25.8% in patients with an unknown rhythm. Of all patients, 16 (4.2%) were discharged alive.Nonshockable rhythms account for the majority of the cardiac arrests in hospitals in a lower middle income country and are associated with unfavorable outcomes. Future work should be directed to training health care personnel in recognizing early warning signs and implementing appropriate measures in a resource-scarce environment.
Published: 2018

36. The association between asymptomatic and mild neurocognitive impairment and adherence to antiretroviral therapy among people living with human immunodeficiency virus

Author: Reena C. Shah, Violet Awori, Gerald Yonga, and Peter Mativo
Subjects: medicine.medical_specialty, Activities of daily living, Population, MEDLINE, Human immunodeficiency virus (HIV), medicine.disease_cause, Asymptomatic, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, 030212 general & internal medicine, education, Association (psychology), Neurocognition, Original Research, education.field_of_study, business.industry, lcsh:Public aspects of medicine, Montreal Cognitive Assessment, HIV, lcsh:RA1-1270, Infectious Diseases, medicine.symptom, business, Neurocognitive, 030217 neurology & neurosurgery
Abstract: Background: Asymptomatic cognitive impairment in human immunodeficiency virus (HIV)-infected patients has recently been recognised as part of HIV-associated neurocognitive disorders. This has been implicated as one of the causes of poor adherence to antiretroviral therapy (ART). Objective: To assess the association between neurocognitive impairment (asymptomatic and mild forms) and adherence to ART. Methods: This was a cross-sectional survey involving 218 participants consecutively sampled from those attending the HIV treatment clinic at Aga Khan University Hospital in Nairobi. Data collected included quantitative primary data on pre-defined baseline characteristics, neurocognitive assessment by Montreal Cognitive Assessment (MoCA) tool ( Appendix 1 ), instrumental activities of daily living by Lawton score and objective and subjective adherence measures by medication possession ratio (MPR) and simplified medication adherence questionnaire (SMAQ) (see Appendix 2 ). Univariate and bivariate analyses were conducted to determine the strengths of association between predictor and the outcome variables. Results: Among the 218 participants in the study, a total of 69% had asymptomatic to mild neurocognitive impairment as assessed by the MoCA tool, while a total of 66% were determined as being adherent to ART by objective measures (by MPR) compared to subjective rates of 77% as assessed by SMAQ. However, no statistically significant association was observed between the presence of asymptomatic or mild neurocognitive impairment and likelihood of adherence to ART ( p > 0.05). Conclusion: Even though asymptomatic and mild forms of cognitive impairment are prevalent in the population studied, there was no significant association between cognitive impairment and adherence to treatment.
Published: 2018

37. Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For Improvement

Author: Tracy L. Rabin, Gerald Mutungi, Justin M. List, Trishul Siddharthan, Kaushik Ramaiya, Sandeep P. Kishore, Gerald Yonga, and Jeremy I. Schwartz
Subjects: Male, medicine.medical_specialty, Economic growth, Civil society, Respiratory Tract Diseases, Alternative medicine, Developing country, Communicable Diseases, Article, Environmental health, Diabetes Mellitus, Prevalence, medicine, Humans, Social determinants of health, Disease management (health), Developing Countries, Chronic care, Health Services Needs and Demand, Communicable disease, business.industry, Health Policy, Public health, Disease Management, Africa, Eastern, Cardiovascular Diseases, Chronic Disease, Female, Public Health, business, Delivery of Health Care
Abstract: The prevalence of noncommunicable diseases in East Africa is rising rapidly. Although the epidemiologic, demographic, and nutritional transitions are well under way in low-income countries, investment and attention in these countries remain focused largely on communicable diseases. We discuss existing infrastructure in communicable disease management as well as linkages between noncommunicable and communicable diseases in East Africa. We describe gaps in noncommunicable disease management within the health systems in this region. We also discuss deficiencies in addressing noncommunicable diseases from basic science research and medical training to health services delivery, public health initiatives, and access to essential medications in East Africa. Finally, we highlight the role of collaboration among East African governments and civil society in addressing noncommunicable diseases, and we advocate for a robust primary health care system that focuses on the social determinants of health.
Published: 2015
Full Text: View/download PDF

38. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

Author: Haidong, Wang, Mohsen, Naghavi, Christine, Allen, Ryan M, Barber Zulfi, qar A, Bhutta, Austin, Carter, Daniel C, Casey Fiona, J Charlson, Alan Zian, Chen Matthew, M Coates, Megan, Coggeshall, Lalit, Dandona, Daniel J, Dicker Holly, E Erskine, Alize J, Ferrari, Christina, Fitzmaurice, Kyle, Foreman, Mohammad H, Forouzanfar Maya, S Fraser, Nancy, Fullman, Peter W, Gething Ellen, M Goldberg, Nicholas, Graetz, Juanita A, Haagsma Simon, I Hay, Chantal, Huynh, Catherine O, Johnson Nicholas, J Kassebaum, Yohannes, Kinfu, Xie Rachel, Kulikoff, Michael, Kutz, Hmwe H, Kyu Heidi, J Larson, Janni, Leung, Xiaofeng, Liang, Stephen S, Lim, Margaret, Lind, Rafael, Lozano, Neal, Marquez, George A, Mensah, Joe, Mikesell, Ali H, Mokdad Meghan, D Mooney, Grant, Nguyen, Elaine, Nsoesie, David M, Pigott, Christine, Pinho, Gregory A, Roth Joshua, A Salomon, Logan, Sandar, Naris, Silpakit, Amber, Sligar, Reed J, D Sorensen, Jeff rey, Stanaway, Caitlyn, Steiner, Stephanie, Teeple, Bernadette A, Thomas, Christopher, Troeger, Amelia, VanderZanden, Stein Emil, Vollset, Valentine, Wanga, Harvey A, Whiteford, Timothy, Wolock, Leo, Zoeckler, Kalkidan Hassen, Abate, Cristiana, Abbafati, Kaja M, Abbas, Foad, Abd-Allah, Semaw Ferede, Abera Daisy, M X, Abreu Laith, J Abu-Raddad, Gebre Yitayih, Abyu, Tom, Achoki, Ademola Lukman, Adelekan Zanfi, na Ademi, Arsène Kouablan, Adou José, C Adsuar, Kossivi Agbelenko, Afanvi, Ashkan, Afshin, Emilie Elisabet, Agardh, Arnav, Agarwal, Anurag, Agrawal, Aliasghar Ahmad, Kiadaliri Oluremi, N Ajala, Ali Shafqat, Akanda Rufus, Olusola Akinyemi, Tomi F, Akinyemiju, Nadia, Akseer, Faris Hasan, Al Lami, Samer, Alabed, Ziyad, Al-Aly, Khurshid, Alam, Noore K, M Alam, Deena, Alasfoor, Saleh Fahed, Aldhahri Robert, William Aldridge, Miguel Angel, Alegretti Alicia, V Aleman, Zewdie Aderaw, Alemu Lily, T Alexander, Samia, Alhabib, Raghib, Ali, Ala’a, Alkerwi, François, Alla, Peter, Allebeck, Rajaa, Al-Raddadi, Ubai, Alsharif, Khalid A, Altirkawi Elena, Alvarez Martin, Nelson, Alvis-Guzman, Azmeraw T, Amare Adeladza, Kofi Amegah, Emmanuel A, Ameh, Heresh, Amini, Walid, Ammar, Stephen Marc, Amrock Hjalte, H Andersen, Benjamin O, Anderson Gregory, M Anderson, Carl Abelardo, T Antonio, Atsede Fantahun, Aregay, Johan, Ärnlöv, Valentina S, Arsic Arsenijevic, Al, Artaman, Hamid, Asayesh, Rana Jawad, Asghar, Suleman, Atique, Euripide Frinel, G Arthur, Avokpaho, Ashish, Awasthi, Peter, Azzopardi, Umar, Bacha, Alaa, Badawi, Maria C, Bahit, Kalpana, Balakrishnan, Amitava, Banerjee, Aleksandra, Barac, Suzanne L, Barker-Collo, Till, Bärnighausen, Lars, Barregard, Lope H, Barrero, Arindam, Basu, Sanjay, Basu, Yibeltal Tebekaw, Bayou, Shahrzad, Bazargan-Hejazi, Justin, Beardsley, Neeraj, Bedi, Ettore, Beghi, Haileeyesus Adamu, Belay, Brent, Bell, Michelle L, Bell Aminu, K Bello, Derrick A, Bennett Isabela, M Bensenor, Adugnaw, Berhane, Eduardo, Bernabé, Balem Demtsu, Betsu Addisu, Shunu Beyene, Neeraj, Bhala, Ashish, Bhalla, Sibhatu, Biadgilign, Boris, Bikbov, Aref A, Bin Abdulhak, Brian J, Biroscak, Stan, Biryukov, Espen, Bjertness, Jed D, Blore Christopher, D Blosser, Megan A, Bohensky, Rohan, Borschmann, Dipan, Bose, Rupert R, A Bourne, Michael, Brainin, Carol E, G Brayne, Alexandra, Brazinova, Nicholas J, K Breitborde, Hermann, Brenner, Jerry D, Brewer, Alexandria, Brown, Jonathan, Brown, Traolach S, Brugha Geoff, rey Colin, Buckle Zahid, A Butt, Bianca, Calabria, Ismael Ricardo, Campos-Nonato Julio, Cesar Campuzano, Jonathan R, Carapetis, Rosario, Cárdenas, David O, Carpenter Juan, Jesus Carrero, Carlos A, Castañeda-Orjuela Jacqueline, Castillo Rivas, Ferrán, Catalá-López, Fiorella, Cavalleri, Kelly, Cercy, Jorge, Cerda, Wanqing, Chen, Adrienne, Chew, Peggy Pei-Chia, Chiang, Mirriam, Chibalabala, Chioma Ezinne, Chibueze, Odgerel, Chimed-Ochir, Vesper Hichilombwe, Chisumpa Jee-Young, Jasmine Choi, Rajiv, Chowdhury, Hanne, Christensen, Devasahayam Jesudas, Christopher Liliana, G Ciobanu, Cirillo Massimo, Aaron J, Cohen, Valentina, Colistro, Mercedes, Colomar, Samantha M, Colquhoun, Cyrus, Cooper, Leslie Trumbull, Cooper, Monica, Cortinovis, Benjamin C, Cowie John, A Crump, James, Damsere-Derry, Hadi, Danawi, Rakhi, Dandona, Farah, Daoud, Sarah C, Darby Paul, I Dargan, José das, Neves, Gail, Davey, Adrian C, Davis Dragos, V Davitoiu, E Filipa, de Castro, Pieter de, Jager Diego, De Leo, Louisa, Degenhardt, Robert P, Dellavalle, Kebede, Deribe, Amare, Deribew, Samath D, Dharmaratne Preet, K Dhillon, Cesar, Diaz-Torné, Eric L, Ding Kadine, Priscila Bender, dos Santos, Edem, Dossou, Tim R, Driscoll, Leilei, Duan, Manisha, Dubey, Bruce Bartholow, Duncan Richard, G Ellenbogen, Christian Lycke, Ellingsen, Iqbal, Elyazar, Aman Yesuf, Endries Sergey, Petrovich Ermakov, Babak, Eshrati, Alireza, Esteghamati, Kara, Estep, Imad D, A Faghmous, Saman, Fahimi, Emerito Jose, Aquino Faraon, Talha A, Farid Carla, Sofi a, e Sa, Farinha, André, Faro, Maryam S, Farvid, Farshad, Farzadfar, Valery L, Feigin, Seyed-Mohammad, Fereshtehnejad, Jeff erson, G Fernandes, Joao C, Fernandes, Florian, Fischer, Joseph R, A Fitchett, Abraham, Flaxman, Nataliya, Foigt, F Gerry, R Fowkes, Elisabeth Barboza, Franca Richard, C Franklin, Joseph, Friedman, Joseph, Frostad, Thomas, Fürst, Neal D, Futran Seana, L Gall, Ketevan, Gambashidze, Amiran, Gamkrelidze, Parthasarathi, Ganguly, Fortuné Gbètoho, Gankpé, Teshome, Gebre, Tsegaye Tsewelde, Gebrehiwot Amanuel, Tesfay Gebremedhin, Alemseged Aregay, Gebru Johanna, M Geleijnse, Bradford D, Gessner Aloke, Gopal Ghoshal, Katherine B, Gibney Richard, F Gillum, Stuart, Gilmour, Ababi Zergaw, Giref, Maurice, Giroud, Melkamu Dedefo, Gishu, Giorgia, Giussani, Elizabeth, Glaser, William W, Godwin, Hector, Gomez-Dantes, Philimon, Gona, Amador, Goodridge, Sameer Vali, Gopalani Richard, A Gosselin, Carolyn C, Gotay, Atsushi, Goto, Hebe N, Gouda, Felix, Greaves, Harish Chander, Gugnani, Rahul, Gupta, Rajeev, Gupta, Vipin, Gupta, Reyna A, Gutiérrez, Nima, Hafezi-Nejad, Demewoz, Haile, Alemayehu Desalegne, Hailu Gessessew, Bugssa Hailu, Yara A, Halasa Randah, Ribhi Hamadeh, Samer, Hamidi, Jamie, Hancock, Alexis J, Handal Graeme, J Hankey, Yuantao, Hao, Hilda L, Harb, Sivadasanpillai, Harikrishnan, Josep Maria, Haro, Rasmus, Havmoeller, Susan R, Heckbert Ileana, Beatriz Heredia-Pi, Pouria, Heydarpour, Henk B, M Hilderink, Hans W, Hoek Robert, S Hogg, Masako, Horino, Nobuyuki, Horita, H Dean, Hosgood Peter, J Hotez, Damian G, Hoy, Mohamed, Hsairi, Aung Soe, Htet Maung, Maung Than, Htike, Guoqing, Hu, Cheng, Huang, Hsiang, Huang, Laetitia, Huiart, Abdullatif, Husseini, Inge, Huybrechts, Grace, Huynh, Kim Moesgaard, Iburg, Kaire, Innos, Manami, Inoue, Veena J, Iyer Troy, A Jacobs, Kathryn H, Jacobsen, Nader, Jahanmehr, Mihajlo B, Jakovljevic, Peter, James, Mehdi, Javanbakht, Sudha P, Jayaraman Achala, Upendra Jayatilleke, Panniyammakal, Jeemon, Paul N, Jensen, Vivekanand, Jha, Guohong, Jiang, Ying, Jiang, Tariku, Jibat, Aida, Jimenez-Corona, Jost B, Jonas Tushar, Kant Joshi, Zubair, Kabir, Ritul, Kamal, Haidong, Kan, Surya, Kant, André, Karch, Corine Kakizi, Karema, Chante, Karimkhani, Dimitris, Karletsos, Ganesan, Karthikeyan, Amir, Kasaeian, Marzieh, Katibeh, Anil, Kaul, Norito, Kawakami, Jeanne Françoise, Kayibanda Peter, Njenga Keiyoro, Laura, Kemmer, Andrew Haddon, Kemp Andre, Pascal Kengne, Andre, Keren, Maia, Kereselidze, Chandrasekharan Nair, Kesavachandran Yousef, Saleh Khader, Ibrahim A, Khalil Abdur, Rahman Khan, Ejaz Ahmad, Khan, Young-Ho, Khang, Sahil, Khera, Tawfi k, Ahmed Muthafer, Khoja, Christian, Kieling, Daniel, Kim, Yun Jin, Kim Brett, M Kissela, Niranjan, Kissoon, Luke D, Knibbs Ann, Kristin Knudsen, Yoshihiro, Kokubo, Dhaval, Kolte, Jacek A, Kopec, Soewarta, Kosen, Parvaiz A, Koul, Ai, Koyanagi, Norun Hjertager, Krog Barthelemy, Kuate Defo, Burcu Kucuk, Bicer Andreas, A Kudom, Ernst J, Kuipers Veena, S Kulkarni, G Anil, Kumar Gene, F Kwan, Aparna, Lal, Dharmesh Kumar, Lal, Ratilal, Lalloo, Hilton, Lam, Jennifer O, Lam Sinead, M Langan, Van C, Lansingh, Anders, Larsson, Dennis Odai, Laryea Asma, Abdul Latif, Alicia Elena, Beatriz Lawrynowicz, James, Leigh, Miriam, Levi, Yongmei, Li, M Patrice, Lindsay Steven, E Lipshultz, Patrick Y, Liu, Shiwei, Liu, Yang, Liu, Loon-Tzian, Lo, Giancarlo, Logroscino, Paulo A, Lotufo Robyn, M Lucas, Raimundas, Lunevicius, Ronan A, Lyons, Stefan, Ma, Vasco Manuel, Pedro Machado, Mark T, Mackay Jennifer, H MacLachlan, Hassan Magdy, Abd El, Razek Mohammed, Magdy Abd, El Razek, Marek, Majdan, Azeem, Majeed, Reza, Malekzadeh, Wondimu Ayele, Ayele Manamo, John, Mandisarisa, Srikanth, Mangalam, Chabila C, Mapoma, Wagner, Marcenes, David Joel, Margolis Gerard, Robert Martin, Jose, Martinez-Raga, Melvin Barrientos, Marzan, Felix, Masiye, Amanda J, Mason-Jones, João, Massano, Richard, Matzopoulos, Bongani M, Mayosi Stephen, Theodore McGarvey, John J, McGrath, Martin, McKee, McMahon Peter, A Meaney, Alem, Mehari, Man Mohan, Mehndiratta, Fabiola, Mejia-Rodriguez, Alemayehu B, Mekonnen Yohannes, Adama Melaku, Peter, Memiah, Ziad A, Memish, Walter, Mendoza, Atte, Meretoja, Tuomo J, Meretoja Francis, Apolinary Mhimbira, Renata, Micha, Ted R, Miller Mojde, Mirarefi n, Awoke, Misganaw, Charles N, Mock Karzan, Abdulmuhsin Mohammad, Alireza, Mohammadi, Shafi u, Mohammed, Viswanathan, Mohan, Glen Liddell, D Mola, Lorenzo, Monasta, Julio Cesar, Montañez Hernandez, Pablo, Montero, Marcella, Montico, Thomas J, Montine, Maziar, Moradi-Lakeh, Lidia, Morawska, Katherine, Morgan, Rintaro, Mori, Dariush Mozaff, arian Ulrich, O Mueller, Gudlavalleti Venkata, Satyanarayana Murthy, Srinivas, Murthy, Kamarul Imran, Musa Jean, B Nachega, Gabriele, Nagel, Kovin S, Naidoo, Nitish, Naik, Luigi, Naldi, Vinay, Nangia, Denis, Nash, Chakib, Nejjari, Subas, Neupane, Charles R, Newton John, N Newton, Marie, Ng, Frida Namnyak, Ngalesoni Jean, de Dieu, Ngirabega Quyen, Le Nguyen, Muhammad Imran, Nisar Patrick, Martial Nkamedjie, Pete, Marika, Nomura, Ole F, Norheim Paul, E Norman, Bo, Norrving, Luke, Nyakarahuka, Felix Akpojene, Ogbo, Takayoshi, Ohkubo, Foluke Adetola, Ojelabi Pedro, R Olivares, Bolajoko Olubukunola, Olusanya Jacob, Olusegun Olusanya, John Nelson, Opio, Eyal, Oren, Alberto, Ortiz, Majdi, Osman, Erika, Ota, Raziye, Ozdemir, Mahesh, PA, Jeyaraj D, Pandian Puspa, Raj Pant, Christina, Papachristou, Eun-Kee, Park, Jae-Hyun, Park, Charles D, Parry, Mahboubeh, Parsaeian, Angel J, Paternina Caicedo, Scott B, Patten George, C Patton, Vinod K, Paul, Neil, Pearce, João Mário, Pedro Ljiljana, Pejin Stokic, Pereira, Norberto, Perico, Konrad, Pesudovs, Max, Petzold, Michael Robert, Phillips Frédéric, B Piel, Julian David, Pillay, Dietrich, Plass, James A, Platts-Mills, Suzanne, Polinder, C Arden, Pope, Svetlana, Popova, Richie G, Poulton, Farshad, Pourmalek, Dorairaj, Prabhakaran, Mostafa, Qorbani, Justice, Quame-Amaglo, D Alex, Quistberg, Anwar, Rafay, Kazem, Rahimi, Vafa, Rahimi-Movaghar, Mahfuzar, Rahman, Mohammad Hifz, Ur Rahman, Sajjad Ur, Rahman Rajesh, Kumar Rai, Zhale, Rajavi, Sasa, Rajsic, Murugesan, Raju, Ivo, Rakovac, Saleem M, Rana Chhabi, L Ranabhat, Thara, Rangaswamy, Puja, Rao, Sowmya R, Rao Amany, H Refaat, Jürgen, Rehm, Marissa B, Reitsma, Giuseppe, Remuzzi, Serge Resnikoff, Antonio L, Ribeiro, Stefano, Ricci, Maria Jesus, Rios Blancas, Bayard, Roberts, Anna, Roca, David, Rojas-Rueda, Luca, Ronfani, Gholamreza, Roshandel, Dietrich, Rothenbacher, Ambuj, Roy, Nawal K, Roy George, Mugambage Ruhago, Rajesh, Sagar, Sukanta, Saha, Ramesh, Sahathevan, Muhammad Muhammad, Saleh Juan, R Sanabria, Maria Dolores, Sanchez-Niño, Lidia, Sanchez-Riera, Itamar S, Santos, Rodrigo, Sarmiento-Suarez, Benn, Sartorius, Maheswar, Satpathy, Miloje, Savic, Monika, Sawhney, Michael P, Schaub Maria, Inês Schmidt, Ione J, C Schneider, Ben, Schöttker, Aletta E, Schutte David, C Schwebel, Soraya, Seedat, Sadaf G, Sepanlou Edson, E Servan-Mori, Katya A, Shackelford, Gavin, Shaddick, Amira, Shaheen, Saeid, Shahraz, Masood Ali, Shaikh, Marina, Shakh-Nazarova, Rajesh, Sharma, Jun, She, Sara, Sheikhbahaei, Jiabin, Shen, Ziyan, Shen, Donald S, Shepard Kevin, N Sheth, Balakrishna P, Shetty, Peilin, Shi, Kenji, Shibuya, Min-Jeong, Shin, Rahman, Shiri, Ivy, Shiue, Mark G, Shrime Inga, Dora Sigfusdottir, Donald H, Silberberg Diego, Augusto Santos, Silva Dayane, Gabriele Alves, Silveira Jonathan, I Silverberg, Edgar P, Simard, Abhishek, Singh, Gitanjali M, Singh Jasvinder, A Singh, Om Prakash, Singh Prashant, Kumar Singh, Virendra, Singh, Samir, Soneji, Kjetil, Søreide, Joan B, Soriano Luciano, A Sposato, Chandrashekhar T, Sreeramareddy, Vasiliki, Stathopoulou, Dan J, Stein Murray, B Stein, Saverio, Stranges, Konstantinos, Stroumpoulis, Bruno F, Sunguya, Patrick, Sur, Soumya, Swaminathan, Bryan L, Sykes Cassandra, E I, Szoeke, Rafael, Tabarés-Seisdedos, Karen M, Tabb, Ken, Takahashi, Jukka S, Takala Roberto, Tchio Talongwa, Nikhil, Tandon, Mohammad, Tavakkoli, Bineyam, Taye, Hugh R, Taylor Braden, J Te, Ao Bemnet, Amare Tedla, Worku Mekonnen, Tefera Margreet, Ten Have, Abdullah Sulieman, Terkawi Fisaha, Haile Tesfay, Gizachew Assefa, Tessema Alan, J Thomson, Andrew L, Thorne-Lyman Amanda, G Thrift, George D, Thurston, Taavi, Tillmann, David L, Tirschwell, Marcello, Tonelli, Roman, Topor-Madry, Fotis, Topouzis, Allen Towbin, Traebert Bach, Xuan Tran, Thomas, Truelsen, Ulises, Trujillo, Abera Kenay, Tura Emin, Murat Tuzcu, Uche S, Uchendu Kingsley, N Ukwaja, Eduardo A, Undurraga Olalekan, A Uthman, Rita Van, Dingenen Aaron, van Donkelaar, Tommi, Vasankari, Ana Maria, Nogales Vasconcelos, Narayanaswamy, Venketasubramanian, Ramesh, Vidavalur, Lakshmi, Vijayakumar, Salvador, Villalpando, Francesco S, Violante Vasiliy, Victorovich Vlassov, Joseph A, Wagner Gregory, R Wagner, Mitchell T, Wallin, Linhong, Wang, David A, Watkins, Scott, Weichenthal, Elisabete, Weiderpass, Robert G, Weintraub, Andrea, Werdecker, Ronny, Westerman, Richard A, White, Tissa, Wijeratne, James D, Wilkinson Hywel, C Williams, Charles Shey, Wiysonge Solomon, Meseret Woldeyohannes, A Wolfe, Sungho, Won, John Q, Wong Anthony, D Woolf, Denis, Xavier, Qingyang, Xiao, Gelin, Xu, Bereket, Yakob, Ayalnesh Zemene, Yalew Lijing, L Yan, Yuichiro, Yano, Mehdi, Yaseri, Pengpeng, Ye, Henock Gebremedhin, Yebyo, Paul, Yip, Biruck Desalegn, Yirsaw, Naohiro, Yonemoto, Gerald, Yonga, Mustafa Z, Younis, Shicheng, Yu, Zoubida, Zaidi, Maysaa El, Sayed Zaki, Faiez, Zannad, Diego E, Zavala, Hajo, Zeeb, Berihun M, Zeleke, Hao, Zhang, Sanjay, Zodpey, David, Zonies, Liesl Joanna, Zuhlke, Theo, Vos, Alan D, Lopez Christopher, J L, Murray., Haidong, Wang, Mohsen, Naghavi, Christine, Allen, Ryan, M, Barber, Zulfi, Qar, A, Bhutta, Austin, Carter, Daniel, C, Casey, Fiona, J, Charlson, Alan, Zian, Chen, Matthew, M, Coate, Megan, Coggeshall, Lalit, Dandona, Daniel, J, Dicker, Holly, E, Erskine, Alize, J, Ferrari, Christina, Fitzmaurice, Kyle, Foreman, Mohammad, H, Forouzanfar, Maya, S, Fraser, Nancy, Fullman, Peter, W, Gething, Ellen, M, Goldberg, Nicholas, Graetz, Juanita, A, Haagsma, Simon, I, Hay, Chantal, Huynh, Catherine, O, Johnson, Nichola, J, Kassebaum, Yohannes, Kinfu, Xie, Rachel, Kulikoff, Michael, Kutz, Hmwe, H, Kyu, Heidi, J, Larson, Janni, Leung, Xiaofeng, Liang, Stephen, S, Lim, Margaret, Lind, Rafael, Lozano, Neal, Marquez, George, A, Mensah, Joe, Mikesell, Ali, H, Mokdad, Meghan, D, Mooney, Grant, Nguyen, Elaine, Nsoesie, David, M, Pigott, Christine, Pinho, Gregory, A, Roth, Joshua, A, Salomon, Logan, Sandar, Naris, Silpakit, Amber, Sligar, Reed, J, D, Sorensen, Jeff, Rey, Stanaway, Caitlyn, Steiner, Stephanie, Teeple, Bernadette, A, Thomas, Christopher, Troeger, Amelia, Vanderzanden, Stein, Emil, Vollset, Valentine, Wanga, Harvey, A, Whiteford, Timothy, Wolock, Leo, Zoeckler, Kalkidan, Hassen, Abate, Cristiana, Abbafati, Kaja, M, Abbas, Foad, Abd-Allah, Semaw, Ferede, Abera, Daisy, M, X, Abreu, Laith, J, Abu-Raddad, Gebre, Yitayih, Abyu, Tom, Achoki, Ademola, Lukman, Adelekan, Zanfi, Na, Ademi, Arsène, Kouablan, Adou, José, C, Adsuar, Kossivi, Agbelenko, Afanvi, Ashkan, Afshin, Emilie, Elisabet, Agardh, Arnav, Agarwal, Anurag, Agrawal, Aliasghar, Ahmad, Kiadaliri, Oluremi, N, Ajala, Ali, Shafqat, Akanda, Rufu, Olusola, Akinyemi, Tomi, F, Akinyemiju, Nadia, Akseer, Faris, Hasan, Al, Lami, Samer, Alabed, Ziyad, Al-Aly, Khurshid, Alam, Noore, K, M, Alam, Deena, Alasfoor, Saleh, Fahed, Aldhahri, Robert, William, Aldridge, Miguel, Angel, Alegretti, Alicia, V, Aleman, Zewdie, Aderaw, Alemu, Lily, T, Alexander, Samia, Alhabib, Raghib, Ali, Ala’A, Alkerwi, François, Alla, Peter, Allebeck, Rajaa, Al-Raddadi, Ubai, Alsharif, Khalid, A, Altirkawi, Elena, Alvarez, Martin, Nelson, Alvis-Guzman, Azmeraw, T, Amare, Adeladza, Kofi, Amegah, Emmanuel, A, Ameh, Heresh, Amini, Walid, Ammar, Stephen, Marc, Amrock, Hjalte, H, Andersen, Benjamin, O, Anderson, Gregory, M, Anderson, Carl, Abelardo, T, Antonio, Atsede, Fantahun, Aregay, Johan, Ärnlöv, Valentina, S, Arsic, Arsenijevic, Al, Artaman, Hamid, Asayesh, Rana, Jawad, Asghar, Suleman, Atique, Euripide, Frinel, G, Arthur, Avokpaho, Ashish, Awasthi, Peter, Azzopardi, Umar, Bacha, Alaa, Badawi, Maria, C, Bahit, Kalpana, Balakrishnan, Amitava, Banerjee, Aleksandra, Barac, Suzanne, L, Barker-Collo, Till, Bärnighausen, Lars, Barregard, Lope, H, Barrero, Arindam, Basu, Sanjay, Basu, Yibeltal, Tebekaw, Bayou, Shahrzad, Bazargan-Hejazi, Justin, Beardsley, Neeraj, Bedi, Ettore, Beghi, Haileeyesus, Adamu, Belay, Brent, Bell, Michelle, L, Bell, Aminu, K, Bello, Derrick, A, Bennett, Isabela, M, Bensenor, Adugnaw, Berhane, Eduardo, Bernabé, Balem, Demtsu, Betsu, Addisu, Shunu, Beyene, Neeraj, Bhala, Ashish, Bhalla, Sibhatu, Biadgilign, Boris, Bikbov, Aref, A, Bin, Abdulhak, Brian, J, Biroscak, Stan, Biryukov, Espen, Bjertne, Jed, D, Blore, Christopher, D, Blosser, Megan, A, Bohensky, Rohan, Borschmann, Dipan, Bose, Rupert, R, A, Bourne, Michael, Brainin, Carol, E, G, Brayne, Alexandra, Brazinova, Nicholas, J, K, Breitborde, Hermann, Brenner, Jerry, D, Brewer, Alexandria, Brown, Jonathan, Brown, Traolach, S, Brugha, Geoff, Rey, Colin, Buckle, Zahid, A, Butt, Bianca, Calabria, Ismael, Ricardo, Campos-Nonato, Julio, Cesar, Campuzano, Jonathan, R, Carapetis, Rosario, Cárdena, David, O, Carpenter, Juan, Jesus, Carrero, Carlos, A, Castañeda-Orjuela, Jacqueline, Castillo, Riva, Ferrán, Catalá-López, Fiorella, Cavalleri, Kelly, Cercy, Jorge, Cerda, Wanqing, Chen, Adrienne, Chew, Peggy, Pei-Chia, Chiang, Mirriam, Chibalabala, Chioma, Ezinne, Chibueze, Odgerel, Chimed-Ochir, Vesper, Hichilombwe, Chisumpa, Jee-Young, Jasmine, Choi, Rajiv, Chowdhury, Hanne, Christensen, Devasahayam, Jesuda, Christopher, Liliana, G, Ciobanu, Cirillo, Massimo, Aaron, J, Cohen, Valentina, Colistro, Mercedes, Colomar, Samantha, M, Colquhoun, Cyrus, Cooper, Leslie, Trumbull, Cooper, Monica, Cortinovi, Benjamin, C, Cowie, John, A, Crump, James, Damsere-Derry, Hadi, Danawi, Rakhi, Dandona, Farah, Daoud, Sarah, C, Darby, Paul, I, Dargan, José, Da, Neves, Gail, Davey, Adrian, C, Davis, Drago, V, Davitoiu, E, Filipa, De, Castro, Pieter, De, Jager, Diego, De, Leo, Louisa, Degenhardt, Robert, P, Dellavalle, Kebede, Deribe, Amare, Deribew, Samath, D, Dharmaratne, Preet, K, Dhillon, Cesar, Diaz-Torné, Eric, L, Ding, Kadine, Priscila, Bender, Dos, Santo, Edem, Dossou, Tim, R, Driscoll, Leilei, Duan, Manisha, Dubey, Bruce, Bartholow, Duncan, Richard, G, Ellenbogen, Christian, Lycke, Ellingsen, Iqbal, Elyazar, Aman, Yesuf, Endries, Sergey, Petrovich, Ermakov, Babak, Eshrati, Alireza, Esteghamati, Kara, Estep, Imad, D, A, Faghmou, Saman, Fahimi, Emerito, Jose, Aquino, Faraon, Talha, A, Farid, Carla, Sofi, A, E, Sa, Farinha, André, Faro, Maryam, S, Farvid, Farshad, Farzadfar, Valery, L, Feigin, Seyed-Mohammad, Fereshtehnejad, Jeff, Erson, G, Fernande, Joao, C, Fernandes, Florian, Fischer, Joseph, R, A, Fitchett, Abraham, Flaxman, Nataliya, Foigt, F, Gerry, R, Fowke, Elisabeth, Barboza, Franca, Richard, C, Franklin, Joseph, Friedman, Joseph, Frostad, Thomas, Fürst, Neal, D, Futran, Seana, L, Gall, Ketevan, Gambashidze, Amiran, Gamkrelidze, Parthasarathi, Ganguly, Fortuné, Gbètoho, Gankpé, Teshome, Gebre, Tsegaye, Tsewelde, Gebrehiwot, Amanuel, Tesfay, Gebremedhin, Alemseged, Aregay, Gebru, Johanna, M, Geleijnse, Bradford, D, Gessner, Aloke, Gopal, Ghoshal, Katherine, B, Gibney, Richard, F, Gillum, Stuart, Gilmour, Ababi, Zergaw, Giref, Maurice, Giroud, Melkamu, Dedefo, Gishu, Giorgia, Giussani, Elizabeth, Glaser, William, W, Godwin, Hector, Gomez-Dante, Philimon, Gona, Amador, Goodridge, Sameer, Vali, Gopalani, Richard, A, Gosselin, Carolyn, C, Gotay, Atsushi, Goto, Hebe, N, Gouda, Felix, Greave, Harish, Chander, Gugnani, Rahul, Gupta, Rajeev, Gupta, Vipin, Gupta, Reyna, A, Gutiérrez, Nima, Hafezi-Nejad, Demewoz, Haile, Alemayehu, Desalegne, Hailu, Gessessew, Bugssa, Hailu, Yara, A, Halasa, Randah, Ribhi, Hamadeh, Samer, Hamidi, Jamie, Hancock, Alexis, J, Handal, Graeme, J, Hankey, Yuantao, Hao, Hilda, L, Harb, Sivadasanpillai, Harikrishnan, Josep, Maria, Haro, Rasmus, Havmoeller, Susan, R, Heckbert, Ileana, Beatriz, Heredia-Pi, Pouria, Heydarpour, Henk, B, M, Hilderink, Hans, W, Hoek, Robert, S, Hogg, Masako, Horino, Nobuyuki, Horita, H, Dean, Hosgood, Peter, J, Hotez, Damian, G, Hoy, Mohamed, Hsairi, Aung, Soe, Htet, Maung, Maung, Than, Htike, Guoqing, Hu, Cheng, Huang, Hsiang, Huang, Laetitia, Huiart, Abdullatif, Husseini, Inge, Huybrecht, Grace, Huynh, Kim, Moesgaard, Iburg, Kaire, Inno, Manami, Inoue, Veena, J, Iyer, Troy, A, Jacob, Kathryn, H, Jacobsen, Nader, Jahanmehr, Mihajlo, B, Jakovljevic, Peter, Jame, Mehdi, Javanbakht, Sudha, P, Jayaraman, Achala, Upendra, Jayatilleke, Panniyammakal, Jeemon, Paul, N, Jensen, Vivekanand, Jha, Guohong, Jiang, Ying, Jiang, Tariku, Jibat, Aida, Jimenez-Corona, Jost, B, Jonas, Tushar, Kant, Joshi, Zubair, Kabir, Ritul, Kamal, Haidong, Kan, Surya, Kant, André, Karch, Corine, Kakizi, Karema, Chante, Karimkhani, Dimitris, Karletso, Ganesan, Karthikeyan, Amir, Kasaeian, Marzieh, Katibeh, Anil, Kaul, Norito, Kawakami, Jeanne, Françoise, Kayibanda, Peter, Njenga, Keiyoro, Laura, Kemmer, Andrew, Haddon, Kemp, Andre, Pascal, Kengne, Andre, Keren, Maia, Kereselidze, Chandrasekharan, Nair, Kesavachandran, Yousef, Saleh, Khader, Ibrahim, A, Khalil, Abdur, Rahman, Khan, Ejaz, Ahmad, Khan, Young-Ho, Khang, Sahil, Khera, Tawfi, K, Ahmed, Muthafer, Khoja, Christian, Kieling, Daniel, Kim, Yun, Jin, Kim, Brett, M, Kissela, Niranjan, Kissoon, Luke, D, Knibbs, Ann, Kristin, Knudsen, Yoshihiro, Kokubo, Dhaval, Kolte, Jacek, A, Kopec, Soewarta, Kosen, Parvaiz, A, Koul, Ai, Koyanagi, Norun, Hjertager, Krog, Barthelemy, Kuate, Defo, Burcu, Kucuk, Bicer, Andrea, A, Kudom, Ernst, J, Kuipers, Veena, S, Kulkarni, G, Anil, Kumar, Gene, F, Kwan, Aparna, Lal, Dharmesh, Kumar, Lal, Ratilal, Lalloo, Hilton, Lam, Jennifer, O, Lam, Sinead, M, Langan, Van, C, Lansingh, Anders, Larsson, Dennis, Odai, Laryea, Asma, Abdul, Latif, Alicia, Elena, Beatriz, Lawrynowicz, James, Leigh, Miriam, Levi, Yongmei, Li, M, Patrice, Lindsay, Steven, E, Lipshultz, Patrick, Y, Liu, Shiwei, Liu, Yang, Liu, Loon-Tzian, Lo, Giancarlo, Logroscino, Paulo, A, Lotufo, Robyn, M, Luca, Raimundas, Luneviciu, Ronan, A, Lyons, Stefan, Ma, Vasco, Manuel, Pedro, Machado, Mark, T, Mackay, Jennifer, H, Maclachlan, Hassan, Magdy, Abd, El, Razek, Mohammed, Magdy, Abd, El, Razek, Marek, Majdan, Azeem, Majeed, Reza, Malekzadeh, Wondimu, Ayele, Ayele, Manamo, John, Mandisarisa, Srikanth, Mangalam, Chabila, C, Mapoma, Wagner, Marcene, David, Joel, Margolis, Gerard, Robert, Martin, Jose, Martinez-Raga, Melvin, Barriento, Marzan, Felix, Masiye, Amanda, J, Mason-Jones, João, Massano, Richard, Matzopoulo, Bongani, M, Mayosi, Stephen, Theodore, Mcgarvey, John, J, Mcgrath, Martin, Mckee, Mcmahon, Peter, A, Meaney, Alem, Mehari, Man, Mohan, Mehndiratta, Fabiola, Mejia-Rodriguez, Alemayehu, B, Mekonnen, Yohanne, Adama, Melaku, Peter, Memiah, Ziad, A, Memish, Walter, Mendoza, Atte, Meretoja, Tuomo, J, Meretoja, Franci, Apolinary, Mhimbira, Renata, Micha, Ted, R, Miller, Mojde, Mirarefi, N, Awoke, Misganaw, Charles, N, Mock, Karzan, Abdulmuhsin, Mohammad, Alireza, Mohammadi, Shafi, U, Mohammed, Viswanathan, Mohan, Glen, Liddell, D, Mola, Lorenzo, Monasta, Julio, Cesar, Montañez, Hernandez, Pablo, Montero, Marcella, Montico, Thomas, J, Montine, Maziar, Moradi-Lakeh, Lidia, Morawska, Katherine, Morgan, Rintaro, Mori, Dariush, Mozaff, Arian, Ulrich, O, Mueller, Gudlavalleti, Venkata, Satyanarayana, Murthy, Srinivas, Murthy, Kamarul, Imran, Musa, Jean, B, Nachega, Gabriele, Nagel, Kovin, S, Naidoo, Nitish, Naik, Luigi, Naldi, Vinay, Nangia, Denis, Nash, Chakib, Nejjari, Subas, Neupane, Charles, R, Newton, John, N, Newton, Marie, Ng, Frida, Namnyak, Ngalesoni, Jean, De, Dieu, Ngirabega, Quyen, Le, Nguyen, Muhammad, Imran, Nisar, Patrick, Martial, Nkamedjie, Pete, Marika, Nomura, Ole, F, Norheim, Paul, E, Norman, Bo, Norrving, Luke, Nyakarahuka, Felix, Akpojene, Ogbo, Takayoshi, Ohkubo, Foluke, Adetola, Ojelabi, Pedro, R, Olivare, Bolajoko, Olubukunola, Olusanya, Jacob, Olusegun, Olusanya, John, Nelson, Opio, Eyal, Oren, Alberto, Ortiz, Majdi, Osman, Erika, Ota, Raziye, Ozdemir, Mahesh, Pa, Jeyaraj, D, Pandian, Puspa, Raj, Pant, Christina, Papachristou, Eun-Kee, Park, Jae-Hyun, Park, Charles, D, Parry, Mahboubeh, Parsaeian, Angel, J, Paternina, Caicedo, Scott, B, Patten, George, C, Patton, Vinod, K, Paul, Neil, Pearce, João, Mário, Pedro, Ljiljana, Pejin, Stokic, Pereira, Norberto, Perico, Konrad, Pesudov, Max, Petzold, Michael, Robert, Phillips, Frédéric, B, Piel, Julian, David, Pillay, Dietrich, Pla, James, A, Platts-Mills, Suzanne, Polinder, C, Arden, Pope, Svetlana, Popova, Richie, G, Poulton, Farshad, Pourmalek, Dorairaj, Prabhakaran, Mostafa, Qorbani, Justice, Quame-Amaglo, D, Alex, Quistberg, Anwar, Rafay, Kazem, Rahimi, Vafa, Rahimi-Movaghar, Mahfuzar, Rahman, Mohammad, Hifz, Ur, Rahman, Sajjad, Ur, Rahman, Rajesh, Kumar, Rai, Zhale, Rajavi, Sasa, Rajsic, Murugesan, Raju, Ivo, Rakovac, Saleem, M, Rana, Chhabi, L, Ranabhat, Thara, Rangaswamy, Puja, Rao, Sowmya, R, Rao, Amany, H, Refaat, Jürgen, Rehm, Marissa, B, Reitsma, Giuseppe, Remuzzi, Serge, Resnikoff, Antonio, L, Ribeiro, Stefano, Ricci, Maria, Jesu, Rios, Blanca, Bayard, Robert, Anna, Roca, David, Rojas-Rueda, Luca, Ronfani, Gholamreza, Roshandel, Dietrich, Rothenbacher, Ambuj, Roy, Nawal, K, Roy, George, Mugambage, Ruhago, Rajesh, Sagar, Sukanta, Saha, Ramesh, Sahathevan, Muhammad, Muhammad, Saleh, Juan, R, Sanabria, Maria, Dolore, Sanchez-Niño, Lidia, Sanchez-Riera, Itamar, S, Santos, Rodrigo, Sarmiento-Suarez, Benn, Sartoriu, Maheswar, Satpathy, Miloje, Savic, Monika, Sawhney, Michael, P, Schaub, Maria, Inês, Schmidt, Ione, J, C, Schneider, Ben, Schöttker, Aletta, E, Schutte, David, C, Schwebel, Soraya, Seedat, Sadaf, G, Sepanlou, Edson, E, Servan-Mori, Katya, A, Shackelford, Gavin, Shaddick, Amira, Shaheen, Saeid, Shahraz, Masood, Ali, Shaikh, Marina, Shakh-Nazarova, Rajesh, Sharma, Jun, She, Sara, Sheikhbahaei, Jiabin, Shen, Ziyan, Shen, Donald, S, Shepard, Kevin, N, Sheth, Balakrishna, P, Shetty, Peilin, Shi, Kenji, Shibuya, Min-Jeong, Shin, Rahman, Shiri, Ivy, Shiue, Mark, G, Shrime, Inga, Dora, Sigfusdottir, Donald, H, Silberberg, Diego, Augusto, Santo, Silva, Dayane, Gabriele, Alve, Silveira, Jonathan, I, Silverberg, Edgar, P, Simard, Abhishek, Singh, Gitanjali, M, Singh, Jasvinder, A, Singh, Om, Prakash, Singh, Prashant, Kumar, Singh, Virendra, Singh, Samir, Soneji, Kjetil, Søreide, Joan, B, Soriano, Luciano, A, Sposato, Chandrashekhar, T, Sreeramareddy, Vasiliki, Stathopoulou, Dan, J, Stein, Murray, B, Stein, Saverio, Strange, Konstantinos, Stroumpouli, Bruno, F, Sunguya, Patrick, Sur, Soumya, Swaminathan, Bryan, L, Sykes, Cassandra, E, I, Szoeke, Rafael, Tabarés-Seisdedo, Karen, M, Tabb, Ken, Takahashi, Jukka, S, Takala, Roberto, Tchio, Talongwa, Nikhil, Tandon, Mohammad, Tavakkoli, Bineyam, Taye, Hugh, R, Taylor, Braden, J, Te, Ao, Bemnet, Amare, Tedla, Worku, Mekonnen, Tefera, Margreet, Ten, Have, Abdullah, Sulieman, Terkawi, Fisaha, Haile, Tesfay, Gizachew, Assefa, Tessema, Alan, J, Thomson, Andrew, L, Thorne-Lyman, Amanda, G, Thrift, George, D, Thurston, Taavi, Tillmann, David, L, Tirschwell, Marcello, Tonelli, Roman, Topor-Madry, Fotis, Topouzi, Allen, Towbin, Traebert, Bach, Xuan, Tran, Thomas, Truelsen, Ulises, Trujillo, Abera, Kenay, Tura, Emin, Murat, Tuzcu, Uche, S, Uchendu, Kingsley, N, Ukwaja, Eduardo, A, Undurraga, Olalekan, A, Uthman, Rita, Van, Dingenen, Aaron, Van, Donkelaar, Tommi, Vasankari, Ana, Maria, Nogales, Vasconcelo, Narayanaswamy, Venketasubramanian, Ramesh, Vidavalur, Lakshmi, Vijayakumar, Salvador, Villalpando, Francesco, S, Violante, Vasiliy, Victorovich, Vlassov, Joseph, A, Wagner, Gregory, R, Wagner, Mitchell, T, Wallin, Linhong, Wang, David, A, Watkins, Scott, Weichenthal, Elisabete, Weiderpa, Robert, G, Weintraub, Andrea, Werdecker, Ronny, Westerman, Richard, A, White, Tissa, Wijeratne, James, D, Wilkinson, Hywel, C, William, Charles, Shey, Wiysonge, Solomon, Meseret, Woldeyohanne, A, Wolfe, Sungho, Won, John, Q, Wong, Anthony, D, Woolf, Denis, Xavier, Qingyang, Xiao, Gelin, Xu, Bereket, Yakob, Ayalnesh, Zemene, Yalew, Lijing, L, Yan, Yuichiro, Yano, Mehdi, Yaseri, Pengpeng, Ye, Henock, Gebremedhin, Yebyo, Paul, Yip, Biruck, Desalegn, Yirsaw, Naohiro, Yonemoto, Gerald, Yonga, Mustafa, Z, Younis, Shicheng, Yu, Zoubida, Zaidi, Maysaa, El, Sayed, Zaki, Faiez, Zannad, Diego, E, Zavala, Hajo, Zeeb, Berihun, M, Zeleke, Hao, Zhang, Sanjay, Zodpey, David, Zonie, Liesl, Joanna, Zuhlke, Theo, Vo, Alan, D, Lopez, Christopher, J, L, Murra, Y., Wang, Haidong, Naghavi, Mohsen, Allen, Christine, Barber, Ryan M, Bhutta, Zulfiqar A, Carter, Austin, Casey, Daniel C, Charlson, Fiona J, Chen, Alan Zian, Coates, Matthew M, Coggeshall, Megan, Dandona, Lalit, Dicker, Daniel J, Erskine, Holly E, Ferrari, Alize J, Fitzmaurice, Christina, Foreman, Kyle, Forouzanfar, Mohammad H, Fraser, Maya S, Fullman, Nancy, Gething, Peter W, Goldberg, Ellen M, Graetz, Nichola, Haagsma, Juanita A, Hay, Simon I, Huynh, Chantal, Johnson, Catherine O, Kassebaum, Nicholas J, Kinfu, Yohanne, Kulikoff, Xie Rachel, Kutz, Michael, Kyu, Hmwe H, Larson, Heidi J, Leung, Janni, Liang, Xiaofeng, Lim, Stephen S, Lind, Margaret, Lozano, Rafael, Marquez, Neal, Mensah, George A, Mikesell, Joe, Mokdad, Ali H, Mooney, Meghan D, Nguyen, Grant, Nsoesie, Elaine, Pigott, David M, Pinho, Christine, Roth, Gregory A, Salomon, Joshua A, Sandar, Logan, Silpakit, Nari, Sligar, Amber, Sorensen, Reed J D, Stanaway, Jeffrey, Steiner, Caitlyn, Teeple, Stephanie, Thomas, Bernadette A, Troeger, Christopher, Vanderzanden, Amelia, Vollset, Stein Emil, Wanga, Valentine, Whiteford, Harvey A, Wolock, Timothy, Zoeckler, Leo, Abate, Kalkidan Hassen, Abbafati, Cristiana, Abbas, Kaja M, Abd-Allah, Foad, Abera, Semaw Ferede, Abreu, Daisy M X, Abu-Raddad, Laith J, Abyu, Gebre Yitayih, Achoki, Tom, Adelekan, Ademola Lukman, Ademi, Zanfina, Adou, Arsène Kouablan, Adsuar, José C, Afanvi, Kossivi Agbelenko, Afshin, Ashkan, Agardh, Emilie Elisabet, Agarwal, Arnav, Agrawal, Anurag, Kiadaliri, Aliasghar Ahmad, Ajala, Oluremi N, Akanda, Ali Shafqat, Akinyemi, Rufus Olusola, Akinyemiju, Tomi F, Akseer, Nadia, Lami, Faris Hasan Al, Alabed, Samer, Al-Aly, Ziyad, Alam, Khurshid, Alam, Noore K M, Alasfoor, Deena, Aldhahri, Saleh Fahed, Aldridge, Robert William, Alegretti, Miguel Angel, Aleman, Alicia V, Alemu, Zewdie Aderaw, Alexander, Lily T, Alhabib, Samia, Ali, Raghib, Alkerwi, Ala'A, Alla, Françoi, Allebeck, Peter, Al-Raddadi, Rajaa, Alsharif, Ubai, Altirkawi, Khalid A, Martin, Elena Alvarez, Alvis-Guzman, Nelson, Amare, Azmeraw T, Amegah, Adeladza Kofi, Ameh, Emmanuel A, Amini, Heresh, Ammar, Walid, Amrock, Stephen Marc, Andersen, Hjalte H, Anderson, Benjamin O, Anderson, Gregory M, Antonio, Carl Abelardo T, Aregay, Atsede Fantahun, Ärnlöv, Johan, Arsenijevic, Valentina S Arsic, Artaman, Al, Asayesh, Hamid, Asghar, Rana Jawad, Atique, Suleman, Avokpaho, Euripide Frinel G Arthur, Awasthi, Ashish, Azzopardi, Peter, Bacha, Umar, Badawi, Alaa, Bahit, Maria C, Balakrishnan, Kalpana, Banerjee, Amitava, Barac, Aleksandra, Barker-Collo, Suzanne L, Bärnighausen, Till, Barregard, Lar, Barrero, Lope H, Basu, Arindam, Basu, Sanjay, Bayou, Yibeltal Tebekaw, Bazargan-Hejazi, Shahrzad, Beardsley, Justin, Bedi, Neeraj, Beghi, Ettore, Belay, Haileeyesus Adamu, Bell, Brent, Bell, Michelle L, Bello, Aminu K, Bennett, Derrick A, Bensenor, Isabela M, Berhane, Adugnaw, Bernabé, Eduardo, Betsu, Balem Demtsu, Beyene, Addisu Shunu, Bhala, Neeraj, Bhalla, Ashish, Biadgilign, Sibhatu, Bikbov, Bori, Abdulhak, Aref A Bin, Biroscak, Brian J, Biryukov, Stan, Bjertness, Espen, Blore, Jed D, Blosser, Christopher D, Bohensky, Megan A, Borschmann, Rohan, Bose, Dipan, Bourne, Rupert R A, Brainin, Michael, Brayne, Carol E G, Brazinova, Alexandra, Breitborde, Nicholas J K, Brenner, Hermann, Brewer, Jerry D, Brown, Alexandria, Brown, Jonathan, Brugha, Traolach S, Buckle, Geoffrey Colin, Butt, Zahid A, Calabria, Bianca, Campos-Nonato, Ismael Ricardo, Campuzano, Julio Cesar, Carapetis, Jonathan R, Cárdenas, Rosario, Carpenter, David O, Carrero, Juan Jesu, Castañeda-Orjuela, Carlos A, Rivas, Jacqueline Castillo, Catalá-López, Ferrán, Cavalleri, Fiorella, Cercy, Kelly, Cerda, Jorge, Chen, Wanqing, Chew, Adrienne, Chiang, Peggy Pei-Chia, Chibalabala, Mirriam, Chibueze, Chioma Ezinne, Chimed-Ochir, Odgerel, Chisumpa, Vesper Hichilombwe, Choi, Jee-Young Jasmine, Chowdhury, Rajiv, Christensen, Hanne, Christopher, Devasahayam Jesuda, Ciobanu, Liliana G, Cohen, Aaron J, Colistro, Valentina, Colomar, Mercede, Colquhoun, Samantha M, Cooper, Cyru, Cooper, Leslie Trumbull, Cortinovis, Monica, Cowie, Benjamin C, Crump, John A, Damsere-Derry, Jame, Danawi, Hadi, Dandona, Rakhi, Daoud, Farah, Darby, Sarah C, Dargan, Paul I, das Neves, José, Davey, Gail, Davis, Adrian C, Davitoiu, Dragos V, de Castro, E Filipa, de Jager, Pieter, Leo, Diego De, Degenhardt, Louisa, Dellavalle, Robert P, Deribe, Kebede, Deribew, Amare, Dharmaratne, Samath D, Dhillon, Preet K, Diaz-Torné, Cesar, Ding, Eric L, dos Santos, Kadine Priscila Bender, Dossou, Edem, Driscoll, Tim R, Duan, Leilei, Dubey, Manisha, Duncan, Bruce Bartholow, Ellenbogen, Richard G, Ellingsen, Christian Lycke, Elyazar, Iqbal, Endries, Aman Yesuf, Ermakov, Sergey Petrovich, Eshrati, Babak, Esteghamati, Alireza, Estep, Kara, Faghmous, Imad D A, Fahimi, Saman, Faraon, Emerito Jose Aquino, Farid, Talha A, Farinha, Carla Sofia e Sa, Faro, André, Farvid, Maryam S, Farzadfar, Farshad, Feigin, Valery L, Fereshtehnejad, Seyed-Mohammad, Fernandes, Jefferson G, Fernandes, Joao C, Fischer, Florian, Fitchett, Joseph R A, Flaxman, Abraham, Foigt, Nataliya, Fowkes, F Gerry R, Franca, Elisabeth Barboza, Franklin, Richard C, Friedman, Joseph, Frostad, Joseph, Fürst, Thoma, Futran, Neal D, Gall, Seana L, Gambashidze, Ketevan, Gamkrelidze, Amiran, Ganguly, Parthasarathi, Gankpé, Fortuné Gbètoho, Gebre, Teshome, Gebrehiwot, Tsegaye Tsewelde, Gebremedhin, Amanuel Tesfay, Gebru, Alemseged Aregay, Geleijnse, Johanna M, Gessner, Bradford D, Ghoshal, Aloke Gopal, Gibney, Katherine B, Gillum, Richard F, Gilmour, Stuart, Giref, Ababi Zergaw, Giroud, Maurice, Gishu, Melkamu Dedefo, Giussani, Giorgia, Glaser, Elizabeth, Godwin, William W, Gomez-Dantes, Hector, Gona, Philimon, Goodridge, Amador, Gopalani, Sameer Vali, Gosselin, Richard A, Gotay, Carolyn C, Goto, Atsushi, Gouda, Hebe N, Greaves, Felix, Gugnani, Harish Chander, Gupta, Rahul, Gupta, Rajeev, Gupta, Vipin, Gutiérrez, Reyna A, Hafezi-Nejad, Nima, Haile, Demewoz, Hailu, Alemayehu Desalegne, Hailu, Gessessew Bugssa, Halasa, Yara A, Hamadeh, Randah Ribhi, Hamidi, Samer, Hancock, Jamie, Handal, Alexis J, Hankey, Graeme J, Hao, Yuantao, Harb, Hilda L, Harikrishnan, Sivadasanpillai, Haro, Josep Maria, Havmoeller, Rasmu, Heckbert, Susan R, Heredia-Pi, Ileana Beatriz, Heydarpour, Pouria, Hilderink, Henk B M, Hoek, Hans W, Hogg, Robert S, Horino, Masako, Horita, Nobuyuki, Hosgood, H Dean, Hotez, Peter J, Hoy, Damian G, Hsairi, Mohamed, Htet, Aung Soe, Htike, Maung Maung Than, Hu, Guoqing, Huang, Cheng, Huang, Hsiang, Huiart, Laetitia, Husseini, Abdullatif, Huybrechts, Inge, Huynh, Grace, Iburg, Kim Moesgaard, Innos, Kaire, Inoue, Manami, Iyer, Veena J, Jacobs, Troy A, Jacobsen, Kathryn H, Jahanmehr, Nader, Jakovljevic, Mihajlo B, James, Peter, Javanbakht, Mehdi, Jayaraman, Sudha P, Jayatilleke, Achala Upendra, Jeemon, Panniyammakal, Jensen, Paul N, Jha, Vivekanand, Jiang, Guohong, Jiang, Ying, Jibat, Tariku, Jimenez-Corona, Aida, Jonas, Jost B, Joshi, Tushar Kant, Kabir, Zubair, Kamal, Ritul, Kan, Haidong, Kant, Surya, Karch, André, Karema, Corine Kakizi, Karimkhani, Chante, Karletsos, Dimitri, Karthikeyan, Ganesan, Kasaeian, Amir, Katibeh, Marzieh, Kaul, Anil, Kawakami, Norito, Kayibanda, Jeanne Françoise, Keiyoro, Peter Njenga, Kemmer, Laura, Kemp, Andrew Haddon, Kengne, Andre Pascal, Keren, Andre, Kereselidze, Maia, Kesavachandran, Chandrasekharan Nair, Khader, Yousef Saleh, Khalil, Ibrahim A, Khan, Abdur Rahman, Khan, Ejaz Ahmad, Khang, Young-Ho, Khera, Sahil, Khoja, Tawfik Ahmed Muthafer, Kieling, Christian, Kim, Daniel, Kim, Yun Jin, Kissela, Brett M, Kissoon, Niranjan, Knibbs, Luke D, Knudsen, Ann Kristin, Kokubo, Yoshihiro, Kolte, Dhaval, Kopec, Jacek A, Kosen, Soewarta, Koul, Parvaiz A, Koyanagi, Ai, Krog, Norun Hjertager, Defo, Barthelemy Kuate, Bicer, Burcu Kucuk, Kudom, Andreas A, Kuipers, Ernst J, Kulkarni, Veena S, Kumar, G Anil, Kwan, Gene F, Lal, Aparna, Lal, Dharmesh Kumar, Lalloo, Ratilal, Lam, Hilton, Lam, Jennifer O, Langan, Sinead M, Lansingh, Van C, Larsson, Ander, Laryea, Dennis Odai, Latif, Asma Abdul, Lawrynowicz, Alicia Elena Beatriz, Leigh, Jame, Levi, Miriam, Li, Yongmei, Lindsay, M Patrice, Lipshultz, Steven E, Liu, Patrick Y, Liu, Shiwei, Liu, Yang, Lo, Loon-Tzian, Logroscino, Giancarlo, Lotufo, Paulo A, Lucas, Robyn M, Lunevicius, Raimunda, Lyons, Ronan A, Ma, Stefan, Machado, Vasco Manuel Pedro, Mackay, Mark T, Maclachlan, Jennifer H, Razek, Hassan Magdy Abd El, Magdy, Mohammed, Razek, Abd El, Majdan, Marek, Majeed, Azeem, Malekzadeh, Reza, Manamo, Wondimu Ayele Ayele, Mandisarisa, John, Mangalam, Srikanth, Mapoma, Chabila C, Marcenes, Wagner, Margolis, David Joel, Martin, Gerard Robert, Martinez-Raga, Jose, Marzan, Melvin Barriento, Masiye, Felix, Mason-Jones, Amanda J, Massano, João, Matzopoulos, Richard, Mayosi, Bongani M, Mcgarvey, Stephen Theodore, Mcgrath, John J, Mckee, Martin, Mcmahon, Brian J, Meaney, Peter A, Mehari, Alem, Mehndiratta, Man Mohan, Mejia-Rodriguez, Fabiola, Mekonnen, Alemayehu B, Melaku, Yohannes Adama, Memiah, Peter, Memish, Ziad A, Mendoza, Walter, Meretoja, Atte, Meretoja, Tuomo J, Mhimbira, Francis Apolinary, Micha, Renata, Miller, Ted R, Mirarefin, Mojde, Misganaw, Awoke, Mock, Charles N, Mohammad, Karzan Abdulmuhsin, Mohammadi, Alireza, Mohammed, Shafiu, Mohan, Viswanathan, Mola, Glen Liddell D, Monasta, Lorenzo, Hernandez, Julio Cesar Montañez, Montero, Pablo, Montico, Marcella, Montine, Thomas J, Moradi-Lakeh, Maziar, Morawska, Lidia, Morgan, Katherine, Mori, Rintaro, Mozaffarian, Dariush, Mueller, Ulrich O, Murthy, Gudlavalleti Venkata Satyanarayana, Murthy, Sriniva, Musa, Kamarul Imran, Nachega, Jean B, Nagel, Gabriele, Naidoo, Kovin S, Naik, Nitish, Naldi, Luigi, Nangia, Vinay, Nash, Deni, Nejjari, Chakib, Neupane, Suba, Newton, Charles R, Newton, John N, Ng, Marie, Ngalesoni, Frida Namnyak, de Dieu Ngirabega, Jean, Nguyen, Quyen Le, Nisar, Muhammad Imran, Pete, Patrick Martial Nkamedjie, Nomura, Marika, Norheim, Ole F, Norman, Paul E, Norrving, Bo, Nyakarahuka, Luke, Ogbo, Felix Akpojene, Ohkubo, Takayoshi, Ojelabi, Foluke Adetola, Olivares, Pedro R, Olusanya, Bolajoko Olubukunola, Olusanya, Jacob Olusegun, Opio, John Nelson, Oren, Eyal, Ortiz, Alberto, Osman, Majdi, Ota, Erika, Ozdemir, Raziye, Pa, Mahesh, Pandian, Jeyaraj D, Pant, Puspa Raj, Papachristou, Christina, Park, Eun-Kee, Park, Jae-Hyun, Parry, Charles D, Parsaeian, Mahboubeh, Caicedo, Angel J Paternina, Patten, Scott B, Patton, George C, Paul, Vinod K, Pearce, Neil, Pedro, João Mário, Stokic, Ljiljana Pejin, Pereira, David M, Perico, Norberto, Pesudovs, Konrad, Petzold, Max, Phillips, Michael Robert, Piel, Frédéric B, Pillay, Julian David, Plass, Dietrich, Platts-Mills, James A, Polinder, Suzanne, Pope, C Arden, Popova, Svetlana, Poulton, Richie G, Pourmalek, Farshad, Prabhakaran, Dorairaj, Qorbani, Mostafa, Quame-Amaglo, Justice, Quistberg, D Alex, Rafay, Anwar, Rahimi, Kazem, Rahimi-Movaghar, Vafa, Rahman, Mahfuzar, Rahman, Mohammad Hifz Ur, Rahman, Sajjad Ur, Rai, Rajesh Kumar, Rajavi, Zhale, Rajsic, Sasa, Raju, Murugesan, Rakovac, Ivo, Rana, Saleem M, Ranabhat, Chhabi L, Rangaswamy, Thara, Rao, Puja, Rao, Sowmya R, Refaat, Amany H, Rehm, Jürgen, Reitsma, Marissa B, Remuzzi, Giuseppe, Resnikoff, Serge, Ribeiro, Antonio L, Ricci, Stefano, Blancas, Maria Jesus Rio, Roberts, Bayard, Roca, Anna, Rojas-Rueda, David, Ronfani, Luca, Roshandel, Gholamreza, Rothenbacher, Dietrich, Roy, Ambuj, Roy, Nawal K, Ruhago, George Mugambage, Sagar, Rajesh, Saha, Sukanta, Sahathevan, Ramesh, Saleh, Muhammad Muhammad, Sanabria, Juan R, Sanchez-Niño, Maria Dolore, Sanchez-Riera, Lidia, Santos, Itamar S, Sarmiento-Suarez, Rodrigo, Sartorius, Benn, Satpathy, Maheswar, Savic, Miloje, Sawhney, Monika, Schaub, Michael P, Schmidt, Maria Inê, Schneider, Ione J C, Schöttker, Ben, Schutte, Aletta E, Schwebel, David C, Seedat, Soraya, Sepanlou, Sadaf G, Servan-Mori, Edson E, Shackelford, Katya A, Shaddick, Gavin, Shaheen, Amira, Shahraz, Saeid, Shaikh, Masood Ali, Shakh-Nazarova, Marina, Sharma, Rajesh, She, Jun, Sheikhbahaei, Sara, Shen, Jiabin, Shen, Ziyan, Shepard, Donald S, Sheth, Kevin N, Shetty, Balakrishna P, Shi, Peilin, Shibuya, Kenji, Shin, Min-Jeong, Shiri, Rahman, Shiue, Ivy, Shrime, Mark G, Sigfusdottir, Inga Dora, Silberberg, Donald H, Silva, Diego Augusto Santo, Silveira, Dayane Gabriele Alve, Silverberg, Jonathan I, Simard, Edgar P, Singh, Abhishek, Singh, Gitanjali M, Singh, Jasvinder A, Singh, Om Prakash, Singh, Prashant Kumar, Singh, Virendra, Soneji, Samir, Søreide, Kjetil, Soriano, Joan B, Sposato, Luciano A, Sreeramareddy, Chandrashekhar T, Stathopoulou, Vasiliki, Stein, Dan J, Stein, Murray B, Stranges, Saverio, Stroumpoulis, Konstantino, Sunguya, Bruno F, Sur, Patrick, Swaminathan, Soumya, Sykes, Bryan L, Szoeke, Cassandra E I, Tabarés-Seisdedos, Rafael, Tabb, Karen M, Takahashi, Ken, Takala, Jukka S, Talongwa, Roberto Tchio, Tandon, Nikhil, Tavakkoli, Mohammad, Taye, Bineyam, Taylor, Hugh R, Ao, Braden J Te, Tedla, Bemnet Amare, Tefera, Worku Mekonnen, Have, Margreet Ten, Terkawi, Abdullah Sulieman, Tesfay, Fisaha Haile, Tessema, Gizachew Assefa, Thomson, Alan J, Thorne-Lyman, Andrew L, Thrift, Amanda G, Thurston, George D, Tillmann, Taavi, Tirschwell, David L, Tonelli, Marcello, Topor-Madry, Roman, Topouzis, Foti, Towbin, Jeffrey Allen, Traebert, Jefferson, Tran, Bach Xuan, Truelsen, Thoma, Trujillo, Ulise, Tura, Abera Kenay, Tuzcu, Emin Murat, Uchendu, Uche S, Ukwaja, Kingsley N, Undurraga, Eduardo A, Uthman, Olalekan A, Dingenen, Rita Van, van Donkelaar, Aaron, Vasankari, Tommi, Vasconcelos, Ana Maria Nogale, Venketasubramanian, Narayanaswamy, Vidavalur, Ramesh, Vijayakumar, Lakshmi, Villalpando, Salvador, Violante, Francesco S, Vlassov, Vasiliy Victorovich, Wagner, Joseph A, Wagner, Gregory R, Wallin, Mitchell T, Wang, Linhong, Watkins, David A, Weichenthal, Scott, Weiderpass, Elisabete, Weintraub, Robert G, Werdecker, Andrea, Westerman, Ronny, White, Richard A, Wijeratne, Tissa, Wilkinson, James D, Williams, Hywel C, Wiysonge, Charles Shey, Woldeyohannes, Solomon Meseret, Wolfe, Charles D A, Won, Sungho, Wong, John Q, Woolf, Anthony D, Xavier, Deni, Xiao, Qingyang, Xu, Gelin, Yakob, Bereket, Yalew, Ayalnesh Zemene, Yan, Lijing L, Yano, Yuichiro, Yaseri, Mehdi, Ye, Pengpeng, Yebyo, Henock Gebremedhin, Yip, Paul, Yirsaw, Biruck Desalegn, Yonemoto, Naohiro, Yonga, Gerald, Younis, Mustafa Z, Yu, Shicheng, Zaidi, Zoubida, Zaki, Maysaa El Sayed, Zannad, Faiez, Zavala, Diego E, Zeeb, Hajo, Zeleke, Berihun M, Zhang, Hao, Zodpey, Sanjay, Zonies, David, Zuhlke, Liesl Joanna, Vos, Theo, Lopez, Alan D, and Murray, Christopher J L
Subjects: VITAL-STATISTICS, INTEGRATED APPROACH, ECONOMIC-DEVELOPMENT, DEVELOPMENT ASSISTANCE, UNITED-STATES, Global Health, Communicable Disease, Communicable Diseases, cause of death, Medicine, General & Internal, Life Expectancy, General & Internal Medicine, Humans, Mortality, Medicine(all), Science & Technology, Mortality, Premature, Medicine (all), EPIDEMIOLOGIC TRANSITION, GBD 2015 Mortality and Causes of Death Collaborators, CIVIL REGISTRATION, Public Health, Global Health, Social Medicine and Epidemiology, Articles, 11 Medical And Health Sciences, ROAD TRAFFIC INJURIES, ALZHEIMERS-DISEASE, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, VERBAL AUTOPSY, Life Sciences & Biomedicine, Human
Abstract: Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing. We also expanded the database of vital registration, survey, and census data to 14 294 geography-year datapoints. For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality. We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes. We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies. First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility. Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality. Finally, we attributed changes in life expectancy to changes in cause of death. We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER). Findings Globally, life expectancy from birth increased from 61.7 years (95% uncertainty interval 61.4-61.9) in 1980 to 71.8 years (71.5-72.2) in 2015. Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS. At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence. From 2005 to 2015, male life expectancy in Syria dropped by 11.3 years (3.7-17.4), to 62.6 years (56.5-70.2). Total deaths increased by 4.1% (2.6-5.6) from 2005 to 2015, rising to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures. The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by 13.1% (11.9-14.3). Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias. By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42.1%, 39.1-44.6), malaria (43.1%, 34.7-51.8), neonatal preterm birth complications (29.8%, 24.8-34.9), and maternal disorders (29.1%, 19.3-37.1). Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders. Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East. In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146 000 deaths, 118 000-183 000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393 000 deaths, 228 000-532 000), although pathogen-specific mortality varied by region. Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause. Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI. Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory. Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI. Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death. Interpretation At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade. Progress has been faster in most countries than expected on the basis of development measured by the SDI. Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing. Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems. Copyright (C) The Author(s). Published by Elsevier Ltd.
Published: 2016

39. An African cardiology summit: The World Heart Federation African Summit on Best Practices in Policy and Access to Care in 2017 concluded with the Khartoum Action Plan, to improve cardiovascular on the African continent

Author: Karen, Sliwa, David, Wood, Ahmed, Suliman, Gerald, Yonga, Jean-Luc, Eisele, Pilar, Millan, George, Nel, and Saad, Subhai
Subjects: health care economics and organizations
Abstract: The World Heart Federation (WHF) is the umbrella organization of continental and national cardiac societies and heart foundations globally, reporting to the World Health Organization (WHO). The WHF is dedicated to the global fight against CVD, including heart disease, stroke, and rheumatic heart disease (RHD). Building on the first Global Summit on Circulatory Health, held at the 2016 World Congress of Cardiology and Cardiovascular Health in Mexico City, the second Summit held in Singapore July 2017 focused on building a civil society movement for circulatory health.
Published: 2018

40. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

Author: Nancy, Fullman, Jamal, Yearwood, Solomon, M, Abay, Cristiana, Abbafati, Foad, Abd-Allah, Jemal, Abdela, Ahmed, Abdelalim, Zegeye, Abebe, Teshome, Abuka, Abebo, Victor, Aboyans, Haftom, Niguse, Abraha, Daisy, M, X, Abreu, Laith, Abu-Raddad, J, Akilew, Awoke, Adane, Rufus, Adesoji, Adedoyin, Olatunji, Adetokunboh, Tara, Ballav, Adhikari, Mohsen, Afarideh, Ashkan, Afshin, Gina, Agarwal, Dominic, Agius, Anurag, Agrawal, Sutapa, Agrawal, Aliasghar, Ahmad, Kiadaliri, Miloud, Taki, Eddine, Aichour, Mohammed, Akibu, Rufus, Olusola, Akinyemi, Tomi, Akinyemiju, F, Nadia, Akseer, Faris, Hasan, Lami, Al, Fares, Alahdab, Ziyad, Al-Aly, Khurshid, Alam, Tahiya, Alam, Deena, Alasfoor, Mohammed, I, Albittar, Kefyalew, Addis, Alene, Ayman, Al-Eyadhy, Syed, Danish, Ali, Mehran, Alijanzadeh, Syed, M, Aljunid, Ala’A, Alkerwi, François, Alla, Peter, Allebeck, Christine, Allen, Mahmoud, A, Alomari, Rajaa, Al-Raddadi, Ubai, Alsharif, Khalid, A, Altirkawi, Nelson, Alvis-Guzman, Azmeraw, T, Amare, Kebede, Amenu, Walid, Ammar, Yaw, Ampem, Amoako, Nahla, Anber, Catalina, Liliana, Andrei, Sofia, Androudi, Carl, Abelardo, Antonio, T, Valdelaine, E, Araújo, M, Olatunde, Aremu, Johan, Ärnlöv, Artaman, Al, Krishna, Kumar, Aryal, Hamid, Asayesh, Ephrem, Tsegay, Asfaw, Solomon, Weldegebreal, Asgedom, Rana, Jawad, Asghar, Mengistu, Mitiku, Ashebir, Netsanet, Abera, Asseffa, Tesfay, Mehari, Atey, Sachin, R, Atre, Madhu, Atteraya, S, Leticia, Avila-Burgos, Euripide, Frinel, Arthur, G, Avokpaho, Ashish, Awasthi, Beatriz, Paulina, Ayala, Quintanilla, Animut, Alebel, Ayalew, Henok, Tadesse, Ayele, Rakesh, Ayer, Tambe, Betrand, Ayuk, Peter, Azzopardi, Natasha, Azzopardi-Muscat, Tesleem, Kayode, Babalola, Hamid, Badali, Alaa, Badawi, Maciej, Banach, Amitava, Banerjee, Amrit, Banstola, Ryan, M, Barber, Miguel, Barboza, A, Suzanne, L, Barker-Collo, Till, Bärnighausen, Simon, Barquera, Lope, H, Barrero, Quique, Bassat, Sanjay, Basu, Bernhard, T, Baune, Shahrzad, Bazargan-Hejazi, Neeraj, Bedi, Ettore, Beghi, Masoud, Behzadifar, Meysam, Behzadifar, Bayu, Begashaw, Bekele, Abate, Bekele, Belachew, Saba, Abraham, Belay, Yihalem, Abebe, Belay, Michelle, L, Bell, Aminu, Bello, K, Derrick, A, Bennett, James, Bennett, R, Isabela, M, Bensenor, Derbew, Fikadu, Berhe, Eduardo, Bernabé, Robert, Steven, Bernstein, Mircea, Beuran, Ashish, Bhalla, Paurvi, Bhatt, Soumyadeep, Bhaumik, Zulfiqar, A, Bhutta, Belete, Biadgo, Ali, Bijani, Boris, Bikbov, Charles, Birungi, Stan, Biryukov, Hailemichael, Bizuneh, Ian, W, Bolliger, Kaylin, Bolt, Ibrahim, R, Bou-Orm, Kayvan, Bozorgmehr, Oliver, Jerome, Brady, Alexandra, Brazinova, Nicholas, J, Breitborde, K, Hermann, Brenner, Gabrielle, Britton, Traolach, S, Brugha, Zahid, Butt, A, Lucero, Cahuana-Hurtado, Ismael, Ricardo, Campos-Nonato, Julio, Cesar, Campuzano, Josip, Car, Mate, Car, Rosario, Cárdenas, Juan, Jesus, Carrero, Felix, Carvalho, Carlos, A, Castañeda-Orjuela, Jacqueline, Castillo, Rivas, Ferrán, Catalá-López, Kelly, Cercy, Julian, Chalek, Hsing-Yi, Chang, Jung-Chen, Chang, Aparajita, Chattopadhyay, Pankaj, Chaturvedi, Peggy, Pei-Chia, Chiang, Vesper, Hichilombwe, Chisumpa, Jee-Young, J, Choi, Hanne, Christensen, Devasahayam, Jesudas, Christopher, Sheng-Chia, Chung, Liliana, G, Ciobanu, Cirillo, Massimo, Danny, Colombara, Sara, Conti, Cyrus, Cooper, Leslie, Cornaby, Paolo, Angelo, Cortesi, Monica, Cortinovis, Alexandre, Costa, Pereira, Ewerton, Cousin, Michael, H, Criqui, Elizabeth, Cromwell, A, Christopher, Stephen, Crowe, John, Crump, A, Alemneh, Kabeta, Daba, Berihun, Assefa, Dachew, Abel, Fekadu, Dadi, Lalit, Dandona, Rakhi, Dandona, Paul, I, Dargan, Ahmad, Daryani, Maryam, Daryani, Jai, Das, Siddharth, Kumar, Das, José, Das, Neves, Nicole, Davis, Weaver, Kairat, Davletov, Barbora, De, Courten, Diego, Leo, De, Jan-Walter, De, Neve, Robert, Dellavalle, P, Gebre, Demoz, Kebede, Deribe, Don, C, Des, Jarlais, Subhojit, Dey, Samath, D, Dharmaratne, Meghnath, Dhimal, Shirin, Djalalinia, David, Teye, Doku, Kate, Dolan, Ray, E, Dorsey, Kadine, Priscila, Bender, Dos, Santos, Kerrie, E, Doyle, Tim, Driscoll, R, Manisha, Dubey, Eleonora, Dubljanin, Bruce, Bartholow, Duncan, Michelle, Echko, Dumessa, Edessa, David, Edvardsson, Joshua, R, Ehrlich, Erika, Eldrenkamp, Ziad, El-Khatib, Matthias, Endres, Aman, Yesuf, Endries, Babak, Eshrati, Sharareh, Eskandarieh, Alireza, Esteghamati, Mahdi, Fakhar, Tamer, Farag, Mahbobeh, Faramarzi, Emerito, Jose, Aquino, Faraon, André, Faro, Farshad, Farzadfar, Adesegun, Fatusi, Mir, Sohail, Fazeli, Valery, Feigin, L, Andrea, B, Feigl, Netsanet, Fentahun, Seyed-Mohammad, Fereshtehnejad, Eduarda, Fernandes, João, C, Fernandes, Daniel, Obadare, Fijabi, Irina, Filip, Florian, Fischer, Christina, Fitzmaurice, Abraham, D, Flaxman, Luisa, Sorio, Flor, Nataliya, Foigt, Kyle, J, Foreman, Joseph, Frostad, J, Thomas, Fürst, Neal, D, Futran, Emmanuela, Gakidou, Silvano, Gallus, Ketevan, Gambashidze, Amiran, Gamkrelidze, Morsaleh, Ganji, Abadi, Kahsu, Gebre, Tsegaye, Tewelde, Gebrehiwot, Amanuel, Tesfay, Gebremedhin, Yalemzewod, Assefa, Gelaw, Johanna, M, Geleijnse, Demeke, Geremew, Peter, W, Gething, Reza, Ghadimi, Khalil, Ghasemi, Falavarjani, Maryam, Ghasemi-Kasman, Paramjit, Singh, Gill, Ababi, Zergaw, Giref, Maurice, Giroud, Melkamu, Dedefo, Gishu, Giorgia, Giussani, William, W, Godwin, Srinivas, Goli, Hector, Gomez-Dantes, Philimon, N, Gona, Amador, Goodridge, Sameer, Vali, Gopalani, Yevgeniy, Goryakin, Alessandra, Carvalho, Goulart, Ayman, Grada, Max, Griswold, Giuseppe, Grosso, Harish, Chander, Gugnani, Yuming, Guo, Rahul, Gupta, Rajeev, Gupta, Tanush, Gupta, Tarun, Gupta, Vipin, Gupta, Juanita, A, Haagsma, Vladimir, Hachinski, Nima, Hafezi-Nejad, Gessessew, Bugssa, Hailu, Randah, Ribhi, Hamadeh, Samer, Hamidi, Graeme, J, Hankey, Hilda, Harb, L, Heather, C, Harewood, Sivadasanpillai, Harikrishnan, Josep, Maria, Haro, Hamid, Yimam, Hassen, Rasmus, Havmoeller, Caitlin, Hawley, Simon, I, Hay, Jiawei, He, Stephen, J, Hearps, C, Mohamed, I, Hegazy, Behzad, Heibati, Mohsen, Heidari, Delia, Hendrie, Nathaniel, J, Henry, Victor, Hugo, Herrera, Ballesteros, Claudiu, Herteliu, Desalegn, Tsegaw, Hibstu, Molla, Kahssay, Hiluf, Hans, W, Hoek, Enayatollah, Homaie, Rad, Nobuyuki, Horita, Dean, H, Hosgood, Mostafa, Hosseini, Seyed, Reza, Hosseini, Mihaela, Hostiuc, Sorin, Hostiuc, Damian, G, Hoy, Mohamed, Hsairi, Aung, Soe, Htet, Guoqing, Hu, John, J, Huang, Kim, Moesgaard, Iburg, Fachmi, Idris, Ehimario, Uche, Igumbor, Chad, Ikeda, Bogdan, Vasile, Ileanu, Olayinka, Ilesanmi, S, Kaire, Innos, Seyed, Sina, Naghibi, Irvani, Caleb, M, Irvine, S, Farhad, Islami, Troy, A, Jacobs, Kathryn, Jacobsen, H, Nader, Jahanmehr, Rajesh, Jain, Sudhir, Kumar, Jain, Mihajlo, Jakovljevic, M, Moti, Tolera, Jalu, Amr, Jamal, A, Mehdi, Javanbakht, Achala, Upendra, Jayatilleke, Panniyammakal, Jeemon, Ravi, Prakash, Jha, Vivekanand, Jha, Jacek, Józwiak, Oommen, John, Sarah, Charlotte, Johnson, Jost, Jonas, B, Vasna, Joshua, Mikk, Jürisson, Zubair, Kabir, Rajendra, Kadel, Amaha, Kahsay, Rizwan, Kalani, Chittaranjan, Kar, Marina, Karanikolos, André, Karch, Corine, Kakizi, Karema, Seyed, Karimi, M, Amir, Kasaeian, Dessalegn, Haile, Kassa, Getachew, Mullu, Kassa, Tesfaye, Dessale, Kassa, Nicholas, Kassebaum, J, Srinivasa, Vittal, Katikireddi, Anil, Kaul, Norito, Kawakami, Konstantin, Kazanjan, Seifu, Kebede, Peter, Njenga, Keiyoro, Grant, Rodgers, Kemp, Andre, Pascal, Kengne, Maia, Kereselidze, Ezra, Belay, Ketema, Yousef, Saleh, Khader, Morteza, Abdullatif, Khafaie, Alireza, Khajavi, Ibrahim, A, Khalil, Ejaz, Ahmad, Khan, Gulfaraz, Khan, Nuruzzaman, Md, Khan, Muhammad, Ali, Khan, Mukti, Nath, Khanal, Young-Ho, Khang, Mona, M, Khater, Abdullah, Tawfih, Abdullah, Khoja, Ardeshir, Khosravi, Jagdish, Khubchandani, Getiye, Dejenu, Kibret, Daniel, Ngari, Kiirithio, Daniel, Kim, Yun, Jin, Kim, Ruth, Kimokoti, W, Yohannes, Kinfu, Sanjay, Kinra, Adnan, Kisa, Niranjan, Kissoon, Sonali, Kochhar, Yoshihiro, Kokubo, Jacek, A, Kopec, Soewarta, Kosen, Parvaiz, A, Koul, Koyanagi, Ai, Michael, Kravchenko, Kewal, Krishan, Kristopher, J, Krohn, Barthelemy, Kuate, Defo, Anil, G, Kumar, Pushpendra, Kumar, Michael, Kutz, Igor, Kuzin, Hmwe, H, Kyu, Deepesh, Pravinkumar, Lad, Alessandra, Lafranconi, Dharmesh, Kumar, Lal, Ratilal, Lalloo, Hilton, Lam, Qing, Lan, Justin, J, Lang, Van, Lansingh, C, Sonia, Lansky, Anders, Larsson, Arman, Latifi, Jeffrey, Victor, Lazarus, Janet, Leasher, L, Paul, H, Lee, Yirga, Legesse, James, Leigh, Cheru, Tesema, Leshargie, Samson, Leta, Janni, Leung, Ricky, Leung, Miriam, Levi, Yongmei, Li, Juan, Liang, Misgan, Legesse, Liben, Lee-Ling, Lim, Stephen, S, Lim, Margaret, Lind, Shai, Linn, Stefan, Listl, Patrick, Y, Liu, Shiwei, Liu, Rakesh, Lodha, Alan, D, Lopez, Scott, Lorch, A, Stefan, Lorkowski, Paulo, A, Lotufo, Timothy, C, D, Lucas, Raimundas, Lunevicius, Grégoire, Lurton, Ronan, A, Lyons, Fadi, Maalouf, Erlyn, Rachelle, King, Macarayan, Mark, T, Mackay, Emilie, Maddison, R, Fabiana, Madotto, Hassan, Magdy, Abd, El, Razek, Mohammed, Magdy, Abd, Razek, El, Marek, Majdan, Reza, Majdzadeh, Azeem, Majeed, Reza, Malekzadeh, Rajesh, Malhotra, Deborah, Carvalho, Malta, Abdullah, Mamun, A, Helena, Manguerra, Treh, Manhertz, Mohammad, Ali, Mansournia, Lorenzo, Mantovani, G, Tsegahun, Manyazewal, Chabila, C, Mapoma, Christopher, Margono, Jose, Martinez-Raga, Sheila, Cristina, Ouriques, Martins, Francisco, Rogerlândio, Martins-Melo, Ira, Martopullo, Winfried, März, Benjamin, Ballard, Massenburg, Manu, Raj, Mathur, Pallab, K, Maulik, Mohsen, Mazidi, Colm, Mcalinden, Mcgrath, Martin, Mckee, Suresh, Mehata, Ravi, Mehrotra, Kala, M, Mehta, Varshil, Mehta, Toni, Meier, Fabiola, Mejia-Rodriguez, Kidanu, Gebremariam, Meles, Mulugeta, Melku, Peter, Memiah, Ziad, A, Memish, Walter, Mendoza, Degu, Abate, Mengiste, Desalegn, Tadese, Mengistu, Bereket, Gebremichael, Menota, George, Mensah, A, Atte, Meretoja, Tuomo, J, Meretoja, Haftay, Berhane, Mezgebe, Tomasz, Miazgowski, Renata, Micha, Robert, Milam, Anoushka, Millear, Ted, R, Miller, Mini, Gk, Shawn, Minnig, Andreea, Mirica, Erkin, M, Mirrakhimov, Awoke, Misganaw, Philip, B, Mitchell, Fitsum, Weldegebreal, Mlashu, Babak, Moazen, Karzan, Abdulmuhsin, Mohammad, Roghayeh, Mohammadibakhsh, Ebrahim, Mohammed, Mohammed, A, Mohammed, Shafiu, Mohammed, Ali, H, Mokdad, Glen, Liddell, D, Mola, Mariam, Molokhia, Fatemeh, Momeniha, Lorenzo, Monasta, Julio, Cesar, Montañez, Hernandez, Mahmood, Moosazadeh, Maziar, Moradi-Lakeh, Paula, Moraga, Lidia, Morawska, Ilais, Moreno, Velasquez, Rintaro, Mori, Shane, D, Morrison, Mark, Moses, Seyyed, Meysam, Mousavi, Ulrich, Mueller, O, Manoj, Murhekar, Gudlavalleti, Venkata, Satyanarayana, Murthy, Srinivas, Murthy, Jonah, Musa, Kamarul, Imran, Musa, Ghulam, Mustafa, Saravanan, Muthupandian, Chie, Nagata, Gabriele, Nagel, Mohsen, Naghavi, Aliya, Naheed, Gurudatta, A, Naik, Nitish, Naik, Farid, Najafi, Luigi, Naldi, Vinay, Nangia, Jobert, Richie, Njingang, Nansseu, K, M, Venkat, Narayan, Bruno, Ramos, Nascimento, Ionut, Negoi, Ruxandra, Irina, Negoi, Charles, Newton, R, Josephine, Wanjiku, Ngunjiri, Grant, Nguyen, Long, Nguyen, Trang, Huyen, Nguyen, Emma, Nichols, Dina, Nur, Anggraini, Ningrum, Ellen, Nolte, Vuong, Minh, Nong, Ole, Norheim, F, Norrving, Bo, Jean, Jacques, Noubiap, N, Alypio, Nyandwi, Carla, Makhlouf, Obermeyer, Richard, Ofori-Asenso, Felix, Akpojene, Ogbo, In-Hwan, Oh, Olanrewaju, Oladimeji, Andrew, Toyin, Olagunju, Tinuke, Oluwasefunmi, Olagunju, Pedro, R, Olivares, Patricia, Pereira, Vasconcelos, Oliveira, De, Helen, E, Olsen, Bolajoko, Olubukunola, Olusanya, Jacob, Olusegun, Olusanya, Kanyin, Ong, John, Nelson, Opio, Eyal, Oren, Doris, V, Ortega-Altamirano, Alberto, Ortiz, Raziye, Ozdemir, Mahesh, Pa, Amanda, W, Pain, Marcos, Roberto, Tovani, Palone, Adrian, Pana, Songhomitra, Panda-Jonas, Jeyaraj, D, Pandian, Eun-Kee, Park, Hadi, Parsian, Tejas, Patel, Sanghamitra, Pati, Snehal, T, Patil, Ajay, Patle, George, C, Patton, Vishnupriya, Rao, Paturi, Deepak, Paudel, Marcel, De, Moares, Pedroso, Sandra, P, Pedroza, David, Pereira, M, Norberto, Perico, Hannah, Peterson, Max, Petzold, Niloofar, Peykari, Michael, Robert, Phillips, Frédéric, Piel, B, David, M, Pigott, Julian, David, Pillay, Michael, A, Piradov, Suzanne, Polinder, Constance, D, Pond, Maarten, Postma, J, Farshad, Pourmalek, Swayam, Prakash, Prakash, V, Narayan, Prasad, Noela, Marie, Prasad, Caroline, Purcell, Mostafa, Qorbani, Hedley, Knewjen, Quintana, Amir, Radfar, Anwar, Rafay, Alireza, Rafiei, Kazem, Rahimi, Afarin, Rahimi-Movaghar, Vafa, Rahimi-Movaghar, Mahfuzar, Rahman, Muhammad, Aziz, Rahman, Sajjad, Rahman, Ur, Rajesh, Kumar, Rai, Sree, Bhushan, Raju, Usha, Ram, Saleem, M, Rana, Zane, Rankin, Davide, Rasella, David, Laith, Rawaf, Salman, Rawaf, Sarah, E, Ray, Christian, Aspacia, Razo-García, Priscilla, Reddy, Robert, C, Reiner, Cesar, Reis, Marissa, B, Reitsma, Giuseppe, Remuzzi, Andre, M, Renzaho, N, Serge, Resnikoff, Satar, Rezaei, Mohammad, Sadegh, Rezai, Antonio, Ribeiro, L, Maria, Jesus, Rios, Blancas, Juan, A, Rivera, Leonardo, Roever, Luca, Ronfani, Gholamreza, Roshandel, Ali, Rostami, Gregory, A, Roth, Dietrich, Rothenbacher, Ambuj, Roy, Nobhojit, Roy, George, Mugambage, Ruhago, Yogesh, Damodar, Sabde, Perminder, S, Sachdev, Nafis, Sadat, Mahdi, Safdarian, Saeid, Safiri, Rajesh, Sagar, Amirhossein, Sahebkar, Sahraian, Haniye, Sadat, Sajadi, Joseph, Salama, Payman, Salamati, Raphael, De, Freitas, Saldanha, Hamideh, Salimzadeh, Joshua, A, Salomon, Abdallah, Samy, M, Juan, Ramon, Sanabria, Parag, Sancheti, K, Maria, Dolores, Sanchez-Niño, Damian, Santomauro, Itamar, S, Santos, Milena, Santric, M, Milicevic, Abdur, Razzaque, Sarker, Nizal, Sarrafzadegan, Benn, Sartorius, Maheswar, Satpathy, Miloje, Savic, Monika, Sawhney, Sonia, Saxena, Mete, I, Saylan, Elke, Schaeffner, Josef, Schmidhuber, Maria, Inês, Schmidt, Ione, J, C, Schneider, Austin, Schumacher, E, Aletta, E, Schutte, David, Schwebel, C, Falk, Schwendicke, Mario, Sekerija, Sadaf, G, Sepanlou, Edson, Servan-Mori, E, Azadeh, Shafieesabet, Masood, Ali, Shaikh, Marina, Shakh-Nazarova, Mehran, Shams-Beyranvand, Heidar, Sharafi, Mahdi, Sharif-Alhoseini, Sheikh, Mohammed, Shariful, Islam, Meenakshi, Sharma, Rajesh, Sharma, Jun, She, Aziz, Sheikh, Mebrahtu, Teweldemedhin, Shfare, Peilin, Shi, Chloe, Shields, Mika, Shigematsu, Yukito, Shinohara, Rahman, Shiri, Reza, Shirkoohi, Ivy, Shiue, Mark, G, Shrime, Sharvari, Rahul, Shukla, Soraya, Siabani, Inga, Dora, Sigfusdottir, Donald, Silberberg, H, Diego, Augusto, Santos, Silva, João, Pedro, Silva, Dayane, Gabriele, Alves, Silveira, Jasvinder, Singh, A, Lavanya, Singh, Narinder, Pal, Singh, Virendra, Singh, Dhirendra, Narain, Sinha, Abiy, Hiruye, Sinke, Mekonnen, Sisay, Vegard, Skirbekk, Karen, Sliwa, Alison, Smith, Adauto, Martins, Soares, Filho, Badr, H, Sobaih, A, Melek, Somai, Samir, Soneji, Moslem, Soofi, Reed, J, Sorensen, D, Joan, B, Soriano, Ireneous, Soyiri, N, Luciano, A, Sposato, Chandrashekhar, Sreeramareddy, T, Vinay, Srinivasan, Jeffrey, D, Stanaway, Vasiliki, Stathopoulou, Nicholas, Steel, Dan, J, Stein, Mark, Andrew, Stokes, Lela, Sturua, Muawiyyah, Babale, Sufiyan, Rizwan, Abdulkader, Suliankatchi, Bruno, F, Sunguya, Patrick, Sur, J, Bryan, L, Sykes, P, Sylaja, N, Cassandra, E, Szoeke, I, Rafael, Tabarés-Seisdedos, Santosh, Kumar, Tadakamadla, Andualem, Henok, Tadesse, Getachew, Redae, Taffere, Nikhil, Tandon, Amare, Tariku, Tariku, Nuno, Taveira, Arash, Tehrani-Banihashemi, Girma, Temam, Shifa, Mohamad-Hani, Temsah, Abdullah, Sulieman, Terkawi, Azeb, Gebresilassie, Tesema, Dawit, Jember, Tesfaye, Belay, Tessema, Thakur, Js, Nihal, Thomas, Matthew, J, Thompson, Taavi, Tillmann, Quyen, G, Ruoyan, Tobe-Gai, Marcello, Tonelli, Roman, Topor-Madry, Fotis, Topouzis, Anna, Torre, Miguel, Tortajada, Bach, Xuan, Tran, Khanh, Bao, Tran, Avnish, Tripathi, Srikanth, Prasad, Tripathy, Christopher, Troeger, Thomas, Truelsen, Derrick, Tsoi, Lorainne, Tudor, Car, Kald, Beshir, Tuem, Stefanos, Tyrovolas, Uche, S, Uchendu, Kingsley, Nnanna, Ukwaja, Irfan, Ullah, Rachel, Updike, Olalekan, A, Uthman, Benjamin, Chudi, S, Uzochukwu, Pascual, Rubén, Valdez, Job, F, Van, M, Boven, Santosh, Varughese, Tommi, Vasankari, Narayanaswamy, Venketasubramanian, Francesco, S, Violante, Sergey, Vladimirov, K, Vasiliy, Victorovich, Vlassov, Stein, Emil, Vollset, Theo, Vos, Fasil, Wagnew, Yasir, Waheed, Mitchell, T, Wallin, Judd, Walson, L, Yafeng, Wang, Yuan-Pang, Wang, Molla, Mesele, Wassie, Marcia, Weaver, R, Elisabete, Weiderpass, Robert, G, Weintraub, Jordan, Weiss, Kidu, Gidey, Weldegwergs, Andrea, Werdecker, Eoin, T, West, Ronny, Westerman, Richard, G, White, Harvey, Whiteford, A, Justyna, Widecka, Andrea, Sylvia, Winkler, Charles, Shey, Wiysonge, Charles, D, Wolfe, A, Yohanes, Ayele, Wondimkun, Abdulhalik, Workicho, Grant, M, Wyper, A, Denis, Xavier, Gelin, Xu, Lijing, L, Yan, Yuichiro, Yano, Mehdi, Yaseri, Nigus, Bililign, Yimer, Peng, Yin, Paul, Yip, Biruck, Desalegn, Yirsaw, Naohiro, Yonemoto, Gerald, Yonga, Seok-Jun, Yoon, Marcel, Yotebieng, Mustafa, Z, Younis, Chuanhua, Yu, Vesna, Zadnik, Zoubida, Zaidi, Maysaa, El, Sayed, Zaki, Sojib, Bin, Zaman, Mohammad, Zamani, Zerihun, Menlkalew, Zenebe, Maigeng, Zhou, Jun, Zhu, Stephanie, R, Zimsen, M, Ben, Zipkin, Sanjay, Zodpey, Liesl, Joanna, Zuhlke, Christopher, J, L, Murray, Rafael, Lozano., Fullman, N, Yearwood, J, Abay, S, Abbafati, C, Abd-Allah, F, Abdela, J, Abdelalim, A, Abebe, Z, Abebo, T, Aboyans, V, Abraha, H, Abreu, D, Abu-Raddad, L, Adane, A, Adedoyin, R, Adetokunboh, O, Adhikari, T, Afarideh, M, Afshin, A, Agarwal, G, Agius, D, Agrawal, A, Agrawal, S, Ahmad Kiadaliri, A, Aichour, M, Akibu, M, Akinyemi, R, Akinyemiju, T, Akseer, N, Al Lami, F, Alahdab, F, Al-Aly, Z, Alam, K, Alam, T, Alasfoor, D, Albittar, M, Alene, K, Al-Eyadhy, A, Ali, S, Alijanzadeh, M, Aljunid, S, Alkerwi, A, Alla, F, Allebeck, P, Allen, C, Alomari, M, Al-Raddadi, R, Alsharif, U, Altirkawi, K, Alvis-Guzman, N, Amare, A, Amenu, K, Ammar, W, Amoako, Y, Anber, N, Andrei, C, Androudi, S, Antonio, C, Araújo, V, Aremu, O, Ärnlöv, J, Artaman, A, Aryal, K, Asayesh, H, Asfaw, E, Asgedom, S, Asghar, R, Ashebir, M, Asseffa, N, Atey, T, Atre, S, Atteraya, M, Avila-Burgos, L, Avokpaho, E, Awasthi, A, Ayala Quintanilla, B, Ayalew, A, Ayele, H, Ayer, R, Ayuk, T, Azzopardi, P, Azzopardi-Muscat, N, Babalola, T, Badali, H, Badawi, A, Banach, M, Banerjee, A, Banstola, A, Barber, R, Barboza, M, Barker-Collo, S, Bärnighausen, T, Barquera, S, Barrero, L, Bassat, Q, Basu, S, Baune, B, Bazargan-Hejazi, S, Bedi, N, Beghi, E, Behzadifar, M, Bekele, B, Belachew, A, Belay, S, Belay, Y, Bell, M, Bello, A, Bennett, D, Bennett, J, Bensenor, I, Berhe, D, Bernabé, E, Bernstein, R, Beuran, M, Bhalla, A, Bhatt, P, Bhaumik, S, Bhutta, Z, Biadgo, B, Bijani, A, Bikbov, B, Birungi, C, Biryukov, S, Bizuneh, H, Bolliger, I, Bolt, K, Bou-Orm, I, Bozorgmehr, K, Brady, O, Brazinova, A, Breitborde, N, Brenner, H, Britton, G, Brugha, T, Butt, Z, Cahuana-Hurtado, L, Campos-Nonato, I, Campuzano, J, Car, J, Car, M, Cárdenas, R, Carrero, J, Carvalho, F, Castañeda-Orjuela, C, Castillo Rivas, J, Catalá-López, F, Cercy, K, Chalek, J, Chang, H, Chang, J, Chattopadhyay, A, Chaturvedi, P, Chiang, P, Chisumpa, V, Choi, J, Christensen, H, Christopher, D, Chung, S, Ciobanu, L, Cirillo, M, Colombara, D, Conti, S, Cooper, C, Cornaby, L, Cortesi, P, Cortinovis, M, Costa Pereira, A, Cousin, E, Criqui, M, Cromwell, E, Crowe, C, Crump, J, Daba, A, Dachew, B, Dadi, A, Dandona, L, Dandona, R, Dargan, P, Daryani, A, Daryani, M, Das, J, Das, S, das Neves, J, Davis Weaver, N, Davletov, K, de Courten, B, De Leo, D, De Neve, J, Dellavalle, R, Demoz, G, Deribe, K, Des Jarlais, D, Dey, S, Dharmaratne, S, Dhimal, M, Djalalinia, S, Doku, D, Dolan, K, Dorsey, E, dos Santos, K, Doyle, K, Driscoll, T, Dubey, M, Dubljanin, E, Duncan, B, Echko, M, Edessa, D, Edvardsson, D, Ehrlich, J, Eldrenkamp, E, El-Khatib, Z, Endres, M, Endries, A, Eshrati, B, Eskandarieh, S, Esteghamati, A, Fakhar, M, Farag, T, Faramarzi, M, Faraon, E, Faro, A, Farzadfar, F, Fatusi, A, Fazeli, M, Feigin, V, Feigl, A, Fentahun, N, Fereshtehnejad, S, Fernandes, E, Fernandes, J, Fijabi, D, Filip, I, Fischer, F, Fitzmaurice, C, Flaxman, A, Flor, L, Foigt, N, Foreman, K, Frostad, J, Fürst, T, Futran, N, Gakidou, E, Gallus, S, Gambashidze, K, Gamkrelidze, A, Ganji, M, Gebre, A, Gebrehiwot, T, Gebremedhin, A, Gelaw, Y, Geleijnse, J, Geremew, D, Gething, P, Ghadimi, R, Ghasemi Falavarjani, K, Ghasemi-Kasman, M, Gill, P, Giref, A, Giroud, M, Gishu, M, Giussani, G, Godwin, W, Goli, S, Gomez-Dantes, H, Gona, P, Goodridge, A, Gopalani, S, Goryakin, Y, Goulart, A, Grada, A, Griswold, M, Grosso, G, Gugnani, H, Guo, Y, Gupta, R, Gupta, T, Gupta, V, Haagsma, J, Hachinski, V, Hafezi-Nejad, N, Hailu, G, Hamadeh, R, Hamidi, S, Hankey, G, Harb, H, Harewood, H, Harikrishnan, S, Haro, J, Hassen, H, Havmoeller, R, Hawley, C, Hay, S, He, J, Hearps, S, Hegazy, M, Heibati, B, Heidari, M, Hendrie, D, Henry, N, Herrera Ballesteros, V, Herteliu, C, Hibstu, D, Hiluf, M, Hoek, H, Homaie Rad, E, Horita, N, Hosgood, H, Hosseini, M, Hosseini, S, Hostiuc, M, Hostiuc, S, Hoy, D, Hsairi, M, Htet, A, Hu, G, Huang, J, Iburg, K, Idris, F, Igumbor, E, Ikeda, C, Ileanu, B, Ilesanmi, O, Innos, K, Irvani, S, Irvine, C, Islami, F, Jacobs, T, Jacobsen, K, Jahanmehr, N, Jain, R, Jain, S, Jakovljevic, M, Jalu, M, Jamal, A, Javanbakht, M, Jayatilleke, A, Jeemon, P, Jha, R, Jha, V, Jóúwiak, J, John, O, Johnson, S, Jonas, J, Joshua, V, Jürisson, M, Kabir, Z, Kadel, R, Kahsay, A, Kalani, R, Kar, C, Karanikolos, M, Karch, A, Karema, C, Karimi, S, Kasaeian, A, Kassa, D, Kassa, G, Kassa, T, Kassebaum, N, Katikireddi, S, Kaul, A, Kawakami, N, Kazanjan, K, Kebede, S, Keiyoro, P, Kemp, G, Kengne, A, Kereselidze, M, Ketema, E, Khader, Y, Khafaie, M, Khajavi, A, Khalil, I, Khan, E, Khan, G, Khan, M, Khanal, M, Khang, Y, Khater, M, Khoja, A, Khosravi, A, Khubchandani, J, Kibret, G, Kiirithio, D, Kim, D, Kim, Y, Kimokoti, R, Kinfu, Y, Kinra, S, Kisa, A, Kissoon, N, Kochhar, S, Kokubo, Y, Kopec, J, Kosen, S, Koul, P, Koyanagi, A, Kravchenko, M, Krishan, K, Krohn, K, Kuate Defo, B, Kumar, G, Kumar, P, Kutz, M, Kuzin, I, Kyu, H, Lad, D, Lafranconi, A, Lal, D, Lalloo, R, Lam, H, Lan, Q, Lang, J, Lansingh, V, Lansky, S, Larsson, A, Latifi, A, Lazarus, J, Leasher, J, Lee, P, Legesse, Y, Leigh, J, Leshargie, C, Leta, S, Leung, J, Leung, R, Levi, M, Li, Y, Liang, J, Liben, M, Lim, L, Lim, S, Lind, M, Linn, S, Listl, S, Liu, P, Liu, S, Lodha, R, Lopez, A, Lorch, S, Lorkowski, S, Lotufo, P, Lucas, T, Lunevicius, R, Lurton, G, Lyons, R, Maalouf, F, Macarayan, E, Mackay, M, Maddison, E, Madotto, F, Magdy Abd El Razek, H, Magdy Abd El Razek, M, Majdan, M, Majdzadeh, R, Majeed, A, Malekzadeh, R, Malhotra, R, Malta, D, Mamun, A, Manhertz, T, Manguerra, H, Mansournia, M, Mantovani, L, Manyazewal, T, Mapoma, C, Margono, C, Martinez-Raga, J, Martins, S, Martins-Melo, F, Martopullo, I, März, W, Massenburg, B, Mathur, M, Maulik, P, Mazidi, M, Mcalinden, C, Mcgrath, J, Mckee, M, Mehata, S, Mehrotra, R, Mehta, K, Mehta, V, Meier, T, Mejia-Rodriguez, F, Meles, K, Melku, M, Memiah, P, Memish, Z, Mendoza, W, Mengiste, D, Mengistu, D, Menota, B, Mensah, G, Meretoja, A, Meretoja, T, Mezgebe, H, Miazgowski, T, Micha, R, Milam, R, Millear, A, Miller, T, Mini, G, Minnig, S, Mirica, A, Mirrakhimov, E, Misganaw, A, Mitchell, P, Mlashu, F, Moazen, B, Mohammad, K, Mohammadibakhsh, R, Mohammed, E, Mohammed, M, Mohammed, S, Mokdad, A, Mola, G, Molokhia, M, Momeniha, F, Monasta, L, Montañez Hernandez, J, Moosazadeh, M, Moradi-Lakeh, M, Moraga, P, Morawska, L, Moreno Velasquez, I, Mori, R, Morrison, S, Moses, M, Mousavi, S, Mueller, U, Murhekar, M, Murthy, G, Murthy, S, Musa, J, Musa, K, Mustafa, G, Muthupandian, S, Nagata, C, Nagel, G, Naghavi, M, Naheed, A, Naik, G, Naik, N, Najafi, F, Naldi, L, Nangia, V, Nansseu, J, Narayan, K, Nascimento, B, Negoi, I, Negoi, R, Newton, C, Ngunjiri, J, Nguyen, G, Nguyen, L, Nguyen, T, Nichols, E, Ningrum, D, Nolte, E, Nong, V, Norheim, O, Norrving, B, Noubiap, J, Nyandwi, A, Obermeyer, C, Ofori-Asenso, R, Ogbo, F, Oh, I, Oladimeji, O, Olagunju, A, Olagunju, T, Olivares, P, Oliveira, P, Olsen, H, Olusanya, B, Olusanya, J, Ong, K, Opio, J, Oren, E, Ortega-Altamirano, D, Ortiz, A, Ozdemir, R, Pa, M, Pain, A, Palone, M, Pana, A, Panda-Jonas, S, Pandian, J, Park, E, Parsian, H, Patel, T, Pati, S, Patil, S, Patle, A, Patton, G, Paturi, V, Paudel, D, Pedroso, M, Pedroza, S, Pereira, D, Perico, N, Peterson, H, Petzold, M, Peykari, N, Phillips, M, Piel, F, Pigott, D, Pillay, J, Piradov, M, Polinder, S, Pond, C, Postma, M, Pourmalek, F, Prakash, S, Prakash, V, Prasad, N, Purcell, C, Qorbani, M, Quintana, H, Radfar, A, Rafay, A, Rafiei, A, Rahimi, K, Rahimi-Movaghar, A, Rahimi-Movaghar, V, Rahman, M, Rahman, S, Rai, R, Raju, S, Ram, U, Rana, S, Rankin, Z, Rasella, D, Rawaf, D, Rawaf, S, Ray, S, Razo-García, C, Reddy, P, Reiner, R, Reis, C, Reitsma, M, Remuzzi, G, Renzaho, A, Resnikoff, S, Rezaei, S, Rezai, M, Ribeiro, A, Rios Blancas, M, Rivera, J, Roever, L, Ronfani, L, Roshandel, G, Rostami, A, Roth, G, Rothenbacher, D, Roy, A, Roy, N, Ruhago, G, Sabde, Y, Sachdev, P, Sadat, N, Safdarian, M, Safiri, S, Sagar, R, Sahebkar, A, Sahraian, M, Sajadi, H, Salama, J, Salamati, P, Saldanha, R, Salimzadeh, H, Salomon, J, Samy, A, Sanabria, J, Sancheti, P, Sanchez-Niño, M, Santomauro, D, Santos, I, Santric Milicevic, M, Sarker, A, Sarrafzadegan, N, Sartorius, B, Satpathy, M, Savic, M, Sawhney, M, Saxena, S, Saylan, M, Schaeffner, E, Schmidhuber, J, Schmidt, M, Schneider, I, Schumacher, A, Schutte, A, Schwebel, D, Schwendicke, F, Sekerija, M, Sepanlou, S, Servan-Mori, E, Shafieesabet, A, Shaikh, M, Shakh-Nazarova, M, Shams-Beyranvand, M, Sharafi, H, Sharif-Alhoseini, M, Shariful Islam, S, Sharma, M, Sharma, R, She, J, Sheikh, A, Shfare, M, Shi, P, Shields, C, Shigematsu, M, Shinohara, Y, Shiri, R, Shirkoohi, R, Shiue, I, Shrime, M, Shukla, S, Siabani, S, Sigfusdottir, I, Silberberg, D, Silva, D, Silva, J, Silveira, D, Singh, J, Singh, L, Singh, N, Singh, V, Sinha, D, Sinke, A, Sisay, M, Skirbekk, V, Sliwa, K, Smith, A, Soares Filho, A, Sobaih, B, Somai, M, Soneji, S, Soofi, M, Sorensen, R, Soriano, J, Soyiri, I, Sposato, L, Sreeramareddy, C, Srinivasan, V, Stanaway, J, Stathopoulou, V, Steel, N, Stein, D, Stokes, M, Sturua, L, Sufiyan, M, Suliankatchi, R, Sunguya, B, Sur, P, Sykes, B, Sylaja, P, Tabarés-Seisdedos, R, Tadakamadla, S, Tadesse, A, Taffere, G, Tandon, N, Tariku, A, Taveira, N, Tehrani-Banihashemi, A, Temam Shifa, G, Temsah, M, Terkawi, A, Tesema, A, Tesfaye, D, Tessema, B, Thakur, J, Thomas, N, Thompson, M, Tillmann, T, To, Q, Tobe-Gai, R, Tonelli, M, Topor-Madry, R, Topouzis, F, Torre, A, Tortajada, M, Tran, B, Tran, K, Tripathi, A, Tripathy, S, Troeger, C, Truelsen, T, Tsoi, D, Tudor Car, L, Tuem, K, Tyrovolas, S, Uchendu, U, Ukwaja, K, Ullah, I, Updike, R, Uthman, O, Uzochukwu, B, Valdez, P, van Boven, J, Varughese, S, Vasankari, T, Violante, F, Vladimirov, S, Vlassov, V, Vollset, S, Vos, T, Wagnew, F, Waheed, Y, Wallin, M, Walson, J, Wang, Y, Wassie, M, Weaver, M, Weiderpass, E, Weintraub, R, Weiss, J, Weldegwergs, K, Werdecker, A, West, T, Westerman, R, White, R, Whiteford, H, Widecka, J, Winkler, A, Wiysonge, C, Wolfe, C, Wondimkun, Y, Workicho, A, Wyper, G, Xavier, D, Xu, G, Yan, L, Yano, Y, Yaseri, M, Yimer, N, Yin, P, Yip, P, Yirsaw, B, Yonemoto, N, Yonga, G, Yoon, S, Yotebieng, M, Younis, M, Yu, C, Zadnik, V, Zaidi, Z, Zaki, M, Zaman, S, Zamani, M, Zenebe, Z, Zhou, M, Zhu, J, Zimsen, S, Zipkin, B, Zodpey, S, Zuhlke, L, Murray, C, Lozano, R, Fullman, Nancy, Yearwood, Jamal, Abay, Solomon M., Abbafati, Cristiana, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abebe, Zegeye, Abebo, Teshome Abuka, Aboyans, Victor, Abraha, Haftom Niguse, Abreu, Daisy M.X., Abu-Raddad, Laith J., Adane, Akilew Awoke, Adedoyin, Rufus Adesoji, Adetokunboh, Olatunji, Adhikari, Tara Ballav, Afarideh, Mohsen, Afshin, Ashkan, Agarwal, Gina, Agius, Dominic, Agrawal, Anurag, Agrawal, Sutapa, Ahmad Kiadaliri, Aliasghar, Aichour, Miloud Taki Eddine, Akibu, Mohammed, Akinyemi, Rufus Olusola, Akinyemiju, Tomi F., Akseer, Nadia, Al Lami, Faris Hasan, Alahdab, Fare, Al-Aly, Ziyad, Alam, Khurshid, Alam, Tahiya, Alasfoor, Deena, Albittar, Mohammed I., Alene, Kefyalew Addi, Al-Eyadhy, Ayman, Ali, Syed Danish, Alijanzadeh, Mehran, Aljunid, Syed M., Alkerwi, Ala'a, Alla, Françoi, Allebeck, Peter, Allen, Christine, Alomari, Mahmoud A., Al-Raddadi, Rajaa, Alsharif, Ubai, Altirkawi, Khalid A., Alvis-Guzman, Nelson, Amare, Azmeraw T., Amenu, Kebede, Ammar, Walid, Amoako, Yaw Ampem, Anber, Nahla, Andrei, Catalina Liliana, Androudi, Sofia, Antonio, Carl Abelardo T., Araújo, Valdelaine E.M., Aremu, Olatunde, Ärnlöv, Johan, Artaman, Al, Aryal, Krishna Kumar, Asayesh, Hamid, Asfaw, Ephrem Tsegay, Asgedom, Solomon Weldegebreal, Asghar, Rana Jawad, Ashebir, Mengistu Mitiku, Asseffa, Netsanet Abera, Atey, Tesfay Mehari, Atre, Sachin R., Atteraya, Madhu S., Avila-Burgos, Leticia, Avokpaho, Euripide Frinel G. Arthur, Awasthi, Ashish, Ayala Quintanilla, Beatriz Paulina, Ayalew, Animut Alebel, Ayele, Henok Tadesse, Ayer, Rakesh, Ayuk, Tambe Betrand, Azzopardi, Peter, Azzopardi-Muscat, Natasha, Babalola, Tesleem Kayode, Badali, Hamid, Badawi, Alaa, Banach, Maciej, Banerjee, Amitava, Banstola, Amrit, Barber, Ryan M., Barboza, Miguel A., Barker-Collo, Suzanne L., Bärnighausen, Till, Barquera, Simon, Barrero, Lope H., Bassat, Quique, Basu, Sanjay, Baune, Bernhard T., Bazargan-Hejazi, Shahrzad, Bedi, Neeraj, Beghi, Ettore, Behzadifar, Masoud, Behzadifar, Meysam, Bekele, Bayu Begashaw, Belachew, Abate Bekele, Belay, Saba Abraham, Belay, Yihalem Abebe, Bell, Michelle L., Bello, Aminu K., Bennett, Derrick A., Bennett, James R., Bensenor, Isabela M., Berhe, Derbew Fikadu, Bernabé, Eduardo, Bernstein, Robert Steven, Beuran, Mircea, Bhalla, Ashish, Bhatt, Paurvi, Bhaumik, Soumyadeep, Bhutta, Zulfiqar A., Biadgo, Belete, Bijani, Ali, Bikbov, Bori, Birungi, Charle, Biryukov, Stan, Bizuneh, Hailemichael, Bolliger, Ian W., Bolt, Kaylin, Bou-Orm, Ibrahim R., Bozorgmehr, Kayvan, Brady, Oliver Jerome, Brazinova, Alexandra, Breitborde, Nicholas J.K., Brenner, Hermann, Britton, Gabrielle, Brugha, Traolach S., Butt, Zahid A., Cahuana-Hurtado, Lucero, Campos-Nonato, Ismael Ricardo, Campuzano, Julio Cesar, Car, Josip, Car, Mate, Cárdenas, Rosario, Carrero, Juan Jesu, Carvalho, Felix, Castañeda-Orjuela, Carlos A., Castillo Rivas, Jacqueline, Catalá-López, Ferrán, Cercy, Kelly, Chalek, Julian, Chang, Hsing-Yi, Chang, Jung-Chen, Chattopadhyay, Aparajita, Chaturvedi, Pankaj, Chiang, Peggy Pei-Chia, Chisumpa, Vesper Hichilombwe, Choi, Jee-Young J., Christensen, Hanne, Christopher, Devasahayam Jesuda, Chung, Sheng-Chia, Ciobanu, Liliana G., Cirillo, Massimo, Colombara, Danny, Conti, Sara, Cooper, Cyru, Cornaby, Leslie, Cortesi, Paolo Angelo, Cortinovis, Monica, Costa Pereira, Alexandre, Cousin, Ewerton, Criqui, Michael H., Cromwell, Elizabeth A., Crowe, Christopher Stephen, Crump, John A., Daba, Alemneh Kabeta, Dachew, Berihun Assefa, Dadi, Abel Fekadu, Dandona, Lalit, Dandona, Rakhi, Dargan, Paul I., Daryani, Ahmad, Daryani, Maryam, Das, Jai, Das, Siddharth Kumar, Das Neves, José, Davis Weaver, Nicole, Davletov, Kairat, De Courten, Barbora, De Leo, Diego, De Neve, Jan-Walter, Dellavalle, Robert P., Demoz, Gebre, Deribe, Kebede, Des Jarlais, Don C., Dey, Subhojit, Dharmaratne, Samath D., Dhimal, Meghnath, Djalalinia, Shirin, Doku, David Teye, Dolan, Kate, Dorsey, E. Ray, Dos Santos, Kadine Priscila Bender, Doyle, Kerrie E., Driscoll, Tim R., Dubey, Manisha, Dubljanin, Eleonora, Duncan, Bruce Bartholow, Echko, Michelle, Edessa, Dumessa, Edvardsson, David, Ehrlich, Joshua R., Eldrenkamp, Erika, El-Khatib, Ziad, Endres, Matthia, Endries, Aman Yesuf, Eshrati, Babak, Eskandarieh, Sharareh, Esteghamati, Alireza, Fakhar, Mahdi, Farag, Tamer, Faramarzi, Mahbobeh, Faraon, Emerito Jose Aquino, Faro, André, Farzadfar, Farshad, Fatusi, Adesegun, Fazeli, Mir Sohail, Feigin, Valery L., Feigl, Andrea B., Fentahun, Netsanet, Fereshtehnejad, Seyed-Mohammad, Fernandes, Eduarda, Fernandes, João C., Fijabi, Daniel Obadare, Filip, Irina, Fischer, Florian, Fitzmaurice, Christina, Flaxman, Abraham D., Flor, Luisa Sorio, Foigt, Nataliya, Foreman, Kyle J., Frostad, Joseph J., Fürst, Thoma, Futran, Neal D., Gakidou, Emmanuela, Gallus, Silvano, Gambashidze, Ketevan, Gamkrelidze, Amiran, Ganji, Morsaleh, Gebre, Abadi Kahsu, Gebrehiwot, Tsegaye Tewelde, Gebremedhin, Amanuel Tesfay, Gelaw, Yalemzewod Assefa, Geleijnse, Johanna M., Geremew, Demeke, Gething, Peter W., Ghadimi, Reza, Ghasemi Falavarjani, Khalil, Ghasemi-Kasman, Maryam, Gill, Paramjit Singh, Giref, Ababi Zergaw, Giroud, Maurice, Gishu, Melkamu Dedefo, Giussani, Giorgia, Godwin, William W., Goli, Sriniva, Gomez-Dantes, Hector, Gona, Philimon N., Goodridge, Amador, Gopalani, Sameer Vali, Goryakin, Yevgeniy, Goulart, Alessandra Carvalho, Grada, Ayman, Griswold, Max, Grosso, Giuseppe, Gugnani, Harish Chander, Guo, Yuming, Gupta, Rahul, Gupta, Rajeev, Gupta, Tanush, Gupta, Tarun, Gupta, Vipin, Haagsma, Juanita A., Hachinski, Vladimir, Hafezi-Nejad, Nima, Hailu, Gessessew Bugssa, Hamadeh, Randah Ribhi, Hamidi, Samer, Hankey, Graeme J., Harb, Hilda L., Harewood, Heather C., Harikrishnan, Sivadasanpillai, Haro, Josep Maria, Hassen, Hamid Yimam, Havmoeller, Rasmu, Hawley, Caitlin, Hay, Simon I., He, Jiawei, Hearps, Stephen J.C., Hegazy, Mohamed I., Heibati, Behzad, Heidari, Mohsen, Hendrie, Delia, Henry, Nathaniel J., Herrera Ballesteros, Victor Hugo, Herteliu, Claudiu, Hibstu, Desalegn Tsegaw, Hiluf, Molla Kahssay, Hoek, Hans W., Homaie Rad, Enayatollah, Horita, Nobuyuki, Hosgood, H. Dean, Hosseini, Mostafa, Hosseini, Seyed Reza, Hostiuc, Mihaela, Hostiuc, Sorin, Hoy, Damian G., Hsairi, Mohamed, Htet, Aung Soe, Hu, Guoqing, Huang, John J., Iburg, Kim Moesgaard, Idris, Fachmi, Igumbor, Ehimario Uche, Ikeda, Chad, Ileanu, Bogdan Vasile, Ilesanmi, Olayinka S., Innos, Kaire, Irvani, Seyed Sina Naghibi, Irvine, Caleb M.S., Islami, Farhad, Jacobs, Troy A., Jacobsen, Kathryn H., Jahanmehr, Nader, Jain, Rajesh, Jain, Sudhir Kumar, Jakovljevic, Mihajlo M., Jalu, Moti Tolera, Jamal, Amr A., Javanbakht, Mehdi, Jayatilleke, Achala Upendra, Jeemon, Panniyammakal, Jha, Ravi Prakash, Jha, Vivekanand, Józwiak, Jacek, John, Oommen, Johnson, Sarah Charlotte, Jonas, Jost B., Joshua, Vasna, Jürisson, Mikk, Kabir, Zubair, Kadel, Rajendra, Kahsay, Amaha, Kalani, Rizwan, Kar, Chittaranjan, Karanikolos, Marina, Karch, André, Karema, Corine Kakizi, Karimi, Seyed M., Kasaeian, Amir, Kassa, Dessalegn Haile, Kassa, Getachew Mullu, Kassa, Tesfaye Dessale, Kassebaum, Nicholas J., Katikireddi, Srinivasa Vittal, Kaul, Anil, Kawakami, Norito, Kazanjan, Konstantin, Kebede, Seifu, Keiyoro, Peter Njenga, Kemp, Grant Rodger, Kengne, Andre Pascal, Kereselidze, Maia, Ketema, Ezra Belay, Khader, Yousef Saleh, Khafaie, Morteza Abdullatif, Khajavi, Alireza, Khalil, Ibrahim A., Khan, Ejaz Ahmad, Khan, Gulfaraz, Khan, Md Nuruzzaman, Khan, Muhammad Ali, Khanal, Mukti Nath, Khang, Young-Ho, Khater, Mona M., Khoja, Abdullah Tawfih Abdullah, Khosravi, Ardeshir, Khubchandani, Jagdish, Kibret, Getiye Dejenu, Kiirithio, Daniel Ngari, Kim, Daniel, Kim, Yun Jin, Kimokoti, Ruth W., Kinfu, Yohanne, Kinra, Sanjay, Kisa, Adnan, Kissoon, Niranjan, Kochhar, Sonali, Kokubo, Yoshihiro, Kopec, Jacek A., Kosen, Soewarta, Koul, Parvaiz A., Koyanagi, Ai, Kravchenko, Michael, Krishan, Kewal, Krohn, Kristopher J., Kuate Defo, Barthelemy, Kumar, G. Anil, Kumar, Pushpendra, Kutz, Michael, Kuzin, Igor, Kyu, Hmwe H., Lad, Deepesh Pravinkumar, Lafranconi, Alessandra, Lal, Dharmesh Kumar, Lalloo, Ratilal, Lam, Hilton, Lan, Qing, Lang, Justin J., Lansingh, Van C., Lansky, Sonia, Larsson, Ander, Latifi, Arman, Lazarus, Jeffrey Victor, Leasher, Janet L., Lee, Paul H., Legesse, Yirga, Leigh, Jame, Leshargie, Cheru Tesema, Leta, Samson, Leung, Janni, Leung, Ricky, Levi, Miriam, Li, Yongmei, Liang, Juan, Liben, Misgan Legesse, Lim, Lee-Ling, Lim, Stephen S., Lind, Margaret, Linn, Shai, Listl, Stefan, Liu, Patrick Y., Liu, Shiwei, Lodha, Rakesh, Lopez, Alan D., Lorch, Scott A., Lorkowski, Stefan, Lotufo, Paulo A., Lucas, Timothy C.D., Lunevicius, Raimunda, Lurton, Grégoire, Lyons, Ronan A., Maalouf, Fadi, Macarayan, Erlyn Rachelle King, Mackay, Mark T., Maddison, Emilie R., Madotto, Fabiana, Magdy Abd El Razek, Hassan, Magdy Abd El Razek, Mohammed, Majdan, Marek, Majdzadeh, Reza, Majeed, Azeem, Malekzadeh, Reza, Malhotra, Rajesh, Malta, Deborah Carvalho, Mamun, Abdullah A., Manguerra, Helena, Manhertz, Treh, Mansournia, Mohammad Ali, Mantovani, Lorenzo G., Manyazewal, Tsegahun, Mapoma, Chabila C., Margono, Christopher, Martinez-Raga, Jose, Martins, Sheila Cristina Ourique, Martins-Melo, Francisco Rogerlândio, Martopullo, Ira, März, Winfried, Massenburg, Benjamin Ballard, Mathur, Manu Raj, Maulik, Pallab K., Mazidi, Mohsen, McAlinden, Colm, McGrath, John J., McKee, Martin, Mehata, Suresh, Mehrotra, Ravi, Mehta, Kala M., Mehta, Varshil, Meier, Toni, Mejia-Rodriguez, Fabiola, Meles, Kidanu Gebremariam, Melku, Mulugeta, Memiah, Peter, Memish, Ziad A., Mendoza, Walter, Mengiste, Degu Abate, Mengistu, Desalegn Tadese, Menota, Bereket Gebremichael, Mensah, George A., Meretoja, Atte, Meretoja, Tuomo J., Mezgebe, Haftay Berhane, Miazgowski, Tomasz, Micha, Renata, Milam, Robert, Millear, Anoushka, Miller, Ted R., Mini, G.K., Minnig, Shawn, Mirica, Andreea, Mirrakhimov, Erkin M., Misganaw, Awoke, Mitchell, Philip B., Mlashu, Fitsum Weldegebreal, Moazen, Babak, Mohammad, Karzan Abdulmuhsin, Mohammadibakhsh, Roghayeh, Mohammed, Ebrahim, Mohammed, Mohammed A., Mohammed, Shafiu, Mokdad, Ali H., Mola, Glen Liddell D., Molokhia, Mariam, Momeniha, Fatemeh, Monasta, Lorenzo, Montañez Hernandez, Julio Cesar, Moosazadeh, Mahmood, Moradi-Lakeh, Maziar, Moraga, Paula, Morawska, Lidia, Moreno Velasquez, Ilai, Mori, Rintaro, Morrison, Shane D., Moses, Mark, Mousavi, Seyyed Meysam, Mueller, Ulrich O., Murhekar, Manoj, Murthy, Gudlavalleti Venkata Satyanarayana, Murthy, Sriniva, Musa, Jonah, Musa, Kamarul Imran, Mustafa, Ghulam, Muthupandian, Saravanan, Nagata, Chie, Nagel, Gabriele, Naghavi, Mohsen, Naheed, Aliya, Naik, Gurudatta A., Naik, Nitish, Najafi, Farid, Naldi, Luigi, Nangia, Vinay, Nansseu, Jobert Richie Njingang, Narayan, K.M. Venkat, Nascimento, Bruno Ramo, Negoi, Ionut, Negoi, Ruxandra Irina, Newton, Charles R., Ngunjiri, Josephine Wanjiku, Nguyen, Grant, Nguyen, Long, Nguyen, Trang Huyen, Nichols, Emma, Ningrum, Dina Nur Anggraini, Nolte, Ellen, Nong, Vuong Minh, Norheim, Ole F., Norrving, Bo, Noubiap, Jean Jacques N., Nyandwi, Alypio, Obermeyer, Carla Makhlouf, Ofori-Asenso, Richard, Ogbo, Felix Akpojene, Oh, In-Hwan, Oladimeji, Olanrewaju, Olagunju, Andrew Toyin, Olagunju, Tinuke Oluwasefunmi, Olivares, Pedro R., De Oliveira, Patricia Pereira Vasconcelo, Olsen, Helen E., Olusanya, Bolajoko Olubukunola, Olusanya, Jacob Olusegun, Ong, Kanyin, Opio, John Nelson, Oren, Eyal, Ortega-Altamirano, Doris V., Ortiz, Alberto, Ozdemir, Raziye, Pa, Mahesh, Pain, Amanda W., Palone, Marcos Roberto Tovani, Pana, Adrian, Panda-Jonas, Songhomitra, Pandian, Jeyaraj D., Park, Eun-Kee, Parsian, Hadi, Patel, Teja, Pati, Sanghamitra, Patil, Snehal T., Patle, Ajay, Patton, George C., Paturi, Vishnupriya Rao, Paudel, Deepak, De Moares Pedroso, Marcel, Pedroza, Sandra P., Pereira, David M., Perico, Norberto, Peterson, Hannah, Petzold, Max, Peykari, Niloofar, Phillips, Michael Robert, Piel, Frédéric B., Pigott, David M., Pillay, Julian David, Piradov, Michael A., Polinder, Suzanne, Pond, Constance D., Postma, Maarten J., Pourmalek, Farshad, Prakash, Swayam, Prakash, V., Prasad, Narayan, Prasad, Noela Marie, Purcell, Caroline, Qorbani, Mostafa, Quintana, Hedley Knewjen, Radfar, Amir, Rafay, Anwar, Rafiei, Alireza, Rahimi, Kazem, Rahimi-Movaghar, Afarin, Rahimi-Movaghar, Vafa, Rahman, Mahfuzar, Rahman, Muhammad Aziz, Rahman, Sajjad Ur, Rai, Rajesh Kumar, Raju, Sree Bhushan, Ram, Usha, Rana, Saleem M., Rankin, Zane, Rasella, Davide, Rawaf, David Laith, Rawaf, Salman, Ray, Sarah E., Razo-García, Christian Aspacia, Reddy, Priscilla, Reiner, Robert C., Reis, Cesar, Reitsma, Marissa B., Remuzzi, Giuseppe, Renzaho, Andre M.N., Resnikoff, Serge, Rezaei, Satar, Rezai, Mohammad Sadegh, Ribeiro, Antonio L., Rios Blancas, Maria Jesu, Rivera, Juan A., Roever, Leonardo, Ronfani, Luca, Roshandel, Gholamreza, Rostami, Ali, Roth, Gregory A., Rothenbacher, Dietrich, Roy, Ambuj, Roy, Nobhojit, Ruhago, George Mugambage, Sabde, Yogesh Damodar, Sachdev, Perminder S., Sadat, Nafi, Safdarian, Mahdi, Safiri, Saeid, Sagar, Rajesh, Sahebkar, Amirhossein, Sahraian, Mohammad Ali, Sajadi, Haniye Sadat, Salama, Joseph, Salamati, Payman, De Freitas Saldanha, Raphael, Salimzadeh, Hamideh, Salomon, Joshua A., Samy, Abdallah M., Sanabria, Juan Ramon, Sancheti, Parag K., Sanchez-Niño, Maria Dolore, Santomauro, Damian, Santos, Itamar S., Santric Milicevic, Milena M., Sarker, Abdur Razzaque, Sarrafzadegan, Nizal, Sartorius, Benn, Satpathy, Maheswar, Savic, Miloje, Sawhney, Monika, Saxena, Sonia, Saylan, Mete I., Schaeffner, Elke, Schmidhuber, Josef, Schmidt, Maria Inê, Schneider, Ione J.C., Schumacher, Austin E., Schutte, Aletta E., Schwebel, David C., Schwendicke, Falk, Sekerija, Mario, Sepanlou, Sadaf G., Servan-Mori, Edson E., Shafieesabet, Azadeh, Shaikh, Masood Ali, Shakh-Nazarova, Marina, Shams-Beyranvand, Mehran, Sharafi, Heidar, Sharif-Alhoseini, Mahdi, Shariful Islam, Sheikh Mohammed, Sharma, Meenakshi, Sharma, Rajesh, She, Jun, Sheikh, Aziz, Shfare, Mebrahtu Teweldemedhin, Shi, Peilin, Shields, Chloe, Shigematsu, Mika, Shinohara, Yukito, Shiri, Rahman, Shirkoohi, Reza, Shiue, Ivy, Shrime, Mark G., Shukla, Sharvari Rahul, Siabani, Soraya, Sigfusdottir, Inga Dora, Silberberg, Donald H., Silva, Diego Augusto Santo, Silva, João Pedro, Silveira, Dayane Gabriele Alve, Singh, Jasvinder A., Singh, Lavanya, Singh, Narinder Pal, Singh, Virendra, Sinha, Dhirendra Narain, Sinke, Abiy Hiruye, Sisay, Mekonnen, Skirbekk, Vegard, Sliwa, Karen, Smith, Alison, Soares Filho, Adauto Martin, Sobaih, Badr H.A., Somai, Melek, Soneji, Samir, Soofi, Moslem, Sorensen, Reed J.D., Soriano, Joan B., Soyiri, Ireneous N., Sposato, Luciano A., Sreeramareddy, Chandrashekhar T., Srinivasan, Vinay, Stanaway, Jeffrey D., Stathopoulou, Vasiliki, Steel, Nichola, Stein, Dan J., Stokes, Mark Andrew, Sturua, Lela, Sufiyan, Muawiyyah Babale, Suliankatchi, Rizwan Abdulkader, Sunguya, Bruno F., Sur, Patrick J., Sykes, Bryan L., Sylaja, P.N., Szoeke, Cassandra E.I., Tabarés-Seisdedos, Rafael, Tadakamadla, Santosh Kumar, Tadesse, Andualem Henok, Taffere, Getachew Redae, Tandon, Nikhil, Tariku, Amare Tariku, Taveira, Nuno, Tehrani-Banihashemi, Arash, Temam Shifa, Girma, Temsah, Mohamad-Hani, Terkawi, Abdullah Sulieman, Tesema, Azeb Gebresilassie, Tesfaye, Dawit Jember, Tessema, Belay, Thakur, J.S., Thomas, Nihal, Thompson, Matthew J., Tillmann, Taavi, To, Quyen G., Tobe-Gai, Ruoyan, Tonelli, Marcello, Topor-Madry, Roman, Topouzis, Foti, Torre, Anna, Tortajada, Miguel, Tran, Bach Xuan, Tran, Khanh Bao, Tripathi, Avnish, Tripathy, Srikanth Prasad, Troeger, Christopher, Truelsen, Thoma, Tsoi, Derrick, Tudor Car, Lorainne, Tuem, Kald Beshir, Tyrovolas, Stefano, Uchendu, Uche S., Ukwaja, Kingsley Nnanna, Ullah, Irfan, Updike, Rachel, Uthman, Olalekan A., Uzochukwu, Benjamin S. Chudi, Valdez, Pascual Rubén, Van Boven, Job F.M., Varughese, Santosh, Vasankari, Tommi, Venketasubramanian, Narayanaswamy, Violante, Francesco S., Vladimirov, Sergey K., Vlassov, Vasiliy Victorovich, Vollset, Stein Emil, Vos, Theo, Wagnew, Fasil, Waheed, Yasir, Wallin, Mitchell T., Walson, Judd L., Wang, Yafeng, Wang, Yuan-Pang, Wassie, Molla Mesele, Weaver, Marcia R., Weiderpass, Elisabete, Weintraub, Robert G., Weiss, Jordan, Weldegwergs, Kidu Gidey, Werdecker, Andrea, West, T. Eoin, Westerman, Ronny, White, Richard G., Whiteford, Harvey A., Widecka, Justyna, Winkler, Andrea Sylvia, Wiysonge, Charles Shey, Wolfe, Charles D.A., Wondimkun, Yohanes Ayele, Workicho, Abdulhalik, Wyper, Grant M.A., Xavier, Deni, Xu, Gelin, Yan, Lijing L., Yano, Yuichiro, Yaseri, Mehdi, Yimer, Nigus Bililign, Yin, Peng, Yip, Paul, Yirsaw, Biruck Desalegn, Yonemoto, Naohiro, Yonga, Gerald, Yoon, Seok-Jun, Yotebieng, Marcel, Younis, Mustafa Z., Yu, Chuanhua, Zadnik, Vesna, Zaidi, Zoubida, El Sayed Zaki, Maysaa, Zaman, Sojib Bin, Zamani, Mohammad, Zenebe, Zerihun Menlkalew, Zhou, Maigeng, Zhu, Jun, Zimsen, Stephanie R.M., Zipkin, Ben, Zodpey, Sanjay, Zuhlke, Liesl Joanna, Murray, Christopher J.L., Lozano, Rafael, Viðskiptadeild (HR), School of Business (RU), Háskólinn í Reykjavík, Reykjavik University, Abay, Sm, Abebo, Ta, Abraha, Hn, Abreu, Dmx, Abu-Raddad, Lj, Adane, Aa, Adedoyin, Ra, Adhikari, Tb, Aichour, Mte, Akinyemi, Ro, Akinyemiju, Tf, Al Lami, Fh, Albittar, Mi, Alene, Ka, Ali, Sd, Aljunid, Sm, Alomari, Ma, Altirkawi, Ka, Amare, At, Amoako, Ya, Andrei, Cl, Antonio, Cat, Araújo, Vem, Aryal, Kk, Asfaw, Et, Asgedom, Sw, Asghar, Rj, Ashebir, Mm, Asseffa, Na, Atey, Tm, Atre, Sr, Avokpaho, Efga, Ayala Quintanilla, Bp, Ayalew, Aa, Ayele, Ht, Ayuk, Tb, Babalola, Tk, Barber, Rm, Barboza, Ma, Barker-Collo, Sl, Barrero, Lh, Baune, Bt, Bekele, Bb, Belachew, Ab, Belay, Sa, Belay, Ya, Bell, Ml, Bello, Ak, Bennett, Da, Bennett, Jr, Bensenor, Im, Berhe, Df, Bhutta, Za, Bolliger, Iw, Bou-Orm, Ir, Brady, Oj, Breitborde, Njk, Butt, Za, Campos-Nonato, Ir, Campuzano, Jc, Carrero, Jj, Castañeda-Orjuela, Ca, Chang, Hy, Chang, Jc, Chiang, Pp, Chisumpa, Vh, Choi, Jj, Christopher, Dj, Chung, Sc, Ciobanu, Lg, Cortesi, Pa, Criqui, Mh, Cromwell, Ea, Crump, Ja, Daba, Ak, Dachew, Ba, Dadi, Af, Dargan, Pi, Das, Sk, De Neve, Jw, Dellavalle, Rp, Des Jarlais, Dc, Dharmaratne, Sd, Doku, Dt, Dorsey, Er, Dos Santos, Kpb, Doyle, Ke, Driscoll, Tr, Duncan, Bb, Ehrlich, Jr, El-Khatib, Zz, Endries, Ay, Faraon, Eja, Feigin, Vl, Feigl, Ab, Fereshtehnejad, Sm, Fernandes, Jc, Fijabi, Do, Flaxman, Ad, Foreman, Kj, Frostad, Jj, Futran, Nd, Gebre, Ak, Gebrehiwot, Tt, Gebremedhin, At, Gelaw, Ya, Geleijnse, Jm, Gething, Pw, Giref, Az, Gishu, Md, Godwin, Ww, Gona, Pn, Gopalani, Sv, Goulart, Ac, Gugnani, Hc, Haagsma, Ja, Hailu, Gb, Hamadeh, Rr, Hankey, Gj, Harb, Hl, Harewood, Hc, Haro, Jm, Hassen, Hy, Hay, Si, Hearps, Sjc, Hegazy, Mi, Henry, Nj, Herrera Ballesteros, Vh, Hibstu, Dt, Hiluf, Mk, Hoek, Hw, Hosgood, Hd, Hosseini, Sr, Hoy, Dg, Huang, Jj, Iburg, Km, Igumbor, Eu, Ileanu, Bv, Irvani, Ssn, Irvine, Cm, Jacobs, Ta, Jacobsen, Kh, Jain, Sk, Jakovljevic, Mb, Jalu, Mt, Jamal, Aa, Jayatilleke, Au, Jha, Rp, Johnson, Sc, Jonas, Jb, Karema, Ck, Karimi, Sm, Kassa, Dh, Kassa, Gm, Kassa, Td, Kassebaum, Nj, Katikireddi, Sv, Keiyoro, Pn, Kemp, Gr, Kengne, Ap, Ketema, Eb, Khafaie, Ma, Khalil, Ia, Khan, Ea, Khan, Mn, Khan, Ma, Khanal, Mn, Khang, Yh, Khater, Mm, Khoja, Ata, Kibret, Gd, Kiirithio, Dn, Kim, Yj, Kimokoti, Rw, Kopec, Ja, Koul, Pa, Krohn, Kj, Kumar, Ga, Kyu, Hh, Lad, Dp, Lal, Dk, Lang, Jj, Lansingh, Vc, Lazarus, Jv, Leasher, Jl, Lee, Ph, Leshargie, Ct, Liben, Ml, Lim, Ll, Lopez, Ad, Lorch, Sa, Lotufo, Pa, Lucas, Tcd, Lyons, Ra, Macarayan, Erk, Mackay, Mt, Maddison, Er, Malta, Dc, Mamun, Aa, Mansournia, Ma, Mantovani, Lg, Mapoma, Cc, Martins, Sco, Martins-Melo, Fr, Massenburg, Bb, Mathur, Mr, Maulik, Pk, Mcgrath, Jj, Mehta, Km, Meles, Kg, Memish, Za, Mengiste, Da, Mengistu, Dt, Menota, Bg, Mensah, Ga, Meretoja, Tj, Mezgebe, Hb, Miller, Tr, Mini, Gk, Mirrakhimov, Em, Mitchell, Pb, Mlashu, Fw, Mohammad, Ka, Mohammed, Ma, Mokdad, Ah, Mola, Gl, Montañez Hernandez, Jc, Morrison, Sd, Mousavi, Sm, Mueller, Uo, Murthy, Gv, Musa, Ki, Naik, Ga, Nansseu, Jrn, Narayan, Kv, Nascimento, Br, Negoi, Ri, Newton, Cr, Ngunjiri, Jw, Nguyen, Th, Ningrum, Dna, Nong, Vm, Norheim, Of, Noubiap, Jjn, Obermeyer, Cm, Ogbo, Fa, Oh, Ih, Olagunju, At, Olagunju, To, Olivares, Pr, Oliveira, Ppv, Olsen, He, Olusanya, Bo, Olusanya, Jo, Opio, Jn, Ortega-Altamirano, Dv, Pain, Aw, Palone, Mrt, Pandian, Jd, Park, Ek, Patil, St, Patton, Gc, Paturi, Vr, Pedroso, Mm, Pedroza, Sp, Pereira, Dm, Phillips, Mr, Piel, Fb, Pigott, Dm, Pillay, Jd, Piradov, Ma, Pond, Cd, Postma, Mj, Prasad, Nm, Quintana, Hk, Rahman, Ma, Rahman, Su, Rai, Rk, Raju, Sb, Rana, Sm, Rawaf, Dl, Ray, Se, Razo-García, Ca, Reiner, Rc, Reitsma, Mb, Renzaho, Amn, Ribeiro, Al, Rios Blancas, Mj, Rivera, Ja, Roth, Ga, Ruhago, Gm, Sabde, Yd, Sahraian, Ma, Saldanha, Rf, Salomon, Ja, Samy, Am, Sanabria, Jr, Sancheti, Pk, Sanchez-Niño, Md, Santric Milicevic, Mm, Sarker, Ar, Saylan, Mi, Schmidt, Mi, Schneider, Ijc, Schumacher, Ae, Schutte, Ae, Schwebel, Dc, Sepanlou, Sg, Servan-Mori, Ee, Shaikh, Ma, Shariful Islam, Sm, Shfare, Mt, Shrime, Mg, Shukla, Sr, Sigfusdottir, Id, Silberberg, Dh, Silva, Da, Silva, Jp, Silveira, Dga, Singh, Ja, Singh, Np, Sinha, Dn, Sinke, Ah, Soares Filho, Am, Sobaih, Bha, Sorensen, Rjd, Soriano, Jb, Soyiri, In, Sposato, La, Sreeramareddy, Ct, Stanaway, Jd, Stein, Dj, Stokes, Ma, Sufiyan, Mb, Suliankatchi, Ra, Sunguya, Bf, Sur, Pj, Sykes, Bl, Sylaja, Pn, Tadakamadla, Sk, Tadesse, Ah, Taffere, Gr, Tariku, At, Temsah, Mh, Tesema, Ag, Tesfaye, Dj, Thompson, Mj, To, Qg, Tran, Bx, Tran, Kb, Tripathy, Sp, Tuem, Kb, Ukwaja, Kn, Uthman, Oa, Uzochukwu, Bsc, Valdez, Pr, van Boven, Jfm, Vladimirov, Sk, Vlassov, Vv, Vollset, Se, Wallin, Mt, Walson, Jl, Wang, Yp, Wassie, Mm, Weaver, Mr, Weintraub, Rg, Weldegwergs, Kg, West, Te, White, Rg, Whiteford, Ha, Wolfe, Cd, Wondimkun, Ya, Wyper, Gma, Yan, Ll, Yimer, Nb, Yirsaw, Bd, Yoon, Sj, Younis, Mz, Zaki, Me, Zaman, Sb, Zenebe, Zm, Zimsen, Srm, Zuhlke, Lj, Murray, Cjl, and Lozano, R.
Subjects: Peformance, Coverage, Dánartíðni, Lífslíkur, Life expectancy, GBD, Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0–100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best), universal health coverage, Article, access quality health care, health care access and quality index, Nations, Healthcare Acce, Cause-specific mortality, Psychology, Healthcare Access and Quality Index, Mælitæki, States, Medicine (all), Health care, Þjóðir, Public Health, Global Health, Social Medicine and Epidemiology, Quality, Heilbrigðisþjónusta, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, Sálfræði, Indicator, Amenable mortality, Transition, we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0–100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97·1 (95% UI 95·8–98·1) in Iceland, followed by 96·6 (94·9–97·9) in Norway and 96·1 (94·5–97·3) in the Netherlands, to values as low as 18·6 (13·1–24·4) in the Central African Republic, 19·0 (14·3–23·7) in Somalia, and 23·4 (20·2–26·8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91·5 (89·1–93·6) in Beijing to 48·0 (43·4–53·2) in Tibet (a 43·5-point difference), while India saw a 30·8-point disparity, from 64·8 (59·6–68·8) in Goa to 34·0 (30·3–38·1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4·8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20·9-point to 17·0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17·2-point to 20·4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage hinges upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view—and subsequent provision—of quality health care for all populations, Trends, Inequalities
Abstract: Background A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthcare Access and Quality (HAQ) Index for 195 countries and territories, as well as subnational locations in seven countries, from 1990 to 2016. Methods Drawing from established methods and updated estimates from GBD 2016, we used 32 causes from which death should not occur in the presence of effective care to approximate personal health-care access and quality by location and over time. To better isolate potential effects of personal health-care access and quality from underlying risk factor patterns, we risk-standardised cause-specific deaths due to non-cancers by location-year, replacing the local joint exposure of environmental and behavioural risks with the global level of exposure. Supported by the expansion of cancer registry data in GBD 2016, we used mortality-to-incidence ratios for cancers instead of risk-standardised death rates to provide a stronger signal of the effects of personal health care and access on cancer survival. We transformed each cause to a scale of 0-100, with 0 as the first percentile (worst) observed between 1990 and 2016, and 100 as the 99th percentile (best); we set these thresholds at the country level, and then applied them to subnational locations. We applied a principal components analysis to construct the HAQ Index using all scaled cause values, providing an overall score of 0-100 of personal health-care access and quality by location over time. We then compared HAQ Index levels and trends by quintiles on the Socio-demographic Index (SDI), a summary measure of overall development. As derived from the broader GBD study and other data sources, we examined relationships between national HAQ Index scores and potential correlates of performance, such as total health spending per capita. Findings In 2016, HAQ Index performance spanned from a high of 97.1 (95% UI 95.8-98.1) in Iceland, followed by 96.6 (94.9-97.9) in Norway and 96.1 (94.5-97.3) in the Netherlands, to values as low as 18.6 (13.1-24.4) in the Central African Republic, 19.0 (14.3-23.7) in Somalia, and 23.4 (20.2-26.8) in Guinea-Bissau. The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between 1990 and 2000. Striking subnational disparities emerged in personal health-care access and quality, with China and India having particularly large gaps between locations with the highest and lowest scores in 2016. In China, performance ranged from 91.5 (89.1-936) in Beijing to 48.0 (43.4-53.2) in Tibet (a 43.5-point difference), while India saw a 30.8-point disparity, from 64.8 (59.6-68.8) in Goa to 34.0 (30.3-38.1) in Assam. Japan recorded the smallest range in subnational HAQ performance in 2016 (a 4.8-point difference), whereas differences between subnational locations with the highest and lowest HAQ Index values were more than two times as high for the USA and three times as high for England. State-level gaps in the HAQ Index in Mexico somewhat narrowed from 1990 to 2016 (from a 20.9-point to 17.0-point difference), whereas in Brazil, disparities slightly increased across states during this time (a 17.2-point to 20.4-point difference). Performance on the HAQ Index showed strong linkages to overall development, with high and high-middle SDI countries generally having higher scores and faster gains for non-communicable diseases. Nonetheless, countries across the development spectrum saw substantial gains in some key health service areas from 2000 to 2016, most notably vaccine-preventable diseases. Overall, national performance on the HAQ Index was positively associated with higher levels of total health spending per capita, as well as health systems inputs, but these relationships were quite heterogeneous, particularly among low-to-middle SDI countries. Interpretation GBD 2016 provides a more detailed understanding of past success and current challenges in improving personal health-care access and quality worldwide. Despite substantial gains since 2000, many low-SDI and middle-SDI countries face considerable challenges unless heightened policy action and investments focus on advancing access to and quality of health care across key health services, especially non-communicable diseases. Stagnating or minimal improvements experienced by several low-middle to high-middle SDI countries could reflect the complexities of re-orienting both primary and secondary health-care services beyond the more limited foci of the Millennium Development Goals. Alongside initiatives to strengthen public health programmes, the pursuit of universal health coverage upon improving both access and quality worldwide, and thus requires adopting a more comprehensive view and subsequent provision of quality health care for all populations., Bill & Melinda Gates Foundation. Barbora de Courten is supported by a National Heart Foundation Future Leader Fellowship (100864). Ai Koyanagi’s work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII —General Branch Evaluation and Promotion of Health Research—and the European Regional Development Fund (ERDF-FEDER). Alberto Ortiz was supported by Spanish Government (Instituto de Salud Carlos III RETIC REDINREN RD16/0019 FEDER funds). Ashish Awasthi acknowledges funding support from Department of Science and Technology, Government of India through INSPIRE Faculty scheme Boris Bikbov has received funding from the European Union’s Horizon 2020 research and innovation programme under Marie Sklodowska-Curie grant agreement No. 703226. Boris Bikbov acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group. Panniyammakal Jeemon acknowledges support from the clinical and public health intermediate fellowship from the Wellcome Trust and Department of Biotechnology, India Alliance (2015–20). Job F M van Boven was supported by the Department of Clinical Pharmacy & Pharmacology of the University Medical Center Groningen, University of Groningen, Netherlands. Olanrewaju Oladimeji is an African Research Fellow hosted by Human Sciences Research Council (HSRC), South Africa and he also has honorary affiliations with Walter Sisulu University (WSU), Eastern Cape, South Africa and School of Public Health, University of Namibia (UNAM), Namibia. He is indeed grateful for support from HSRC, WSU and UNAM. EUI is supported in part by the South African National Research Foundation (NRF UID: 86003). Ulrich Mueller acknowledges funding by the German National Cohort Study grant No 01ER1511/D, Gabrielle B Britton is supported by Secretaría Nacional de Ciencia, Tecnología e Innovación and Sistema Nacional de Investigación de Panamá. Giuseppe Remuzzi acknowledges that the work related to this paper has been done on behalf of the GBD Genitourinary Disease Expert Group. Behzad Heibati would like to acknowledge Air pollution Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. Syed Aljunid acknowledges the National University of Malaysia for providing the approval to participate in this GBD Project. Azeem Majeed and Imperial College London are grateful for support from the Northwest London National Insititute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care. Tambe Ayuk acknowledges the Institute of Medical Research and Medicinal Plant Studies for office space provided. José das Neves was supported in his contribution to this work by a Fellowship from Fundação para a Ciência e a Tecnologia, Portugal (SFRH/BPD/92934/2013). João Fernandes gratefully acknowledges funding from FCT–Fundação para a Ciência e a Tecnologia (grant number UID/Multi/50016/2013). Jan-Walter De Neve was supported by the Alexander von Humboldt Foundation. Kebede Deribe is funded by a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (201900). Kazem Rahimi was supported by grants from the Oxford Martin School, the NIHR Oxford BRC and the RCUK Global Challenges Research Fund. Laith J Abu-Raddad acknowledges the support of Qatar National Research Fund (NPRP 9-040-3-008) who provided the main funding for generating the data provided to the GBD-IHME effort. Liesl Zuhlke is funded by the national research foundation of South Africa and the Medical Research Council of South Africa. Monica Cortinovis acknowledges that work related to this paper has been done on the behalf of the GBD Genitourinary Disease Expert Group. Chuanhua Yu acknowleges support from the National Natural Science Foundation of China (grant number 81773552 and grant number 81273179) Norberto Perico acknowledges that work related to this paper has been done on behalf of the GBD Genitourinary Disease Expert Group. Charles Shey Wiysonge’s work is supported by the South African Medical Research Council and the National Research Foundation of South Africa (grant numbers 106035 and 108571). John J McGrath is supported by grant APP1056929 from the John Cade Fellowship from the National Health and Medical Research Council and the Danish National Research Foundation (Niels Bohr Professorship). Quique Bassat is an ICREA (Catalan Institution for Research and Advanced Studies) research professor at ISGlobal. Richard G White is funded by the UK MRC and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement that is also part of the EDCTP2 programme supported by the European Union (MR/P002404/1), the Bill & Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276/OPP1135288, CORTIS: OPP1137034/OPP1151915, Vaccines: OPP1160830), and UNITAID (4214-LSHTM-Sept15; PO 8477-0-600). Rafael Tabarés-Seisdedos was supported in part by grant number PROMETEOII/2015/021 from Generalitat Valenciana and the national grant PI17/00719 from ISCIII-FEDER. Mihajlo Jakovljevic acknowleges contribution from the Serbian Ministry of Education Science and Technological Development of the Republic of Serbia (grant OI 175 014). Shariful Islam is funded by a Senior Fellowship from Institute for Physical Activity and Nutrition, Deakin University and received career transition grants from High Blood Pressure Research Council of Australia. Sonia Saxena is funded by various grants from the NIHR. Stefanos Tyrovolas was supported by the Foundation for Education and European Culture, the Sara Borrell postdoctoral program (reference number CD15/00019 from the Instituto de Salud Carlos III (ISCIII–Spain) and the Fondos Europeo de Desarrollo Regional. Stefanos was awarded with a 6 months visiting fellowship funding at IHME from M-AES (reference no. MV16/00035 from the Instituto de Salud Carlos III). S Vittal Katikreddi was funded by a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the MRC (MC_UU_12017/13 & MC_ UU_12017/15) and the Scottish Government Chief Scientist Office (SPHSU13 & SPHSU15). Traolach S Brugha has received funding from NHS Digital UK to collect data used in this study. The work of Hamid Badali was financially supported by Mazandaran University of Medical Sciences, Sari, Iran. The work of Stefan Lorkowski is funded by the German Federal Ministry of Education and Research (nutriCARD, Grant agreement number 01EA1411A). Mariam Molokhia’s research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. We also thank the countless individuals who have contributed to GBD 2016 in various capacities.
Published: 2018

41. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE) : an international, randomised, placebo-controlled trial

Author: P J Devereaux, Emmanuelle Duceppe, Gordon Guyatt, Vikas Tandon, Reitze Rodseth, Bruce M Biccard, Denis Xavier, Wojciech Szczeklik, Christian S Meyhoff, Jessica Vincent, Maria Grazia Franzosi, Sadeesh K Srinathan, Jason Erb, Patrick Magloire, John Neary, Mangala Rao, Prashant V Rahate, Navneet K Chaudhry, Bongani Mayosi, Miriam de Nadal, Pilar Paniagua Iglesias, Otavio Berwanger, Juan Carlos Villar, Fernando Botto, John W Eikelboom, Daniel I Sessler, Clive Kearon, Shirley Pettit, Mukul Sharma, Stuart J Connolly, Shrikant I Bangdiwala, Purnima Rao-Melacini, Andreas Hoeft, Salim Yusuf, P.J. Devereaux, Shrikant I. Bangdiwala, Stuart Connolly, John Eikelboom, Janice Pogue, Daniel I. Sessler, Sara Di Diodato, Zora Gasic, Louise J. Mastrangelo, Sarah H. Molnar, Jennifer L. Swanson, Makayla L. Tosh, Jennifer R. Wells, Rafael Diaz, Clara K. Chow, Beatriz Gonzales, Skarlet Vásquez, Petr Jansky, Radovan Dušek, Christian S. Meyhoff, Pierre Coriat, Maria Wittmann, Gerald Yonga, Nandini Mathur, Elena Seletti, German Malaga, Bernadette A. Tumanan-Mendoza, Maria Pamela A. Tagle, Bruce M. Biccard, Pablo Alonso-Coello, Ekaterine Popova, Martin Shields, Yannick Le Manach, Paul Moayyedi, Sander van Zanten, Edith Fleischmann, Amit Garg, Kamilu Karaye, Edward McFalls, Alben Sigamani, Emilie Belley-Côté, Grzegorz Biedroń, Flavia Borges, Steffan Frosi Stella, Christian Haarmark Nielsen, Darryl P. Leong, Jessica Spence, Allen Tran, Katarzyna Wawrzycka-Adamczyk, Stephen S. Yang, Terence Yung, D. George Wyse, Davy Cheng, David E. Johnstone, George A. Wells, Philip Joseph, Ameen Patel, Krysten Gregus, Kelly Lawrence, Lindsay Doharris, David Conen, Jason Cheung, Jim Douketis, Douglas Wright, Spencer Wikkerink, William Dechert, Mohamed Panju, Khalid Azzam, Theodore Rapanos, Tomas Van Helder, Anjali Shroff, Jacqueline Hare, Biniam Kidane, Thang Nguyen, Larissa Leydier, Vanessa Bayaraa, Joel Parlow, Deborah A. DuMerton, Amar Thakrar, Jessica Shelley, Benoit Deligne, Roberta Daila Carling, Marko Mrkobrada, George K. Dresser, Michael J. Jacka, David Hornstein, Gerrit B. Winkelaar, Zoeb Hussain Haider, Pravina Prashant Lanjewar, Valsamma Varughese, Rajneesh Calton, Hemani Ahuja, Preetha George, Ambika Sharma, Keyur Sureshchandra Bhatt, Dhaval Odhavajibhai Mangukiya, Karshan Vira Nandaniya, Viral Vasantrai Parekh, Ashok Bhaskaran Pillai, Vidya P. Menon, Sanjay Channappa Desai, Ravinder Singh Sidhu, Sandeep Kumar Gupta, Robbie K. George, T.R. Gurunath, Leanne W. Drummond, Alexandra M. Torborg, Belinda S. Küsel, Prebashini Naidoo, Datshana P. Naidoo, Chantal Rajah, Zane Farina, Richard Peter von Rahden, Simphiwe Gumede, Chishala Chishala, Ettienne Coetzee, Robert A. Dyer, Johan Diedericks, Piotr Bielański, Bogusz Kaczmarek, Dorota Studzińska, Maciej Zaniewski, Marek Józef Libura, Tomasz Mikołaj Zacharias-Nalichowski, Aurelia A.S. Sega, Jakub Salwa, Mateusz Kózka, Jacek Górka, Anna Wludarczyk, Ilona Nowak-Kózka, Paweł Szczepan Grudzień, Jaroslaw W. Gucwa, Michał Piotr Słowiaczek, Paweł P.D. Dobosz, Ismail Gögenur, Jens Ravn Eriksen, Tine Borup, Tove Kirkegaard, Dan Isbye, Asger Sonne, Lars S. Rasmussen, Sofie Pedersen, Hannibal Troensegaard, Camilla L. Duus, Benedikte M. Halle, Ossian N. Gundel, Katrine F. Bernholm, Kristian Rønsholt Martinsen, Søren Pedersen, Theis S. Itenov, Elena Camio, Carles Vázquez, Silvia Matarin, Esther Cano, Jesús Álvarez-García, Inmaculada India, Aránzazu González-Osuna, Marc Vives, Elena Rosselló, Ana B. Serrano, Maurizio Turiel, Lorenzo Drago, Chiara Colombo, Federica Marra, Lucio Mos, Franco Arteni, Rosalba Lembo, Alessandro Ortalda, Simonetta Passarani, Zhirajr Mokini, Estevao Lanna Figueiredo, Gustavo Fonseca Werner, Joao Luiz Petriz, Lilia Nigro Maia, Ricardo R. Bergo, Dalton Bertolim Precoma, José Francisco Kerr Saraiva, Oscar Gomez Vilamajo, Eduardo Allegrini, Mariano Benzadón, Maria Leonor Parody, Ernesto A. Duronto, Adrián C. Ingaramo, Gustavo Adolfo Parra, Danny Novoa, Scott A. Miller, Sabu Thomas, Sudhakar P. Karlapudi, Mohamad H. Bourji, Subhash Banerjee, Anita Gupta, Isaac O. Opole, Michal Fischer, Victor Lecaros Mendoza, Eugenio Borja Reyes, Richard J. Pierson, Martin O. Shields, Vincent Piriou, Kai Zacharowski, Aida Rotta-Rotta, Main Paper, Sadeesh K. Srinathan, Prashant Rahate, Navneet Chaudhry, Bogani Mayosi, and Mike Sharma
Subjects: Male, medicine.medical_specialty, Myocardial Infarction, Placebo-controlled study, Hemorrhage, 030204 cardiovascular system & hematology, Placebo, Antithrombins, Dabigatran, law.invention, Peripheral Arterial Disease, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, 030202 anesthesiology, law, Internal medicine, medicine, Humans, Perioperative Period, Stroke, Aged, Aged, 80 and over, business.industry, Hazard ratio, Proton Pump Inhibitors, Thrombosis, Venous Thromboembolism, General Medicine, Perioperative, Placebo Effect, medicine.disease, Troponin, Clinical trial, Treatment Outcome, Female, business, Omeprazole, medicine.drug
Abstract: Summary Background Myocardial injury after non-cardiac surgery (MINS) increases the risk of cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran prevents perioperative venous thromboembolism, but whether this drug can prevent a broader range of vascular complications in patients with MINS is unknown. The MANAGE trial assessed the potential of dabigatran to prevent major vascular complications among such patients. Methods In this international, randomised, placebo-controlled trial, we recruited patients from 84 hospitals in 19 countries. Eligible patients were aged at least 45 years, had undergone non-cardiac surgery, and were within 35 days of MINS. Patients were randomly assigned (1:1) to receive dabigatran 110 mg orally twice daily or matched placebo for a maximum of 2 years or until termination of the trial and, using a partial 2-by-2 factorial design, patients not taking a proton-pump inhibitor were also randomly assigned (1:1) to omeprazole 20 mg once daily, for which results will be reported elsewhere, or matched placebo to measure its effect on major upper gastrointestinal complications. Research personnel randomised patients through a central 24 h computerised randomisation system using block randomisation, stratified by centre. Patients, health-care providers, data collectors, and outcome adjudicators were masked to treatment allocation. The primary efficacy outcome was the occurrence of a major vascular complication, a composite of vascular mortality and non-fatal myocardial infarction, non-haemorrhagic stroke, peripheral arterial thrombosis, amputation, and symptomatic venous thromboembolism. The primary safety outcome was a composite of life-threatening, major, and critical organ bleeding. Analyses were done according to the intention-to-treat principle. This trial is registered with ClinicalTrials.gov, number NCT01661101. Findings Between Jan 10, 2013, and July 17, 2017, we randomly assigned 1754 patients to receive dabigatran (n=877) or placebo (n=877); 556 patients were also randomised in the omeprazole partial factorial component. Study drug was permanently discontinued in 401 (46%) of 877 patients allocated to dabigatran and 380 (43%) of 877 patients allocated to placebo. The composite primary efficacy outcome occurred in fewer patients randomised to dabigatran than placebo (97 [11%] of 877 patients assigned to dabigatran vs 133 [15%] of 877 patients assigned to placebo; hazard ratio [HR] 0·72, 95% CI 0·55–0·93; p=0·0115). The primary safety composite outcome occurred in 29 patients (3%) randomised to dabigatran and 31 patients (4%) randomised to placebo (HR 0·92, 95% CI 0·55–1·53; p=0·76). Interpretation Among patients who had MINS, dabigatran 110 mg twice daily lowered the risk of major vascular complications, with no significant increase in major bleeding. Patients with MINS have a poor prognosis; dabigatran 110 mg twice daily has the potential to help many of the 8 million adults globally who have MINS to reduce their risk of a major vascular complication. Funding Boehringer Ingelheim and Canadian Institutes of Health Research.
Published: 2018

42. Research for Actionable Policies: implementation science priorities to scale up non–communicable disease interventions in Kenya

Author: Onyango Sangoro, Julius Mwangi, Evans Amukoye, Dorcas Kiptui, Daniel Mwai, Walter Mwanda, Alfred Karagu, Jonathan J. Dick, Lydia Kaduka, David Wata, Rose Rao, Joseph Kibachio, James Kayima, Elijah Ogola, Muhammad Jami Husain, Naftali Busakhala, Abigail Chakava, Mary Amuyunzu–nyamongo, Gerald Yonga, Gladwell Gathecha, Gisela Abbam, Zachary Muriuki, Saras Rosin, Pamela Williams, Deborah Olwal–modi, Robai Gakunga, Breda Munoz-Hernandez, Esther Munyoro, Patrick Edwards, Daniel von Rège, Anne Korir, Sujha Subramanian, Nkatha Meme, Sonja Hoover, Carol Olale, James Njoroge, and Rainer Hilscher
Subjects: business.industry, Health Policy, Public Health, Environmental and Occupational Health, Psychological intervention, Non-communicable disease, medicine.disease, News 4: Meeting Report, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Environmental health, Medicine, 030212 general & internal medicine, business
Published: 2017

43. Corrigendum to 'Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design' [212 (2019) 36–44]

Author: Ambuj Roy, Kamilu M. Karaye, Hisham Dokainish, Gerald Yonga, Salim Yusuf, Albertino Damasceno, Antonio L. Dans, Charles Mondo, Ivve investigators, Yan Liang, Mark Loeb, Jun Zhu, Lia M. Palileo-Villanueva, Wael Almahmeed, Arif Al Mulla, Fastone Goma, and Khalid F. AlHabib
Subjects: Adult, Male, medicine.medical_specialty, Time Factors, Adolescent, Influenza vaccine, MEDLINE, Global Health, Risk Assessment, Article, law.invention, Young Adult, Randomized controlled trial, law, Risk Factors, Internal medicine, Cause of Death, Influenza, Human, medicine, Humans, In patient, Aged, Heart Failure, business.industry, Incidence, Middle Aged, medicine.disease, Survival Rate, Influenza Vaccines, Heart failure, Female, Cardiology and Cardiovascular Medicine, business, Follow-Up Studies
Abstract: Influenza is associated with an increase in the risk of cardiac and other vascular events. Observational data and small randomized trials suggest that influenza vaccination may reduce such adverse vascular events.In a randomized controlled trial patients with heart failure are randomized to receive either inactivated influenza vaccine or placebo annually for 3 years. Patients aged ≥18 years with a clinical diagnosis of heart failure and NYHA functional class II, III and IV are eligible. Five thousand patients from 10 countries where influenza vaccination is not common (Asia, the Middle East, and Africa) have been enrolled. The primary outcome is a composite of the following: cardiovascular death, non-fatal myocardial infarction, non-fatal stroke and hospitalizations for heart failure using standardized criteria. Analyses will be based on comparing event rates between influenza vaccine and control groups and will include time to event, rate comparisons using Poisson methods, and logistic regression. The analysis will be conducted by intention to treat i.e. patients will be analyzed in the group in which they were assigned. Multivariable secondary analyses to assess whether variables such as age, sex, seasonality modify the benefits of vaccination are also planned for the primary outcome.This is the largest randomized trial to test if influenza vaccine compared to control reduces adverse vascular events in high risk individuals.Clinicaltrials.govNCT02762851.
Published: 2020

44. Healthy Heart Africa—Kenya: A 12-Month Prospective Evaluation of Program Impact on Health Care Providers’ Knowledge and Treatment of Hypertension

Author: Francis Okello, Elijah Ogola, Gerald Yonga, Ashling Mulvaney, Jane L. Herr, and Elizabeth Macgregor-Skinner
Subjects: Adult, Program evaluation, medicine.medical_specialty, Time Factors, Epidemiology, Service delivery framework, Health Personnel, MEDLINE, Blood Pressure, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Surveys and Questionnaires, Intervention (counseling), Health care, Humans, Medicine, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Health Education, Antihypertensive Agents, Quality of Health Care, Community and Home Care, business.industry, Kenya, Stratified sampling, Family medicine, Hypertension, Female, Morbidity, Cardiology and Cardiovascular Medicine, business, Follow-Up Studies, Program Evaluation, Patient education
Abstract: Background: Given the rising burden of hypertension in Africa, the Healthy Heart Africa program was developed to improve access to quality hypertension care in the primary care setting. The Healthy Heart Africa program provides a comprehensive, coordinated intervention directed at health care providers (HCPs) and the general public. Objective: The impact of Healthy Heart Africa on HCPs’ knowledge of hypertension and facility-level services in Kenya was evaluated by a 12-month prospective study. Methods: Intervention facilities were selected by stratified random sampling and matched to similar control facilities. Intervention facilities received a hypertension treatment protocol, equipment, training and patient education materials, and improved medical supply chain, whereas control facilities did not. HCPs responsible for hypertension care were surveyed at baseline and 12 months later. Hypertension screening and treatment data were abstracted from service delivery registers. A differences-in-differences analysis estimated the impact of Healthy Heart Africa on HCPs’ knowledge, hypertension services, and the number of patients diagnosed with and seeking treatment for hypertension. Results: Sixty-six intervention and 66 control facilities were surveyed. Healthy Heart Africa improved HCPs’ knowledge of ≥5 hypertension risk factors and ≥5 methods for reducing/managing hypertension but not hypertension consequences. At end line, more intervention than control facilities measured blood pressure more than once during the same visit to diagnose hypertension, dedicated days to hypertension care, used posters to increase hypertension awareness, and provided access to hypertension medications. The number of patients diagnosed with hypertension and those seeking treatment for hypertension increased with intervention, but the change was not significant relative to control subjects. Conclusions: HCP-directed hypertension education and provision of basic resources positively influenced hypertension care in Kenya in the first 12 months of implementation. Highlights The increasing prevalence of HTN in Africa is a growing concern. HHA is an HTN intervention directed at providers and the public. HHA aims to raise HTN awareness and care through public-private collaboration. HHA had a positive effect on providers’ knowledge of HTN. Provider-directed education and access to basic services may improve HTN care.
Published: 2019
Full Text: View/download PDF

45. Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry

Author: Neshaad Schrueder, Bekele Alemayehu, Gad Cotter, Charles Kouam Kouam, Fikru Maru, Ahmed Suliman, Beth A. Davison, Mahmoud U Sani, Dike B. Ojji, Charles Mondo, O.S. Ogah, Christopher L. Edwards, Anastase Dzudie, Gerald Yonga, Bongani M. Mayosi, Karen Sliwa, Sergine Abdou Ba, and Albertino Damasceno
Subjects: Lung Diseases, Male, medicine.medical_specialty, Orthopnea, Anemia, Population, Peripheral edema, Neoplasms, Internal medicine, Heart rate, Humans, Medicine, Intensive care medicine, education, Africa South of the Sahara, Heart Failure, education.field_of_study, Ejection fraction, business.industry, Arrhythmias, Cardiac, Stroke Volume, Middle Aged, Prognosis, medicine.disease, Hospitalization, Blood pressure, Heart failure, Acute Disease, Hypertension, Female, Kidney Diseases, medicine.symptom, Epidemiologic Methods, Cardiology and Cardiovascular Medicine, business
Abstract: Aims Contrary to elderly patients with ischaemic-related acute heart failure (AHF) typically enrolled in North American and European registries, patients enrolled in the sub-Saharan Africa Survey of Heart Failure (THESUS-HF) were middle-aged with AHF due primarily to non-ischaemic causes. We sought to describe factors prognostic of re-admission and death in this developing population. Methods and results Prognostic models were developed from data collected on 1006 patients enrolled in THESUS-HF, a prospective registry of AHF patients in 12 hospitals in nine sub-Saharan African countries, mostly in Nigeria, Uganda, and South Africa. The main predictors of 60-day re-admission or death in a model excluding the geographic region were a history of malignancy and severe lung disease, admission systolic blood pressure, heart rate and signs of congestion (rales), kidney function (BUN), and echocardiographic ejection fraction. In a model including region, the Southern region had a higher risk. Age and admission sodium levels were not prognostic. Predictors of 180-day mortality included malignancy, severe lung disease, smoking history, systolic blood pressure, heart rate, and symptoms and signs of congestion (orthopnoea, peripheral oedema and rales) at admission, kidney dysfunction (BUN), anaemia, and HIV positivity. Discrimination was low for all models, similar to models for European and North American patients, suggesting that the main factors contributing to adverse outcomes are still unknown. Conclusion Despite the differences in age and disease characteristics, the main predictors for 6 months mortality and combined 60 days re-admission and death are largely similar in sub-Saharan Africa as in the rest of the world, with some exceptions such as the association of the HIV status with mortality.
Published: 2013
Full Text: View/download PDF

46. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi : cardiovascular topics

Author: Harun Otieno, Ashna Jinah, Gerald Yonga, Abednego Moriasi, Sitna Mwanzi, and J. Shavadia
Subjects: medicine.medical_specialty, Digoxin, business.industry, Retrospective cohort study, Atrial fibrillation, General Medicine, medicine.disease, Comorbidity, Heart failure, Internal medicine, Epidemiology, medicine, Cardiology, Palpitations, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Atrial flutter, medicine.drug
Abstract: Introduction : Scant data exist on the epidemiology and clinical characteristics of atrial fibrillation in Kenya. Traditionally, atrial fibrillation (AF) in sub-Saharan Africa is as a result of rheumatic valve disease. However, with the economic transition in sub-Saharan Africa, risk factors and associated complications of this arrhythmia are likely to change. Methods : A retrospective observational survey was carried out between January 2008 and December 2010. Patients with a discharge diagnosis of either atrial fibrillation or flutter were included for analysis. The data-collection tool included clinical presentation, risk factors and management strategy. Follow-up data were obtained from the patients' medical records six months after the index presentation. Results : One hundred and sixty-two patients were recruited (mean age 67 ± 17 years, males 56%). The distribution was paroxysmal (40%), persistent (20%) and permanent AF (40%). Associated co-morbidities included hypertension (68%), heart failure (38%) diabetes mellitus (33%) and valvular abnormalities (12%). One-third presented with palpitations, dizziness or syncope and 15% with a thromboembolic complication as the index AF presentation. Rate-control strategies were administered to 78% of the patients, with beta-blockers and digoxin more commonly prescribed. Seventy-seven per cent had a CHA2DS2VASC score ≥ 2, but one-quarter did not receive any form of oral anticoagulation. At the six-month follow up, 6% had died and 12% had been re-admitted at least once. Of the high-stroke risk patients on anticoagulation, just over one-half were adequately anticoagulated. Conclusion : Hypertension and diabetes mellitus, not rheumatic valve disease were the more common co-morbidities. Stroke risk stratification and prevention needs to be emphasised and appropriately managed.
Published: 2013
Full Text: View/download PDF

47. Echocardiographic predictors of outcome in acute heart failure patients in sub-saharan africa: insights from THESUS-HF

Author: Ahmed Suliman, Charles Mondo, Bekele Alemayehu, Karen Sliwa, Charles Kouam Kouam, Fikru Maru, Okechukwu S Ogah, Bongani M. Mayosi, Christopher L. Edwards, Mahmoud U Sani, Gad Cotter, Sergine Abdou Ba, Beth A. Davison, Dike B. Ojji, Anastase Dzudie, Gerald Yonga, and Albertino Damasceno
Subjects: Male, medicine.medical_specialty, acute heart failure, Heart Ventricles, Diastole, 030204 cardiovascular system & hematology, Ventricular Function, Left, predictors, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Internal medicine, Heart rate, medicine, Humans, echocardiography, Prospective Studies, 030212 general & internal medicine, Africa South of the Sahara, Heart Failure, business.industry, Incidence, Cardiovascular Topics, Mortality rate, valvular heart disease, Stroke Volume, General Medicine, Stroke volume, Middle Aged, Prognosis, medicine.disease, Survival Rate, Stenosis, Predictive value of tests, Heart failure, Acute Disease, Cardiology, outcome, Female, Cardiology and Cardiovascular Medicine, business, Follow-Up Studies
Abstract: Summary Background: The role of echocardiography in the risk stratification of acute heart failure (HF) is unknown. Some small studies and retrospective analyses have found little change in echocardiographic variables during admission for acute HF and some echocardiographic parameters were not found to be associated with outcomes. It is unknown which echocardiographic variables will predict outcomes in sub-Saharan African patients admitted with acute HF. Using echocardiograms, this study aimed to determine the predictors of death and re-admissions within 60 days and deaths up to 180 days in patients with acute heart failure. Methods: Out of the 1 006 patients in the THESUS-HF registry, 954 had had an echocardiogram performed within a few weeks of admission. Echocardiographic measurements were performed according to the American Society of Echocardiography guidelines. We examined the associations between each echocardiographic predictor and outcome using regression models. Results: Heart rate and left atrial size predicted death within 60 days or re-admission. Heart rate, left ventricular posterior wall thickness in diastole (PWTd), and presence of aortic stenosis were associated with the risk of death within 180 days. PTWd added to clinical variables in predicting 180-day mortality rates. Conclusions: Echocardiographic variables, especially those of left ventricular size and function, were not found to have additional predictive value in patients admitted for acute HF. Left atrial size, aortic stenosis, heart rate and measures of hypertrophy (LV PWTd) had some predictive value, suggesting the importance of early treatment of hypertension and severe valvular heart disease.
Published: 2017

48. Health effects of overweight and obesity in 195 countries over 25 years

Author: Yun Jin Kim, Kalkidan Hassen Abate, Hirbos Shore Roba, Rafael Lozano, Lalit Dandona, Xiaofeng Liang, Azeem Majeed, Stephen M. Amrock, Yousef Khader, Derrick A Bennett, Theo Vos, Stephen T. McGarvey, Carla Makhlouf Obermeyer, Johan Ärnlöv, Liliana G Ciobanu, Diego Augusto Santos Silva, Rajaa Al-Raddadi, Tommi Vasankari, Tsegaye Tewelde Gebrehiwot, Samath D Dharmaratne, Sibhatu Biadgilign, Azmeraw T. Amare, Erkin M. Mirrakhimov, Rakhi Dandona, Philimon Gona, Jonathan I. Silverberg, Andre Pascal Kengne, Amir Kasaeian, Sadaf G. Sepanlou, Colm McAlinden, Stefanos Tyrovolas, Ivy Shiue, Saverio Stranges, Moretza Shamsizadeh, Kelly Cercy, Nima Hafezi-Nejad, Alireza Esteghamati, Patrick Liu, Maziar Moradi-Lakeh, Zerihun Menlkalew Zenebe, Saeid Safiri, Marissa B Reitsma, Abdullah Sulieman Terkawi, Jean Jacques Noubiap, Mall Leinsalu, Mohammad H. Forouzanfar, Jarnail Singh Thakur, Kingsley N. Ukwaja, Ismael R. Campos-Nonato, Barthelemy Kuate Defo, Rajesh Kumar Rai, Ala'a Alkerwi, Nikolas Reinig, Joshua Wesana, Christopher J L Murray, Benn Sartorius, Adeladza Kofi Amegah, Alan D. Lopez, João C. Fernandes, Elisabete Weiderpass, Kokeb T. Hadush, Aleksandra Barac, Amitava Banerjee, Juan Sanabria, Leslie Cornaby, Ritul Kamal, Felix Akpojene Ogbo, Joseph Salama, Yuichiro Yano, Gerald Yonga, Maria Inês Schmidt, Simon I. Hay, Solomon Abrha Damtew, Deborah Carvalho Malta, Haftay Berhane Mezgebe, Addisu Shunu Beyene, Gert B. M. Mensink, Audra L Gold, Dube Jara Boneya, George C Patton, Mayowa O. Owolabi, Mohsen Naghavi, Estifanos Baye, Chhabi Lal Ranabhat, Laurie B. Marczak, Patrick J Sur, Zoubida Zaidi, Stein Emil Vollset, Andrea Werdecker, Olalekan A. Uthman, Reza Malekzadeh, Kara Estep, Alexander Lee, Jasvinder A. Singh, Masako Horino, Chandrasekharan Nair Kesavachandran, Cristiana Abbafati, Vasiliy Victorovich Vlassov, Balewgizie Sileshi Tegegne, Ulrich O Mueller, Min Jeong Shin, Farhad Islami, Ben Zipkin, Srinivasa Vittal Katikireddi, Ali H. Mokdad, Soumya Swaminathan, Monika Sawhney, Mostafa Qorbani, Marcello Tonelli, Juan Jesus Carrero, Jagdish Khubchandani, Pedro Cecilio, Valery L. Feigin, Thomas Fürst, Bruce Bartholow Duncan, Joshua A. Salomon, Mohsen Mazidi, Tiffany Ku, Ziad Al-Aly, Alemayehu Amberbir, Itamar S. Santos, Soewarta Kosen, Atsushi Goto, Ronny Westerman, Anwar Rafay, Desalegn Tadese Mengistu, Stephen S Lim, Espen Bjertness, Tesfa Dejenie Habtewold, Muktar Beshir Ahmed, Naohiro Yonemoto, Hamid Asayesh, Young-Ho Khang, Rafael Tabarés-Seisdedos, Ashkan Afshin, Heidi J. Larson, Farshad Pourmalek, Sara Sheikhbahaei, Josef Schmidhuber, Yohannes Kinfu, Roman Topor-Madry, Babak Eshrati, Aletta E. Schutte, Rahman Shiri, Masoud Vaezghasemi, Ranjit Mohan Anjana, Erfan Amini, Stan Biryukov, Fentaw Tadese, George A. Mensah, Anil Kumar, Daniel Kim, Bemnet Amare Tedla, Afshin, Ashkan, Forouzanfar, Mohammad H, Reitsma, Marissa B, Sur, Patrick, Ciobanu, Liliana G, Murray, Christopher JL, and Veritati - Repositório Institucional da Universidade Católica Portuguesa
Subjects: Male, Gerontology, Pediatric Obesity, obesity, VDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803, global health, Disease, Overweight, Global Health, VDP::Social science: 200::Demography: 300, DISEASE, VDP::Medical disciplines: 700::Health sciences: 800::Nutrition: 811, Body Mass Index, 0302 clinical medicine, RA0421, Pandemic, Prevalence, adults, Global health, 030212 general & internal medicine, Child, humans, ALL-CAUSE MORTALITY, child, adult, 1. No poverty, pediatric obesity/epidemiology, 11 Medical And Health Sciences, General Medicine, CANCER, 3. Good health, female, VDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803, Cardiovascular Diseases, Cohort, Female, medicine.symptom, Life Sciences & Biomedicine, obesitat, Research Article, Adult, prevalence, overweight/complications/epidemiology, WEIGHT-LOSS, 030209 endocrinology & metabolism, KNEE OSTEOARTHRITIS, VDP::Samfunnsvitenskap: 200::Demografi: 300, VDP::Medisinske Fag: 700::Helsefag: 800::Ernæring: 811, 03 medical and health sciences, cardiovascular diseases/complications/mortality, Medicine, General & Internal, children, male, General & Internal Medicine, Environmental health, medicine, Humans, overweight, COHORT, Obesity, Disease burden, METAANALYSIS, Science & Technology, GBD 2015 Obesity Collaborators, business.industry, ADULTS, medicine.disease, PREVENTION, BODY-MASS INDEX, Cross-Sectional Studies, business, Body mass index, obesity/complications/*epidemiology
Abstract: Source at: http://doi.org/10.1056/NEJMoa1614362 Background: Although the rising pandemic of obesity has received major attention in many countries, the effects of this attention on trends and the disease burden of obesity remain uncertain. Methods: We analyzed data from 68.5 million persons to assess the trends in the prevalence of overweight and obesity among children and adults between 1980 and 2015. Using the Global Burden of Disease study data and methods, we also quantified the burden of disease related to high body-mass index (BMI), according to age, sex, cause, and BMI in 195 countries between 1990 and 2015. Restults: In 2015, a total of 107.7 million children and 603.7 million adults were obese. Since 1980, the prevalence of obesity has doubled in more than 70 countries and has continuously increased in most other countries. Although the prevalence of obesity among children has been lower than that among adults, the rate of increase in childhood obesity in many countries has been greater than the rate of increase in adult obesity. High BMI accounted for 4.0 million deaths globally, nearly 40% of which occurred in persons who were not obese. More than two thirds of deaths related to high BMI were due to cardiovascular disease. The disease burden related to high BMI has increased since 1990; however, the rate of this increase has been attenuated owing to decreases in underlying rates of death from cardiovascular disease. Conclusions: The rapid increase in the prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence-based interventions to address this problem.
Published: 2017

49. Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry

Author: Bekele Alemayehu, Dike B. Ojji, Bongani M. Mayosi, Fikru Maru, Ahmed Suliman, Serigne Abdou Ba, Christopher L. Edwards, Karen Sliwa, Charles Kouam Kouam, Albertino Damasceno, Anastase Dzudie, Gerald Yonga, Mahmoud U Sani, Gad Cotter, Beth A. Davison, Okechukwu S Ogah, and Charles Mondo
Subjects: Male, sub-Saharan Africa, medicine.medical_specialty, Time Factors, Heart disease, Diastole, Heart Valve Diseases, Black People, heart failure, 030204 cardiovascular system & hematology, Patient Readmission, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Cause of Death, Atrial Fibrillation, medicine, Prevalence, Humans, 030212 general & internal medicine, Prospective Studies, Registries, Prospective cohort study, Africa South of the Sahara, Cause of death, Aged, business.industry, Cardiovascular Topics, valvular heart disease, Rheumatic Heart Disease, Atrial fibrillation, General Medicine, Middle Aged, medicine.disease, Prognosis, Blood pressure, Heart failure, Acute Disease, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, valvular
Abstract: Introduction: Rheumatic heart disease (RHD) is the commonest cause of valvular heart disease and a common cause of heart failure in sub-Saharan Africa (SSA). Atrial fibrillation (AF) complicates RHD, precipitates and worsens heart failure and cause unfavourable outcomes. We set out to describe the prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure (AHF). Methods: The sub-Saharan Africa Survey of Heart Failure (THESUS-HF) was a prospective, observational survey of AHF in nine countries. We collected demographic data, medical history and signs and symptoms of HF. Electrocardiograms (ECGs) were done in a standard fashion. AF was defined as either a history of AF or AF on the admission ECG. Using Cox regression models, we examined the associations of AF with all-cause death over 180 days and a composite endpoint of all-cause death or readmission over 60 days. Results: There were 1 006 patients in the registry. The mean age was 52.3 years and 50.8% were women. AF was present in 209 (20.8%) cases. Those with AF were older (57.1 vs 51.1 years), more likely to be female (57.4 vs 49.1%), had significantly lower systolic (125 vs 132 mmHg) and diastolic (81 vs 85 mmHg) blood pressure (BP), and higher heart rates (109 vs 102 bpm). Ninety-two (44%) AF patients had valvular heart disease. The presence of AF was not associated with the primary endpoints, but having valvular AF predicted death within 180 days. Conclusion: AF was present in one-fifth of African patients with AHF. Almost half of the AF patients had valvular disease (RHD) and were significantly younger and at risk of dying within six months. It is important to identify these high-risk patients and prioritise their management, especially in SSA where resources are limited.
Published: 2016

50. Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)

Author: Dike B. Ojji, Charles Kouam Kouam, Bongani M. Mayosi, Karen Sliwa, Serigne Abdou Ba, Christopher L. Edwards, Olga Milo, Elijah Ogola, Charles Mondo, O.S. Ogah, Gad Cotter, Anastase Dzudie, Gerald Yonga, Beth A. Davison, Albertino Damasceno, and Mahmoud U Sani
Subjects: Adult, medicine.medical_specialty, Vasodilator Agents, Black People, 030204 cardiovascular system & hematology, Isosorbide Dinitrate, Placebo, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Africa South of the Sahara, Aged, Heart Failure, Nitrates, business.industry, Hazard ratio, Acute heart failure, Hydralazine, Middle Aged, medicine.disease, Surgery, Blood pressure, Heart failure, Africa, Acute Disease, Isosorbide dinitrate, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract: Aims Patients with acute heart failure in Africa are rarely being treated with a hydralazine/nitrates combination. Therefore the effect of this treatment was studied here Methods and results The study was planned to enrol 500 patients during an acute heart failure (HF) admission, from nine sub-Saharan African countries. Patients were randomized in a double-blind manner to receive 50 mg hydralazine/20 mg isosorbide dinitrate (HYIS) t.i.d. or matching placebo for 24 weeks followed by open label HYIS for all patients. The study was terminated after 147 patients were enrolled due mostly to issues with recruitment into a prospective, placebo-controlled study. Most patients were recruited from Mozambique, South Africa, Kenya, and Uganda. The primary endpoint of death or HF readmission through 24 weeks was neutral [hazard ratio (HR) 1.05, 95% confidence interval (CI) 0.48–2.27, P = 0.90] in the 133 randomized patients included in the analyses. There were non-signficant effects in favour of HYIS in secondary endpoints including change in dyspnoea severity at day 7 or discharge, decrease in systolic blood pressure, greater decrease in weight, and increase in 6-min walk test distance at week 24. There were also small changes in echocardiographic indices of cardiac size and function in favour or HYIS, but none was significant. Conclusion The BA-HEF trial demonstrated challenges in recruiting the expected number of patients with acute HF in a number of African countries, which highlights the need for strategic logistic support. Trial registration: NCT01822808.
Published: 2016

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

73 results on '"Gerald Yonga"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources